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1 Introduction
1.1 Marine organisms as a source of new and biologically active metabolites
The marine environment comprises 71 % of the earth’s surface, and consists of extreme
and contrasting habitats, ranging from tropical reefs to ice-shelfs of the polar seas, and
to black smokers in the deep sea. The biodiversity in the worlds oceans is immense,
e.g., of 33 known animal phyla 15 are exclusively marine, and 32 of them have marine
representatives (Norse, 1995). Some habitats are known to be particularly numerous in
species, e.g., tropical marine reefs, which represent one of the most diverse ecosystems
encountered on earth, comparable in diversity to tropical rain forests.
Nearly all forms of marine life have attracted the attention of natural products
chemists, with reports about secondary metabolites from sponges dominating by
number (de Vries & Hall, 1994). Marine natural products are distinguished by a great
chemical diversity. Metabolites from nearly all groups of natural products have been
discovered. Halogenated compounds are particularly numerous due to the natural
abundance of chlorine, bromine and to a lesser extent iodine in sea water (Gribble,
1996). The annual reviews on marine natural products by Faulkner (1998, and
previous reviews), and the database MARIN LIT (Blunt & Munro, 1999) provide an
overview of the impressive variety of the compounds encountered.
Some of these compounds clearly serve an ecological purpose. A laboratory feeding
assay with organic sponge extracts for example revealed that 69 % of 71 Caribbean
Demosponges contained metabolites which deterred feeding by the wrasse Thalassoma
bifasciatum (Pawlik et al., 1995). Natural products are also involved in the
competition for the limited space on coral reefs. The red alga Plocamium hamatum for
example could be shown to induce necrosis in the soft coral Sinularia cruciata on
direct contact, with the algal metabolite chloromertensene being largely responsible for
the observed effect (de Nys, Coll & Price, 1991).
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1.2 Metabolites with prominent pharmacological activities - example
halichondrin B
The reported metabolites from marine organisms are not only interesting from an
ecological or chemical point of view. Some of them have been shown to possess
prominent biological (pharmacological) activities, e.g., bryostatins (Schaufelberger
et al., 1991), didemnins (Rinehart et al., 1988), ecteinascidins (Rinehart et al., 1990).
These findings, and the fact that some of these metabolites belong to unique structural
types brought them into the focus of the pharmaceutical industry. A small number of
compounds are currently being evaluated in clinical trials, many of them as antitumor
agents (see current reviews, e.g., K|nig & Wright, 1998). The supply of sufficient
amounts of compounds for pharmaceutical development is often problematic. This
issue will be discussed using the example of halichondrin B, an antineoplastic
compound currently in preclinical evaluation.
Halichondrin B was first isolated from the sponge Halichondria okadai as the most
potent member of a series of related antitumor compounds (Uemura et al., 1985).
Later on, it was also reported from other sponge species including Phakellia carteri
(Pettit et al., 1993), and Lissodendoryx sp. (Litaudon et al., 1994). The absolute
stereochemistry was deduced from comparisons with the related compound,
norhalichondrin A, the structure of which had been established by X-ray
crystallographic analysis of its p-bromophenacyl ester (Hirata & Uemura, 1986).
Halichondrin B showed in vitro cytotoxicity against B-16 melanoma cells with an IC50
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of 0.093 ng/mL, and also significant in vivo activity against B-16, P-388 and L-1210
tumours in mice (Hirata & Uemura, 1986). Mechanism of action studies at the NCI
revealed it to bind to the vinca domain of tubulin, and to arrest cells in mitosis (Bai
et al., 1991). In the same study, it could be shown to inhibit the in vitro polymerisation
of purified tubulin, and the microtubule assembly. Such mechanism of action studies,
and even more in vivo experiments and future clinical trials, depend on sufficient
supply of this very complex natural product. Its natural content in sponges ranges from
10-5 - 10-6 %. Mass collection of biomass is thus not very effective, if ever applicable,
and may have massive ecological impacts, even leading to the extinction of a
population or species. A total synthesis of halichondrin B has been reported (Aicher et
al., 1992), but probably involves too many steps for being an economically valid
alternative. Thus, to obtain further amounts of halichondrin B for clinical trials a large-
scale culture of the macroorganism, i.e. the sponge Lissodendoryx sp., has been
established (Munro, 1998). This is the first example of mass cultivation of sponge
species for pharmaceutical purposes.
A further possibility to obtain sufficient amounts of a selected compound vividly
discussed in the scientific community is the discovery of a microorganism producing
the desired metabolite. Microorganisms are in some cases suspected to be the true
biosynthetic producers of metabolites isolated from marine macroorganisms. This is
especially likely, if the compound in question has been obtained from various
macroorganisms not closely related taxonomically, and if the compound belongs to a
structural type already known from microorganisms. Although halichondrin B has been
found in several sponge species from different origins, and its structure resembles that
of polyethers known from dinoflagelates, to date there is no direct evidence for the
contribution of microorganism to its biosynthesis (Munro, 1998).
1.3 Marine microorganisms
The example of halichondrin B demonstrates that some marine natural products have
such complex structures, that the only reasonable supply is their isolation from the
producing organism. Organisms that could easily be cultured in large amounts would
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thus be ideal. Such organisms might be marine microorganisms. The fact that some
marine microorganisms are easily cultured and that they had long been neglected by
many marine natural product chemists, has led to an increased research effort in this
area during the last 10 years. Research is focusing mainly on marine bacteria, fungi and
microalgae as reflected by the number of natural products described from each group
of organisms (Faulkner, 1998; Blunt & Munro, 1999).
1.3.1 Marine fungi
The current project focused on marine fungi. Although the occurrence of fungi in the
sea has been known since the middle of the 18th century (see, e.g., Kohlmeyer &
Kohlmeyer, 1979), they received broader interest only during the last six decades. The
work of Barghoorn & Linder (1944) provided the first key to marine fungi and
stimulated further research in this area. Other important milestones in marine mycology
include the publications "Marine Mycology: The higher Fungi" (Kohlmeyer &
Kohlmeyer, 1979), a comprehensive book dealing with virtually all aspects of marine
mycology, and "Illustrated key to the filamentous higher marine fungi" (Kohlmeyer &
Volkmann-Kohlmeyer, 1991).
Fungi growing in the sea can be grouped into obligate and facultative marine fungi.
According to a definition made by Kohlmeyer (1974), "obligate marine fungi are those
that grow and sporulate exclusively in a marine or estuarine (brackish water) habitat;
facultative marine are fungi from freshwater or terrestrial areas able to grow also in the
natural marine environment". In 1991 Kohlmeyer & Volkmann-Kohlmeyer listed 321
filamentous higher marine fungi. Their key included 255 Ascomycetes, 60 mitosporic
fungi, and only six Basidiomycetes. Since then, numerous new marine fungi have been
described every year. The direct isolation method is most commonly applied
(Kohlmeyer & Kohlmeyer, 1979; Hyde, Farrant & Jones, 1987). It includes collection
and direct examination of marine substrates under a dissecting microscope for fungi,
e.g., visible in the form of ascomata, and the isolation and inoculation of single fungal
spores thereof. This procedure allows to show that the fungus isolated was active in
the marine environment, and therefore is either an obligate or facultative marine
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fungus. In this respect it is important to note that to date there is no other way to
prove that an isolated fungal strain is marine other than to observe in vivo its ability to
grow in the marine environment.
Among the classical substrates for the isolation of marine fungi are marine algae. Apart
from lichens, algae-inhabiting fungi consist of parasitic and saprobic species
(Kohlmeyer & Kohlmeyer, 1979). Most strains were obtained by direct isolation
methods.
While algae have long been known for the occurrence of specifically adapted marine
fungi (Kohlmeyer & Kohlmeyer, 1979), sponges as a source of fungi only recently
came into focus. In contrast to symbiotic bacteria and cyanobacteria (e.g., Vacelet,
1975; Bergquist, 1978; Rai, 1990), some of which seem to play an important role in
the production of biologically active secondary metabolites found in the host animals
(Elyakov et al., 1991; Unson, Holland & Faulkner, 1994), the occurrence of fungi in
sponges is less well documented. Siepmann & Höhnk (1962) isolated yeasts and two
Fusarium spp. from the tissue of sponges from the North Atlantic and discussed the
possible ecological role of yeasts as producers of vitamins for their host organisms.
Höhnk & Ulken (1979) isolated Phycomycetes and members of seven genera of
mitosporic fungi from the liquid of squeezed tissue of sponges from the Mediterranean.
The relationship between host sponges and fungi is still unknown; only marine
Ascomycetes of the genus Koralionastes have been reported to be in some way
associated with crustaceous sponges (Kohlmeyer & Volkmann-Kohlmeyer, 1990).
As sponges are filter-feeding organisms, spores and mycelium fragments of terrestrial
fungi, washed into the sea, are likely to be present in these animals. The presence of
these propagules in the sea water all over the world is well established, and they are
known to be able to germinate and grow under laboratory conditions (e.g., Roth,
Orpurt & Ahearn, 1964; Schaumann, 1974; Miller & Whitney, 1981). Thus, isolates
obtained from sponges may represent such terrestrial strains, which is also suggested
by the taxonomy of the fungal strains in question, e.g. Aspergillus niger and
Trichoderma harzianum (cf. 1.3.3, Table 2).
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1.3.2 Secondary metabolites from marine fungi
Marine-derived fungi have been shown to produce interesting and biologically active
metabolites (cf. the reviews of Liberra & Lindequist, 1995; K|nig & Wright, 1996;
Pietra, 1997, Biabani & Laatsch, 1998). This is reflected in the number of literature
records dealing with secondary metabolites from marine fungi, which have significantly
increased over the past five years.
Substrates used for the isolation of marine-derived fungi for chemical investigations are
very diverse. Besides marine sponges (see 1.3.3), predominantly algae (e.g., Chen et
al., 1996; Belofsky et al., 1998; Numata et al., 1993; Takahashi et al., 1994a), crab
shell (e.g., Sugano et al., 1991), fish (e.g., Shigemori et al., 1991), mangroves (e.g.,
Poch & Gloer, 1991), a sea hare (Numata et al., 1997b), a tunicate (Wang, Borgeson
& Crews, 1997), and sediment samples (e.g., Onuki et al., 1998) were used.
Investigations dealing with clearly obligate marine fungi contributed only moderately
to the overall number of records. As the number of obligate marine fungi described to
date is low, especially when compared to a total of about 71,000 fungal species known
(Hawksworth et al., 1995), and many of them are slow-growing and therefore not
convenient for the usually applied chemical and biological screening methods, this is
not overly surprising.
Reports dealing with the isolation of secondary metabolites from obligate marine fungi
are summarised in Table 1. Thus far, this list includes less than 5 % of the known
species of higher filamentous marine fungi. Many of the reported metabolites are
similar to, and some even identical with compounds previously obtained from
terrestrial fungi. For example, the antibiotic siccayne isolated from the marine
Basidiomycete Halocyphina villosa (Kupka et al., 1981) was already known to be
produced by the terrestrial mitosporic fungus Helminthosporium siccans (Ishibashi
et al., 1968), and isolculmorin isolated from the marine Ascomycete Kallichroma
tethys (Alam et al., 1996) belongs to a series of similar culmorins, known for example
from the terrestrial mitosporic fungus Fusarium culmorum (Barton & Werstiuk,
1967). The low percentage of species and genera of obligate marine fungi chemically
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investigated to date makes it, however, impossible to oversee the biosynthetic potential
of this group of fungi.
Table 1: Reports on secondary metabolites from higher filamentous obligate
marine fungi.
Fungus investigated Literature citation
a) Ascomycetes
Corollospora maritima Liberra, Jansen & Lindequist (1998)
C. pulchella Furuya et al. (1985)
Alvi, Casey & Nair (1998)
Helicascus kanaloanus Poch & Gloer (1989a)
Hypoxylon oceanicum Schlingmann et al. (1998)
Kallichroma tethys Alam et al. (1996)
Leptosphaeria sp. Takahashi et al. (1994a and b, 1995)
L. obiones Poch & Gloer (1989b)
L. oraemaris Schiehser et al. (1986)
Miller & Savard (1989)
Guerriero et al. (1991)
Lignincola laevis Abraham et al. (1994)
Zopfiella marina Kondo et al. (1987)
b) Basidiomycetes
Halocyphina villosa Kupka et al. (1981)
c) Mitosporic fungi
Asteromyces cruciatus Shin & Fenical (1987)
Cirrenalia pygmea Ravishankar et al. (1995)
Dendryphiella salina Guerriero et al. (1988, 1989, 1990)
Additionally, many genera of obligate marine fungi have thus far not been investigated
at all. The order Spathulosporales for example consists of algae-inhabiting species that
are believed to have evolved exclusively in the sea (Kohlmeyer, 1986), in contrast to
many other obligate marine fungi, e.g., members of the order Halosphaeriales, which
probably have re-migrated to the oceans from the land (Spatafora, Volkmann-
Kohlmeyer & Kohlmeyer, 1998). These fungi may have evolved a distinct secondary
metabolism, with structural variations yet to be discovered.
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1.3.3 Secondary metabolites from sponge-derived fungi
Many reports on secondary metabolites from marine-derived fungi deal with fungal
isolates from sponges. The majority of these fungi belongs to genera of mitosporic
fungi typically known from terrestrial habitats, e.g., Aspergillus or Trichoderma.
Biological details, e.g., about the relationship between the isolated strain and its host
sponge or the number and taxonomy of fungi obtained from a particular sponge
species typically are not discussed in the literature reports. Nevertheless, a growing
number of metabolites from sponge-derived fungal strains has been reported in the last
years. Table 2 provides an overview of sponge species investigated, taxonomy of
isolated fungi, and reported metabolites. The structures of these compounds are given
in Figures 1-4. These structures suggest most of the metabolites to be derived from
metabolic pathways common also to terrestrial fungi. Such a similarity is, for example,
obvious for sesquiterpenes of the hirsutane-type (Figures 1 and 4): Two unidentified
sponge-derived fungal strains were found to produce new metabolites of this structural
class, that is chloriolins A-C, hirsutanols A-C, and ent-gloeosteretriol (Cheng et al.,
1994; Wang et al., 1998). One of these isolates additionally yielded coriolin B and
dihydrocoriolin C, previously reported from the terrestrial fungus Coriolus consors
(Cheng et al., 1994). These findings reflect the close phylogenetic relationship between
many marine-derived fungi and their terrestrial counterparts.
If indeed sponge-derived fungi represent a competitive source for new and biologically
active natural products cannot be concluded thus far. The results already published are
promising, but future prospect will rely on the isolation of more specifically adapted
fungal strains producing secondary metabolites clearly distinct from those known from
terrestrial species.
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Table 2. Metabolites reported from sponge-derived fungi.
Sponge species
investigated
Fungus isolated &
investigated
Metabolite(s)
isolated
Literature citation
Micale cecilia Trichoderma
harzianum
Trichoharzin Kobayashi et al.
(1993)
Stylotella sp. unidentified Nectriapyrone A-B Abrell, Cheng &
Crews (1994)
Jaspis aff.
johnstoni
unidentified Chloriolin A-C,
coriolin B,
dihydrocoriolin C
Cheng et al. (1994)
Taxonomy not
given
Microascus
longirostris
Cathestatin A-C Yu et al. (1996a)
Jaspis cf. coriacea Aspergillus
?ochraceus
Chlorocarolide A-
B, R-mellein,
penicillic acid,
hexylitaconic acid
Abrell, Borgeson &
Crews (1996a)
Agelus sp. Microspaeropsis
olivacea
Cerebroside Keusgen et al. (1996)
10-Methyl-(9Z)-
octadecenoic acid,
1-O-(10-methyl-
(9Z)-octadecenoyl)-
glycerol
Yu et al. (1996b)
Mycale adhaerens Exophiala
pisciphila
Exophilin A Doshida et al. (1996)
Spirastrella
vagabunda
unidentified Secocurvularin Abrell, Borgeson &
Crews (1996b)
Hyrtios proteus Aspergillus niger Asperazine Varoglu et al. (1997)
Halichondria
japonica
Gymnascella
dankaliensis
Gymnastatin A-C Numata et al.
(1997a)
Gymnasterone A-B Amagata, Minoura &
Numata (1998b)
Halichondria
okadai
Trichoderma
harzianum
Trichodenone A-C,
harzialactone A-B,
R-mevalonolactone
Amagata et al.
(1998b)
Taxonomy not
given
Aureobasidium
pullulans
cyclo(D-cis-Hyp-L-
Phe), cyclo(D-cis-
Hyp-L-Leu),
orcinotriol
Shigemori et al.
(1998)
Haliclona sp. unidentified Hirsutanol A-C,
ent-gloeosteretriol
Wang et al. (1998)
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Figure 1: Metabolites from sponge-derived fungi I.
Introduction 11
O
O
OH O
O
OOH
HO O
O
HO
O
HO
HO
HO
OH
n-C9H19
H
N
n-C14H29
HO
O
OH
O
RO
O
O
OHO
O
OHO
HO
OH
OH
OH
HO
O
O
O
NH
N
NH
H
N
NH
HN
O
O
O
O H
H
H
H
O
R-Mellein
Penicillic acid
Hexylitaconic acid
N-2’-Hydroxy-(3’E)-octadecenoyl-1-O-β-D-gluco-
pyranosyl-9-methyl-(4E,8E)-sphingadiene
10-Methyl-(9Z)-octadecenoic acid  R = H
1-O-(10-Methyl-(9Z)-octadecenoyl)-glycerol
  R =CH2CH(OH)CH2OH
Exophilin A
14,15-Secocurvularin
Asperazine
Figure 2: Metabolites from sponge-derived fungi II.
Introduction12
N
H
O
O
O
Cl
Cl
OH
N
H
O
O
O
Cl
Cl
O
N
H
O
O
O
Cl
Cl
O
HO
OH
HO
O
OO
HO
HO
HO
Cl
O O
Cl
OH
O
H
OH
O
HO
O
HO
O
Gymnastatin A
Gymnastatin B
Gymnastatin C
Trichodenone A Trichodenone B Trichodenone C
Harzialactone A Harzialactone B R-Mevalonolactone
Figure 3: Metabolites from sponge-derived fungi III.
Introduction 13
N
H
N
OH
O
O
N
H
N
OH
O
O
OH
OHHO
HOH
HN CHO
H
H
HO
H
O
O
O
O
H
O
H
O
R
O
OH
OH
OH
H
HO
HO
HO
H
Orcinotriol
cyclo(D-cis-Hyp-L-Phe)
cyclo(D-cis-Hyp-L-Leu)
Gymnasterone A
Gymnasterone B
Hirsutanol A   R = α-OH
Hirsutanol B   R = β-OH
Hirsutanol C
ent-Gloeosteretriol
Figure 4: Metabolites from sponge-derived fungi IV.
Scope of the present study 14
2 Scope of the present study
The main goal of the present investigation was the isolation of new and preferably
biologically active secondary metabolites from marine organisms, with an emphasis on
marine-derived fungi. Substrates for the isolation of fungi were marine sponges, and to
a lesser degree algae.
The study can be divided into four main parts:
2.1 Isolation of fungi from marine sponges and algae
This part of the work aimed at finding a suitable isolation method for obtaining fungi in
a great taxonomic variety from marine sponges and algae. For subsequent chemical
investigations it was attempted to obtain specifically adapted strains, and to exclude
terrestrial contaminants of chemically well investigated genera. The isolated fungi then
were to be identified taxonomically in order to select promising strains for biological
screening and chemical investigations.
2.2 Biological and chemical screening of fungal extracts
The selected strains had to be small scale cultured in order to obtain amounts of
extracts suitable for the biological tests. These tests mainly consisted of agar diffusion
assays for antibacterial, antifungal and antialgal activity, and ELISA based test systems
for inhibition of tyrosine kinase and HIV-1 reverse transcriptase. They aimed at
estimating the potential of the isolated fungi to produce biologically active metabolites,
and served for the selection of strains for chemical investigations. An additional
investigation by TLC should further characterise the fungal culture extracts in order to
estimate number and amount of contained metabolites.
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2.3 Chemical investigations of selected fungal strains and sponge species
The main purpose of the chemical investigations was to isolate pure and biologically
active metabolites from fungal culture extracts. To achieve this, selected strains had to
be cultured on a large-scale, extracted, and the extracts separated using diverse
chromatographic methods, mainly HPLC. In order to identify biologically active
compounds, a bio-assay guided isolation was attempted. The chemical investigations
were completed by structure elucidation and physical characterisation of the isolated
metabolites.
Additionally, some sponge samples, parts of which had been used for the isolation of
fungal strains, were investigated for their secondary metabolite content.
2.4 Biological evaluation of isolated pure compounds
Natural products may serve as lead structures for new pharmaceuticals. Thus, any pure
compound obtained in this study was evaluated in a diverse set of bio-assays. This
included the same assays as used for the evaluation of the extracts, and additional
specific assays, e.g. for antimalarial activity and cytotoxicity, performed in cooperation
with other research groups, and Industry high-throughput screening (HTS).
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3 Materials and methods
3.1 Animal and plant material
3.1.1 Origin and taxonomy of sponge samples
Marine sponge samples investigated in this study originated from six different
locations, including temperate (Helgoland, Germany and Bear Island, Australia),
subtropical (Malta and Tenerife, Spain) and tropical (Dominica and The Great Barrier
Reef, Australia) regions. All samples were collected by SCUBA divers working at
depths between 3 and 15 m and mainly belonged to the subclasses Tetractinomorpha
and Ceractinomorpha (Demospongiae).
Samples from Helgoland were collected by the scientific dive team of the Biologische
Bundesanstalt Helgoland with support of Dr. C. Schtt, samples from all other
locations were collected by Prof. Dr. G. M. König and Dr. A. D. Wright. The
taxonomical identification of the sponge samples was performed by
Dr. R. Desqueroux-Faundez, Musée d'Histoire Naturelle Genève, (samples from
Australia, Dominica, Malta and Tenerife) and Dr. D. Barthel, Institut für Meereskunde
Universität Kiel (samples from Helgoland).
Samples  from Australia, Dominica and Malta  were frozen after collection and stored
at -18°C, samples from Tenerife were stored in sterile sea water supplied with
250 mg/L benzylpenicillin and streptomycin sulphate at 4°C for one week until
examination, whereas samples from Helgoland were processed immediately after
collection.
a) Samples from Australia:
Biemna sp., (CT 902 U), Pelorus Island, Great Barrier Reef; Callyspongia sp. cf.
C. flammea Desqueyroux-Faundez 1984 (CT 293 K), Bear Island, Sydney;
Leucosolenia challengeri Poleajaeff 1883 (CT 293 T), Kelso Reef (Great Barrier
Reef).
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b) Samples from Dominica (Lauro Club Reef):
Callyspongia vaginalis Lamarck 1814 (CT 193 A); Ectyplasia perox Duch. & Mich.
1864 (CT 193 H) and Neofibularia nolitangere Duch. & Mich. 1864 (CT 193 I).
c) Samples from Germany (Helgoland):
Halichondria panicea Pallas 1766 (H-4); Myxilla incrustans Johnston 1842 (H-5);
Leucosolenia sp., (H-6); Sycon sp., (H-7), and Halichondria panicea Pallas 1766
(H-8); the two samples of H. panicea are from different collection sites.
d) Samples from Malta:
Ircinia oros Schmidt 1864 (CT 912 J), and Ircinia variabilis Schmidt 1862
(CT 912 K).
e) Samples from Spain (Tenerife):
Aplysina aerophoba Schmidt 1862 (CT 195 T); Petrosia ficiformis Poiret 1789
(CT 195 V), and Oscarella lobularis Schmidt 1862 (CT 195 W).
3.1.2 Origin and taxonomy of algal samples
All algal samples were collected by Prof. G. M. König and/or Dr. A. D. Wright in the
intertidal zones of Helgoland and Tenerife. Samples from Tenerife were stored in
sterile sea water supplied with 250 mg/L benzylpenicillin and streptomycin sulphate at
4°C for one week until examination, whereas samples from Helgoland were processed
immediately after collection.
a) Samples from Germany (Helgoland):
Unidentified brown or red alga (H-1); unidentified brown alga (H-2); Plocamium sp.
(H-3).
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b) Samples from Spain (Tenerife):
Cytoseira sp. (CT 195 D); unidentified red alga (CT 195 E); unidentified green or
blue-green alga (CT 195 I); Cytoseira sp. (CT 195 L); Hypnea ?pinnosa (CT 195 M);
unidentified brown alga (CT 195 X); unidentified brown alga (CT 195 Y).
3.2 Isolation of fungal strains
3.2.1 Preparation of animal and plant material
Small pieces of inner tissue of fresh sponge material were rinsed three times with sterile
artificial sea water (ASW); both fresh and frozen sponges were then aseptically cut into
small cubes, approx. (0.5 cm)3. A total of 50 - 75 cubes of each sample was placed on
different isolation media. During the initial investigations, cubes from sponge sample
CT 912 J were placed in EtOH (70 %) for various times between 5 and 30 s and
subsequently squeezed three times in sterile ASW before inoculation.
Algal samples were rinsed three times with sterile sea water. One half of the sample
was then cut aseptically into small pieces (ca. 0.5 cm2) and placed on different isolation
media. The other half was placed in EtOH (70 %) for 30 s (5 s for sample H-1, 5-10 s
for samples from Tenerife), rinsed three times with sterile ASW to remove the EtOH,
aseptically cut into small pieces and placed on different isolation media.
3.2.2 Media and inoculation conditions
Medium I: Biomalt agar (BIO): biomalt 20 g/L, agar 15g/L, ASW 800 mL/L.
Medium II: Malt extract soymeal agar (MS): malt extract 30 g/L, peptone from
soymeal 3 g/L, agar 12 g/L, ASW 800 mL/L, pH adjusted to 5.5 with HCl prior to
sterilisation.
Medium III: Potato carrot agar (KM): cooked and mashed potatoes 20 g/L, cooked
and mashed carrots 20 g/L, agar 20 g/L, ASW 800 mL/L.
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Medium IV: Cellulose agar: cellulose 10 g/L, yeast extract 1 g/L, agar 15 g/L, ASW
800 mL/L.
Medium V: Glucose peptone yeast extract agar (GPY): glucose × H2O 1 g/L, peptone
from soymeal 0.5 g/L, yeast extract 0.1 g/L, agar 15 g/L, ASW 800 mL/L.
Medium VI: Cornmeal agar: 42 g cornmeal was stirred in 500 mL destilled water at
60°C for 12 h, filtered and the filtrate diluted with water to 1 L. To this solution 15 g
agar and the salts contained in 800 mL ASW were added.
Artificial sea water (ASW) contained the following salts (g/L): KBr 0.1, NaCl 23.48,
MgCl2 × 6 H2O 10.61, CaCl2 × 2 H2O 1.47, KCl 0.66, SrCl2 × 6 H2O 0.04, Na2SO4
3.92, NaHCO3 0.19, H3BO3 0.03. All media were supplemented with 250 mg/L
benzylpenicillin and 250 mg/L streptomycin sulphate to prevent bacterial growth. To
some media (see below) 0.5 mg/L cyclosporine A (Sandoz) was added to inhibit fast
growing fungal isolates.
Media for the inoculation of sponge samples were used as follows; samples from
Australia: media I-VI, additionally media II and III without ASW; samples from
Dominica: media V and VI, media IV and V with added cyclosporine A; samples from
Germany: media IV and V, and the same media with cyclosporine A; samples from
Malta: media I-IV, as well as media II and III without ASW, and media IV and V with
cyclosporine A; samples from Spain: media V and VI, and the same media with
cyclosporine A.
Samples were incubated at RT (approx. 20°C) except for those from Helgoland, which
were incubated at 14°C, and regularly examined under a dissection microscope for the
presence of developing fungal hyphae. Fungal colonies were transferred to one or more
of the media for identification. These included media I, II, III, V and VI as above,
standard nutrient agar (SNA): KH2PO4 1 g/L, KNO3 1 g/L, MgSO4 × 7 H2O 0.5 g/L,
KCl 0.5 g/L, glucose × H2O 0.2 g/L, sucrose 0.2 g/L, agar 20 g/L, and starch yeast
extract agar (SYA): soluble starch 15 g/L, yeast extract 4 g/L, ASW 800 mL/L, agar
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20 g/L. Strains which remained sterile were further cultivated using the "balsa broth
shake culture technique" (Hyde, Farrant & Jones, 1987).
Media for the inoculation of algal samples were media I-IV as above for samples from
Helgoland, and media V and VI, and the same media with cyclosporine A for samples
from Tenerife. Samples were inoculated at RT and further treated as described for the
sponge samples.
3.2.3 Identification of fungal strains
Most fungal strains were identified by, or with kind support of, Dr. S. Draeger,
Institute for Microbiology, TU Braunschweig. Strain H5-50 was identified by
Dr. R. A. Samson, Centraalbureau voor Schimmelcultures, Baarn, The Netherlands.
Because of the great number of isolates, in most cases only the genus of the strains was
determined. A species determination was attempted for strains further investigated for
their secondary metabolite chemistry.
3.2.4 Origin and taxonomy of fungal strains investigated for their secondary
metabolite chemistry
Fungal strains investigated chemically were isolated as described above, and are
deposited in the fungal culture collection of both the research group of
Prof. G. M. K|nig and Dr. A. D. Wright, and the Institute for Microbiology,
TU Braunschweig.
Strain H5-65 was isolated from the sponge M. incrustans (Helgoland), and identified
as belonging to the genus Acremonium.
Strain H5-81 was isolated from the sponge M. incrustans (Helgoland), and identified
as Asteromyces cruciatus Moreau et Moreau ex Hennebert 1962.
Strain 193H77 was isolated from the sponge E. perox (Dominica), and identified as
belonging to the genus Coniothyrium. Morphology on SNA agar: Mycelium
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superficial, partly immersed, branched, septate, hyaline. Conidiomata pycnidial,
85 - 125 µm in diameter, globose, brownish black, superficial, unilocular, wall of dark
brown textura angularis. Conidiogenous cells annellidic, ampulliform, 1.7 - 2.6 × 2.2 -
6.0 µm, hyaline. Conidia (1.3) - 1.7 × 2.2 - 3.0 µm, brown, thick-walled, smooth,
aseptate, cylindrical, apices obtuse.
Strain H7-65 was isolated from an unidentified sponge species of the genus Sycon
(Helgoland), and identified as Emericellopsis minima Stolk 1955.
Strain K14 was isolated from the sponge I. variabilis (Malta), and identified as
belonging to the genus Microascus.
Strain H5-50 was isolated from the sponge M. incrustans (Helgoland), and identified
as belonging to the genus Microsphaeropsis. Morphology on SNA agar: Mycelium
superficial, partly immersed, branched, septate, hyaline. Conidiomata pycnidial,
65 - 110 µm in diameter, globose, dark brown, superficial, unilocular, ostiole slightly
papillate, wall of olivaceous brown textura angularis. Conidiogenous cells phialidic,
cylindrical, 1.5 × 4.5 µm. Conidia 1.3 - 1.7 × 3.0 - 4.3 µm, olivaceous brown, thin-
walled, aseptate, smooth, cylindrical, some slightly allantoid, apices obtuse.
Strain 193A20 was isolated from the sponge C. vaginalis (Dominica), and identified as
belonging to the genus Monochaetia. On the occasion of a re-examination of this strain
by Dr. R. Emmens, Centraalbureau voor Schimmelcultures, Baarn, The Netherlands,
no sporulation occurred.
Strain H4-77 was isolated from the sponge H. panicea (Helgoland), and identified as
belonging to the genus Phoma. On the occasion of a re-examination of this strain no
sporulation occurred.
Strain H7-19 was isolated from an unidentified sponge species of the genus Sycon
(Helgoland), and identified as Scopulariopsis candida (Guéguen) Vuillemin 1911.
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Strain 193A4 was isolated from the sponge C. vaginalis (Dominica), and identified as
Ulocladium botrytis Preuss 1851.
Strain 195-31 was isolated from an unidentified species of brown alga of the genus
Cytoseira (Tenerife), and identified as Varicosporina ramulosa Meyers et Kohlmeyer
1965.
3.2.5 Preparation and maintenance of stock cultures
All fungal strains were kept on two different media in test-tubes in duplicate at 4°C:
Medium 1 (One tube per strain, 7 mL medium, sealed with cotton wool): Biomalt
50 g/L, agar 20 g/L, dest. H2O 1 L.
Medium 2 (One tube per strain, 7 mL medium, sealed with aluminium cap and
parafilm): Biomalt 50 g/L, agar 20 g/L, ASW 800 mL, dest. H2O 200 mL.
Strains for further chemical investigations were kept in additional five tubes with
medium 1 (medium 2 for obligate marine species), sealed with aluminium-cap and
parafilm. Slants were prepared and inoculated using standard microbiological
techniques.
3.3 Culture and extraction of selected fungal strains
3.3.1 Strains for screening purposes
Isolates were inoculated on two or three (see 8.3 for details) of the following four
media (50 mL each) for 14 days at RT (20°C):
Medium A (B): biomalt 20 g/L, agar 6.8 g/L.
Medium B (Bs): biomalt 20 g/L, ASW 800 mL/L, agar 6.8 g/L.
Medium C (Bfl): biomalt 20 g/L, ASW 800 mL/L.
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Medium D (MS): Malt extract soymeal agar (see 3.2.2) with 7.6 g/L agar.
Liquid cultures were shaken on an Infors Novotron rotary shaker at 65 rpm. After two
weeks, cultures were homogenised using an Ika Ultra-Turrax T 25 at 8000 rpm for
2 min. 50 mL of water were added to solid cultures prior to homogenisation. Resultant
mixtures were extracted with EtOAc (3 × 50 mL), the organic fractions were
combined, and the solvent removed at reduced pressure and 30°C. Residues were
redissolved in 2 mL of a mixture of acetone/MeOH (1:1; v/v) and this solution was
then used for the agar diffusion assays and TLC. 28 selected cultures were extracted
successively with the same amounts of n-BuOH (see 8.3). For the ELISA based assays
500 µg extract was dissolved in 250 µL DMSO to give the appropriate sample
solutions.
3.3.2 Strains for chemical investigations
Strains were cultured in penicillium or fernbach flasks containing 0.5 or 0.25 L solid
medium respectively. Liquid cultures were grown in 1 L erlenmeyer flasks with
indentations containing 0.5 L medium, and shaken on an Infors Novotron rotary shaker
at 65 rpm. Media were inoculated with small mycelium plugs from stock culture (liquid
media) or a suspension of mycelium from small scale cultivations (one petri dish per
five penicillium flasks) in water (solid media).
Media used for cultivation were biomalt agar, malt extract soymeal (MS) agar (3.2.2),
and starch yeast extract agar (soluble starch 15 g/L, yeast extract 4 g/L, agar 20 g/L).
If not stated otherwise, solid media contained 6.8 g/L (biomalt agar) and 7.6 g/L
(MS agar) agar; media with ASW contained 80 % ASW.
The isolate of A. cruciatus (H5-85) was cultured on solid medium (Biomalt agar with
20 g/L agar) and starch yeast extract agar (20 g/L agar), both with ASW; 2.5 L each at
RT for three months.
The Coniothyrium strain (193H77) was cultured in liquid biomalt medium with ASW
(7.5 L) at RT for 16 days.
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The isolate of E. minima (H7-65) was cultured on solid medium (biomalt agar 4.25 L
and MS agar 4.5 L) at RT for three months.
The Microascus strain (K14) was cultured on solid medium (biomalt agar 0.75 L and
MS agar 0.75 L, both with ASW) at RT for six weeks.
The Microsphaeropsis strain (H5-50) was cultured on solid biomalt medium (4.5 L) at
RT for 40 days.
The Monochaetia strain (193A20) was cultured on solid medium (MS agar with ASW,
5.75 L) at RT for five weeks.
The Phoma strain (H4-77) was cultured on solid medium (Biomalt agar with ASW,
and MS agar with ASW; 1.5 L each) at RT for 9 weeks.
The isolate of S. candida (H7-19) was cultured in liquid biomalt medium with ASW
(7.5 L) at RT for one month.
The isolate of U. botrytis (193A4) was cultured on solid biomalt medium (1 L) at RT
for 14 days.
The isolate of V. ramulosa (195-31) was cultured on solid biomalt medium with ASW
(6.5 L) at RT for five weeks.
If not stated otherwise (see 4.4) medium and mycelium were homogenised together
using a Waring blender. To cultures on solid medium, 500 mL water were added to
1 L medium prior to homogenisation. Resultant mixtures were subsequently extracted
with EtOAc (3 × 300 mL per 1 L medium) to yield crude extracts.
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3.4 Biological testing
3.4.1 Agar diffusion assays
Agar diffusion assays were carried out according to Schulz et al., (1995). Test
organisms were the bacteria Bacillus megaterium de Bary (gram positive) and
Escherichia coli (Migula) Castellani & Chambers (gram negative), the fungi
Microbotryum violaceum (Pers.) Roussel (Ustomycetes), Mycotypha microspora
Fenner (Zygomycetes), Eurotium repens Corda (Ascomycetes) and Fusarium
oxysporum Schltdl. (mitosporic fungi), and the alga Chlorella fusca Shih Krauss
(Chlorophyceae).
If not stated otherwise, sample solutions contained 5 mg/mL extract or 1 mg/mL pure
compound. Samples were prepared by taking 50 µL of each solution and pipetting it
onto a sterile antibiotic filter disk (Schleicher & Schuell 2668), which was then placed
onto the appropriate agar medium and sprayed with a suspension of the test organism.
Growth media, preparation of spraying suspensions, and conditions of incubation were
as employed by Schulz et al., (1995). The radii of the resultant zones of inhibition were
measured from the edge of the filter disks. For extracts, a growth inhibition zone
≥ 3 mm and/or a complete inhibition ≥ 1 mm were regarded as a positive result; growth
inhibition: growth of the appropriate test organism was significantly inhibited
compared to a negative control; complete inhibition: no growth at all in the appropriate
zone.
3.4.2 Tyrosine kinase inhibitory activity
The DMSO sample solution (see 3.3.1) of the appropriate extract/pure compound was
diluted with H2O (1:1 v/v) to yield corresponding sample solutions. Pure compounds,
if active, were tested at various concentrations.
TK inhibitory activity was determined using a commercial test kit (Tyrosine Kinase
Assay Kit, non-radioactively, Boehringer Mannheim, Cat. No. 1 534 513), modified by
Ms. G. F. Matthée. Assays were carried out by either Ms. G. F. Matthée or
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Ms. I. Rahaus using T cell tyrosine kinase p56lck (Upstate Biotechnology). Sample
solutions were incubated with 1 µM TK substrate II, biotin-labelled (Boehringer
Mannheim), 1 mM ATP, 10 mM MgCl2, 1 U TK p56lck, 20 µL dilution buffer, and
20 µL assay buffer for 1 hour at 30°C. The resultant concentration of the
extract/compound in the test mixture was 200 µg/mL. Dilution buffer (pH 7.0)
contained 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid (HEPES),
10 % glycerol, and 0.1 % ethylphenolpoly(ethylene-glycolether)n (NP-40). Assay
buffer (pH 7.5) contained 250 mM Tris, 25 mM NaF, 2.5 mM EDTA-Na2, 4.0 mM
[ethylenebis(oxyethylenenitrilo)]tetraacetic acid (EGTA), 5 mM DTT, and 150 µM
Na3VO4. The enzyme activity was determined as described in the TK Assay Kit, except
the measuring wavelength was 415 nm instead of 405 nm. In each test series 3 mM
piceatannol (Boehringer Mannheim) was included as a positive control. Samples which
reduced the enzyme activity by 60 % or more relative to a negative control were
regarded as active.
3.4.3 HIV-1 reverse transcriptase inhibitory activity
The assay was performed by Mr. C. Dreikorn or Ms. G. F. Matthée according to a
protocol established by the latter. DMSO standard solutions (see 3.3.1) of the
appropriate extracts/compounds were diluted with lysis buffer (1:10 v/v) to yield
corresponding sample solutions.
HIV-1 RT inhibitory activity was measured using 20 µL of the sample solution, 20 µL
lysis buffer, and 20 µL reaction mixture which were then incubated for 1 hour at 37°C.
The resultant concentration of the extract in the test mixture was 66 µg/mL. Lysis
buffer (pH 7.8) contained 1 ng recombinant HIV-1 RT (Boehringer Mannheim),
50 mM Tris, 80 mM KCl, 2.5 mM dithiothreitol (DTT), 0.75 mM ethylendiamintetra-
acetic acid (EDTA), and 0.5 % Triton-X100. The reaction mixture contained
template/primer hybrid poly(A)*oligo(dT)15 (600A260nm/mL), 8 µM thymidine-5'-
triphosphate (dTTP), 8 µM digoxigenin- and biotin-labeled-2'-deoxy-(uridine-5'-
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triphosphate) (dUTP), 40 µM TrisHCl, 230 mM KCl, 24 mM MgCl2, and 8 mM DTT
(all Boehringer Mannheim).
Enzyme activity was measured following the ELISA protocol described by Eberle &
Seibl (1992) at λ = 415 nm versus λ = 490 nm using an ELISA reader (Rainbow, SLT
Labinstruments Deutschland GmbH). As a positive control, 10 µM of
phosphonoformic acid (Sigma) was included in each test series. Extracts which
reduced the enzyme activity by 20 % or more relative to a negative control were
regarded as active.
3.4.4 Inhibition of Mycobacterium tuberculosis
Activity of extracts against M. tuberculosis H37Rv (ATCC 7294) was tested in
cooperation with the research group of Prof. S. Franzblau, U.S. Department of Health
and Human Services, GWL Hansen’s Disease Center, Baton Rouge, Louisiana, USA,
in the BATEC 460 system (Collins & Franzblau, 1997). Percent inhibition was
calculated as [1-(growth index of test sample/growth index of control)] î 100.
3.4.5 Cytotoxicity
Cytotoxicity data of extracts towards KB cells were provided by Prof. Dr. C. K.
Angerhofer, Department of Medicinal Chemistry and Pharmacognosy, University of
Illinois at Chicago, USA. Tests were performed as previously published
(Likhitwiayawuid et al., 1993).
3.4.6 Antimalarial activity
Antimalarial activity of pure compounds was determined by Dr. N. Lang-Unnasch,
Division of Geographic Medicine, University of Alabama at Birmingham, USA. Tests
were performed as previously published (Angerhofer et al., 1992).
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3.5 Chromatography
3.5.1 Thin layer chromatography (TLC)
TLC was carried out using either TLC aluminium sheets silica gel 60 F254 (Merck
5554) or pre-coated TLC plates SIL RP-18W / UV 254 (Macherey-Nagel).
Standard chromatograms of fungal extracts were prepared by applying 20 µL solution
to a silica gel TLC plate and developing it with DCM/MeOH (98/2; v/v) under
saturated conditions.
Chromatograms were detected under UV-light (254 and 366 nm), and with vanillin-
H2SO4 reagent (1 g vanillin dissolved in 100 ml H2SO4, heated at 100°C after
spraying).
3.5.2 Vacuum-liquid chromatography (VLC)
Sorbents for VLC were either silica gel 60 (70-230 mesh ASTM, Merck 7734; normal-
phase) or Polyprep 60-50 C18 (Machery-Nagel 71150; reversed-phase). Columns were
filled with the appropriate sorbent soaked with hexane or MeOH. Before applying the
sample, the column was equilibrated with the first designated eluent.
3.5.3 High performance liquid chromatography (HPLC)
HPLC was carried out either using a Merck-Hitachi system equipped with a L-6200A
Intelligent Pump, a L-4500A diode array detector, a D-6000A interface with D-7000
HSM software, a Rheodyne 7725i injection system, or a system equipped with a
Waters associates chromatography pump, a Knauer Differential refractometer, a
Rheodyne 7725i injection system and a Linseis L 200 E recorder. If not stated
otherwise, the system with differential refractometer as detector was used.
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Columns used were either a Knauer Spherisorb S ODS 2 (5 µm, 250 × 8 mm), a
Merck LiChrospher Si 60 (5 µm, 250 × 7 mm), or similar columns. Typical flow rates
were 1.5 mL/min (reversed-phase) and 2.0 - 3.0 mL/min (normal-phase).
All solvents, except H2O, were distilled prior to use. The eluents were degassed under
reduced pressure. If not stated otherwise, samples were diluted in the eluent to yield
solutions of 20 - 40 mg/mL. Injected amounts usually equalled 10 mg of extract/run.
3.6 Structure elucidation
Structures were elucidated mainly using one and two dimensional NMR techniques and
various MS methods. If necessary, additional parameters such as optical rotation, UV
and IR properties were determined. Identity of isolated compounds with compounds
previously published ("known compounds") was judged, if not stated otherwise, based
on 1H and 13C NMR spectroscopic data, and specific optical rotation. For some known
compounds, mainly those first reported before 1980, no or no complete NMR data
have been published. Furthermore, in some cases the published values were found to be
insufficient to prove the identity of an isolated metabolite with the published compound
in question. In these cases, a complete structure elucidation was performed. Literature
searches were done using Chapman & Hall Natural Products on CD-ROM
(Buckingham, 1996) and Beilstein on-line databases. Structures were designated as
new, if they could not be found in Chemical Abstracts.
3.6.1 NMR spectroscopy
1H NMR spectra of extracts and pure compounds as a purity check were recorded at
the Department of Chemistry, TU Braunschweig, on a Bruker AC-200 spectrometer
operating at 200 MHz or a Bruker AM-400 spectrometer operating at 400 MHz (with
CD3OD as solvent) by Ms. P. Holba-Schulz and Ms. I. Rübesamen.
1H NMR spectra of pure compounds and all other NMR measurements were
performed at the GBF Braunschweig by Dr. V. Wray, Ms. B. Jaschok-Kentner and
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Ms. C. Kokoschke on Bruker DPX-300, ARX-400 or DMX-600 NMR spectrometer
operating at 300, 400 or 600 MHz (1H), and 75.5, 100 or 125 MHz for 13C,
respectively.
Spectra of pure compounds were processed using Bruker 1D WIN-NMR or
2D WIN-NMR software. They were calibrated using solvent signals (13C: CDCl3
77.00 ppm, CD3OD 49.00 ppm, CD3COCD3 30.50 ppm, DMSO-d6 39.70 ppm) or a
signal of the portion of the partly or not deuterated solvent (1H: CHCl3 in CDCl3
δ 7.26, HDO in D2O δ 4.79, CH3OD in CD3OD δ 3.35, DMSO in DMSO-d6 δ 2.50,
acetone in acetone-d6 δ 2.05). Multiplicity for 13C was deduced from DEPT
experiments; s = C, d = CH, t = CH2, q = CH3. Structural assignments were based on
spectra resulting from one or more of the following NMR experiments: 1H, 13C, DEPT,
1H-1H COSY, 1H-13C direct correlation (HMQC), 1H-13C long-range correlation
(HMBC), 1H-1H ROESY and 1H difference NOE.
3.6.2 Mass spectrometry
Mass spectral measurements were performed by Dr. H.-M. Schiebel, Dr. U. Papke and
Ms. D. Döring (all Department of Chemistry, TU Braunschweig) using a Finnigan
MAT 8430 spectrometer (EI, 70 eV; CI; FAB, Xe). Selected measurements were
performed by Dr. R. Christ, GBF Braunschweig, on a Finnigan MAT 95 spectrometer:
DCI-MS of compound 8, HREIMS of compound 9, CIMS (NH3) of compound 17.
3.6.3 UV and CD measurements
UV spectra were recorded on a Shimadzu UV-200S double beam spectrophotometer
coupled with a Kipp & Zonen BD-40 recorder using 1.000 cm quartz cells. The
CD-spectrum of 46a was recorded by Ms. H.-S. Cho, Institute for Pharmaceutical
Technology, TU Braunschweig, on a Jasco J-715 spectropolarimeter using EtOH as
solvent. Cell length was 0.500 cm.
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3.6.4 IR spectroscopy
IR spectra were recorded by Ms. P. Reich and Mr. T. Kroker, Institute for
Pharmaceutical Chemistry, TU Braunschweig, on an ATI Mattson Genesis Series
FTIR. Samples were measured on NaCl (film).
3.6.5 GC and GC-MS methods
Qualitative determination of D-arabitol, D-mannitol and D-trehalose from A. cruciatus
was performed after derivatisation with MSTFA using an Intersmat IGC 120 FL
GC-system, equipped with a 15 m DB-1 capillary column and a Shimadzu C-R1B
integrator. GC-conditions: injection block 250°C, detector 300°C, He 75 kPa, oven
temperature 100-300°C (6°C/min), split 1:20. To < 250 µg of each hydrocarbon
sample 50 µL MSTFA was added, mixture kept at 80°C for 30 min and directly
injected; injected volume ~0.5 µL. Retention times of authentic material: meso-
erythritol 8.6 min, D-arabitol 12.7 min, D-xylose 12.8 min, D-mannitol 13.7 min,
D-trehalose 28.2 min.
GC-MS analysis were performed by Dr. L. Witte using a Carlo-Erba HRGC 5160
linked to a Finnigan MAT 4515 spectrometer (40 eV). The GC was equipped with a
DB1-30W column (30 m × 0.32 mm i.D., stationary phase 0.25 µm; split 1:20). Oven
temperature program was modified for each individual sample but usually started at
100oC, increasing 6oC/min.
3.6.6 Optical rotation
Optical rotations were measured using a Perkin Elmer 241 Polarimeter equipped with
an 1 mL cell, cell length 10.000 cm.
Materials and methods32
3.6.7 Melting point
Melting points were recorded on a Wena thermoblock apparatus heated by a small
Bunsen burner and are not corrected.
3.6.8 Single crystal X-ray analysis
The single crystal X-ray analysis of colletoketol (43) was performed by Prof. P. G.
Jones, Institute for Inorganic and Analytical Chemistry, TU Braunschweig. Crystals
were grown from EtOAc.
3.7 Chemical derivatisations
3.7.1 Methylation of variabilins
Methylation was carried out in a MNNG diazomethane-generating apparatus (Aldrich
Z10,100-1) using the conditions described by Ngan & Toofan (1991). The
sesterterpene tetronic acids containing fraction (250 mg) was dissolved in 5 mL diethyl
ether/EtOAc 75/25 in the outer tube. In the inner tube 1 mL diethyl ether, 1 mL
diethylene glycol monoethyl ether and 0.4 g N-methyl-N-nitroso-p-toluenesulfonamide
(Diazald®, Aldrich D2,800-0) were placed. The lower part of the apparatus (up to the
solvent level in the outer tube) was immersed in an ice water bath. Reaction was
started by injecting dropwise 1.5 mL 37% KOH through the septum into the inner
tube. The apparatus was gently shaken every 5 min by hand. After a total reaction time
of 30 min, surplus Diazald® was destroyed by gently injecting 2 mL 30% acetic acid
into the inner tube. Diethyl ether and surplus diazomethane were evaporated out of the
opened apparatus in a waterbath at 40 °C in a fume hood. Methylation occurred to
100% as monitored by normal-phase TLC (acetone/hexane 30/70).
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3.7.2 p-Bromo-benzoylation of 9,10-dihydro-(6R,11R,12R,14R)-colletodiol
5 mg 46, 15 mg p-bromobenzoyl chloride (Fluka 16450) and 3 mg 4-(dimethyl-
amino)pyridine (Schuchard 820499) were dissolved in 2 mL DCM in a pear shaped
flask sealed with a plastic stopper. The mixture was kept in an ultrasonic bath for 4 h; a
warming up to 35°C occurred during this time. The resulting mixture was separated
from excess p-bromobenzoyl chloride by normal-phase VLC (hexane/EtOAc 50/50),
followed by normal-phase HPLC (hexane/EtOAc 80/20) to yield 9,10-dihydro-11,12-
di-p-bromobenzoate-(6R,11R,12R,14R)-colletodiol (46a, 8.8 mg) as a clear oil.
3.7.3 Hydrogenation of macrodiolides
31 mg (6R,11R,12R,14R)-colletodiol (44) was dissolved in 5 mL EtOAc and
hydrogenated with H2 after addition of 5 mg 10% Pd/C under stirring for 2 h. Pd/C
was removed by normal-phase VLC (acetone). The reaction mixture was further
separated by normal-phase HPLC (acetone/petrol ether 50/50) to yield 3,4,9,10-
tetrahydro-(6R,11R,12R,14R)-colletodiol (8.0 mg) and (5R)-((1'R,3'R)-
dihydroxybutyl)-dihydrofuran-2-one (8.9 mg).
9,10-dihydro-(6R,11R,12R,14R)-colletodiol (46, 5.2 mg) was hydrogenated
analogously to yield 4.8 mg 3,4,9,10-tetrahydro-(6R,11R,12R,14R)-colletodiol after
VLC. Decomposition started during the reaction and proceeded almost completely in
CDCl3 solution in the NMR tubes during three weeks. The decomposition products
were separated by HPLC (as above) to yield 1.1 mg (5R)-((1'R,3'R)-dihydroxybutyl)-
dihydrofuran-2-one.
3.7.4 Hydrolysis of colletoketol
To 43 mg colletoketol (43), 20 ml 0.05 n NaOH were added. The mixture was stirred
for 24 h at RT, gently acidified with conc. HCl and extracted with diethyl ether
(5 × 50 ml). The combined organic layers were dried over Na2SO4, the solvent
evaporated and the residue subjected to preparative TLC (Si-60, three plates,
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EtOAc/petrol ether/acetic acid 45/50/5). A blue zone (UV 254 nm) at Rf 0.45 was
extracted with EtOAc to yield (5R)-hydroxy-(2E)-hexenoic acid (10.5 mg).
3.8 Chemicals
Media components:
Agar (Fluka 05040)
Biomalt (Villa Natura, Kirn)
Malt extract (Merck 5391)
Peptone from casein, tryptic digest (Fluka 70172)
Peptone from meat, enzymatic digest (Fluka 70175)
Peptone from soymeal, papain-digested (Merck 7212)
Yeast extract (Fluka 70161)
Benzylpenicillin (Fluka 13750)
Streptomycin sulfate (Fluka 85880)
Carrots, potatoes and cornmeal were supplied by local food stores.
Water used was de-ionised using a Millipore (milli-Q) system.
All other chemicals/components were research grade, and if not stated otherwise in the
text, supplied by Merck.
Solvents:
EtOH for UV-measurements was from Merck (Uvasol 980). All other solvents were
research grade and supplied by Merck, except n-BuOH (Roth). Water used was
deionised using a Millipore (milli-Q) system. Acetone, CHCl3, DCM, EtOAc, hexane,
MeOH and petrol ether were distilled prior to use.
Aceton-d6 (Chemotrade 97509, 99.8 % D)
Chloroform-d (Chemotrade, 99.87 % D)
Deuteriumoxid (Merck 518, 99.75 % D)
Dimethylsulphoxid-d6 (Merck Sharp & Dohme MD-1313, 99.5 % D)
Methanol-d4 (ICB 0844-25, 99.8 % D)
Results 35
4 Results
4.1 Isolation and taxonomy of fungal strains
4.1.1 Fungal isolates from sponges
The main purpose for the isolation of fungi from marine sponges in this study was their
subsequent investigation for the production of new and biologically active metabolites. It
was thus aimed to obtain a great variety of preferably adapted strains, and to exclude
terrestrial contaminants of ubiquitous fungal genera which are well investigated
chemically. This was attempted either by destroying contaminants with surface
sterilisation or by the use of media inhibiting the growth of these fungi.
Surface sterilisation with EtOH (70 %) was attempted with the sponge Ircinia variabilis,
and showed that this method is not suitable for sponges. The EtOH could not be
removed completely in a defined time, and obviously damaged the sponge tissue after
about 10 s. As a sterilisation time of 10 s is surely not sufficient to destroy all fungal
spores on a sponge surface, surface sterilisation was not further applied to sponge
samples.
During the initial investigation with sponge samples from Malta, small pieces of the inner
tissue of the sponges were incubated on the nutrient rich media I-IV. The first fungal
colonies could be detected after four to five days as they developed on individual sponge
segments. The isolation media quickly became dominated by fast growing fungi such as
Aspergillus and Penicillium spp., even on media supplemented with ASW. To reduce the
growth of such fungi, nutrient poor media V and VI, suitable for the isolation of marine
fungi, were used and supplemented with cyclosporine A (Dreyfuss, 1986). With these
media the resulting fungal colonies remained discrete and did not overgrow the entire
agar medium, thus allowing slow growing strains of different genera to be detected. To
ensure that as many slow growing fungi as possible were obtained, the size of the sponge
pieces was reduced until some remained from which no fungal colonies developed. This
protocol was then used for all sponge samples.
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From 16 sponge samples a total of 681 fungal strains were isolated. Due to the great
number of isolates and the difficulties of taxonomic identification for some species of the
genera of mitosporic fungi (e.g., the genus Phoma), in most cases only the genus was
determined. A different morphology on the same growth medium suggested the isolates
of many genera to represent several species. An overview of the genera obtained and the
number of isolates from each sponge sample is given in Table 3.
Of the employed media, none selectively inhibited the growth of ubiquitous fungi such as
Aspergillus and Penicillium spp. Since the use of different isolation media resulted only
in a quantitative difference in fungal isolates obtained, the results in Table 3 are not
differentiated as to the media used.
The isolated fungi were identified as belonging to 13 genera of Ascomycetes, two genera
of Zygomycetes and 38 genera of Mitosporic fungi; 37 strains remained sterile even
though diverse media and conditions of culture were used to induce sporulation. The
only clearly obligate marine fungi (Kohlmeyer & Volkmann-Kohlmeyer, 1991) isolated
were Phialophorophoma litoralis Linder from the sponge Aplysina aerophoba from
Tenerife and Asteromyces cruciatus Moreau et Moreau ex Hennebert from the sponges
Halichondria panicea and Myxilla incrustans from Helgoland. Since some genera of
mitosporic fungi, e.g., Cladosporium, Coniothyrium and Phoma are known to have
marine representatives (Kohlmeyer & Volkmann-Kohlmeyer, 1991), it is likely that the
real number of obligate marine fungi obtained was somewhat higher. This was supported
by the finding that 11 Phoma sp. originating from sponge samples from Helgoland
sporulated only on media supplemented with salt.
Many genera of fungi were found in samples from only one or two collection sites
(Table 3), e.g. fungi of the genera Arthrinium and Niesslia were almost exclusively
isolated from sponges from Helgoland and those of the genus Eurotium from sponge
samples from Malta. In contrast, fungi of the genera Acremonium, Cladosporium,
Fusarium and Penicillium were isolated from sponges from almost every location. Fungi
of other genera, e.g., Aplosporella, Monochaetia, and Myrothecium were obtained
exclusively from single sponge samples.
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Table 3. Genera and total number of fungal isolates obtained from marine sponge
samples by incubation of sponge cubes on different media.
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a) Ascomycetes
Chaetomium - - - - 4 - - 1 - 1 1 - - - 7
Emericella 1 - - - - - - - - - - - - - 1
Emericellopsis - - - - 1 3 - 2 - - - - - - 6
Eupenicillium 1 - - - - - - 1 - - - - - - 2
Eurotium - - - - - - - - - 8 4 - - - 12
Leptosphaeria - 1 - - - - - - - - - - - - 1
Microascus - - - - - - 1 1 - - 1 - - - 3
Monascus - - - - - - - - - - 1 - - - 1
Myxotrichum - - - - - - - - - - 1 - - - 1
Niesslia - - - - 4 1 2 3 1 - - - - - 11
Preussia - - - - - 1 - - - - - - - - 1
Sporormiella 1 - - - - - - - - - - - - - 1
Talaromyces - - 1 - - - - - - 1 - - - - 2
b) Zygomycetes
Mucor - - - - 4* 5* -* 6* -* - - - - - 15
Syncephalastrum - - - - - - - - - 2 1 - - - 3
c) Mitosporic fungi
Acremonium 1 4 3 9 8* 15* 24* 11* 6* - 1 1 1 4 88
Alternaria - 1 - 1 - - - 1 1 - - - - - 4
Aplosporella - - 2 - - - - - - - - - - - 2
Arthrinium - - - - 13* 13* 7* 7* 10* 2 - - - - 52
Aspergillus - - - - - - - - 1 26 24 - 1 - 52
Asteromyces - - - - 8 1 - - - - - - - - 9
Beauveria - - 1 - - 1 - - 1 - - - - - 3
Botrytis 1 - - - - - 1 - - - - - - - 2
Cladosporium - 15 3 - - 2 - 2 - 3 - 1 - 2 28
Clamnopygnis - - - - - - - - 1 - - - - - 1
Coniothyrium - - 8 1 8 9 - 8 10 - - - - - 44
Doratomyces - 1 2 - 1 1 3 - - - - - - - 8
Drechslera - - - - 2 1 - - 1 - - - - - 4
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Table 3 continued
1
 Origin of the sponge samples: (A) Australia, (D) Dominica, (H) Helgoland, (M) Malta, (T)
Tenerife; no fungal isolates were obtained from the sponges Leucosolenia challengeri and
Biemna sp. from Australia.
*Due to the great number of isolates from the genera Acremonium, Arthrinium, Fusarium,
Mucor, Penicillium, Phoma, Trichoderma and Verticillium from the samples from Helgoland,
numbers in the table marked with an asterisk represent only those species which were retained
in pure culture; - no isolates obtained; -* no isolates retained.
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Epicoccum - - - - - - 1 - - - - - - - 1
Fusarium 2 1 1 - 13* 3* 5* 5* 6* - - - 2 - 38
Geomyces - - - - 1 1 - - 1 1 - - - - 4
Geotrichum - - - - - - - 1 - - - - - - 1
Gliocladium - - 1 - 2 - - 1 1 - - - - - 5
Gonatobotrys - - - - - - 1 - - - - - - - 1
Microsphaeropsis - - - - - 1 - - - - - - - - 1
Moniliella - - - - - - - - - - 1 - - - 1
Monochaetia - 3 - - - - - - - - - - - - 3
Myrothecium - 3 - - - - - - - - - - - - 3
Oidiodendron - - - - - - - - - 1 - - - - 1
Paecilomyces - - 1 - - 6 11 - 2 - - - 1 2 23
Penicillium 4 1 3 - -* 3* 4* 4* 1* 9 13 1 2 - 45
Phialophorophoma - - - - - - - - - - - 1 - - 1
Phoma - 12 37 5 7* 14* 6* 2* 1* - - - - - 83
Scolecobasidium - - - - - - - - - - - 1 - - 1
Scopulariopsis - - - - - 1 1 3 - 8 - - - - 13
Sporothrix - - 1 - - - - - - - - - - - 1
Stachybotrys - - - - - - - 1 - 1 - - - - 2
Stachylidium 1 - - - - - - - - - - - - - 1
Tolypocladium - - - - - 1 1 1 1 - - - - - 4
Trichoderma - 3 3 - -* 5* -* 1* 4* - - - - - 16
Ulocladium - 1 - 3 - - - - - - - - - - 4
Verticillium - 1 1 - 4* 3* 4* 4* 5* 3 - - - - 25
Mycelia sterilia 3 3 12 11 3 - 1 2 2 - - - - - 37
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The taxonomic spectrum of fungal isolates, and the number of isolates showed some
correlations for sponge samples of the same location. Sponge samples from Australia
in general yielded very few fungi. The sponge Callyspongia sp. cf. C. flammea
contained a few fungi, but Leucosolenia challengeri and Biemna sp. did not. Isolates
from the sponge samples from Dominica mainly belonged to the genera Acremonium
and Phoma, and to a lesser extent to the genera Cladosporium and Coniothyrium.
From these samples no Aspergillus spp., and only few Penicillium spp., were isolated,
whereas the number of Mycelia sterilia (16 %) was high compared to other locations.
Sponge samples from Helgoland yielded the greatest number of isolates and the highest
diversity of genera: 27 genera of mitosporic fungi, six genera of Ascomycetes, and one
genus of Zygomycetes. The dominating genera were Acremonium, Arthrinium,
Fusarium, Mucor, Penicillium, Phoma, Trichoderma and Verticillium. Due to the
large number of isolates from each genus, and the fact that these genera (with the
exception of the genus Phoma) were not planned to be further investigated chemically,
not all colonies were isolated and registered. Hence, the numbers given in Table 3 do
not represent the absolute abundance of these genera in the samples investigated. With
the exception of the genera Asteromyces and Chaetomium, the two samples of the
sponge H. panicea from different collection sites from Helgoland yielded an almost
identical spectrum of fungal isolates. Sponge samples from Malta were dominated by
the presence of Aspergillus (mostly of the A. niger and A. ochraceus group), Eurotium
and Penicillium spp. Sponge samples from Tenerife yielded only few isolates, all being
mitosporic fungi.
4.1.2 Fungal isolates from algae
Algal samples were cut into small pieces and placed on the different isolation media.
About half of the sample was surface sterilised using EtOH prior to its inoculation.
Development of fungal colonies visible under the dissecting microscope started about
four days after inoculation on the agar plates. From 10 algal samples a total of 105
fungal strains belonging to 25 genera (4 genera of Ascomycetes, 1 genus of
Zygomycetes, 19 genera of Mitosporic fungi) and 7 Mycelia sterilia were obtained
(Table 4).
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Table 4. Genera and total number of fungal strains obtained from algal samples.
Alga sample1
/
Fungal genera
H-1 H-2 H-3
CT
195
D
CT
195
E
CT
195
I
CT
195
L
CT
195
M
CT
195
X
CT
195
Y
total
no. of
isolates
a) Ascomycetes
Achaetomium -2 - - - - 1(1)3 - - - - 1(1)
Chaetomium - - - 1(1) - 1(1) - - - - 2(2)
Gymnoascus - - 1(1) - - - - - - - 1(1)
Leptosphaeria - - - - - - - - - 1(-) 1(-)
Westerdykella - - 2(1) - - - - - - - 2(1)
b) Zygomycetes
Mucor - - 1(-) - - - - - - - 1(-)
c) Mitosporic fungi
Acremonium 2(-) - 2(-) - - 6(2) 1(-) - - 3(1) 14(5)
Alternaria - - - - - 1(1) - - - - 1(1)
Arthrinium - - 1(1) - - - - - - - 1(1)
Aspergillus - - 1(1) 1(1) 1(-) 6(2) - - - 4(-) 13(5)
Cladosporium - - - - - - - 1(-) 1(1) 3(2) 5(3)
Chrysosporium - - - - - - 1(-) - - - 1(-)
Coniothyrium - - 2(1) - - - - - - - 2(1)
Curvularia - - - - - 1(1) - - - 2(-) 3(1)
Drechslera - - - - - - - - - 1(-) 1(-)
Fusarium 4(1) - 9(6) - - 3(3) - - - 5(3) 21(13)
Paecilomyces - - - - - - 1(-) - - 1(1) 2(1)
Penicillium - - 1(-) - 1(-) 2(-) - - - 1(1) 5(2)
Phoma 1(1) - 3(1) - - 2(2) - - - 2(2) 8(6)
Scolecobasidium - - - - 1(-) - - - - 1(1) 2(2)
Scopulariopsis - - - 1(1) - - - - - 2(-) 3(1)
Trichoderma 1(-) - 2(-) 1(-) - 1(-) - - - - 5(-)
Ulocladium - - - - - - - - - 1(1) 1(1)
Varicosporina - - - - - - 1(-) - - - 1(-)
Verticillium - - - - - 1(1) - - - - 1(1)
Mycelia sterilia 1(-) 1(1) - - - 2(1) - - 2(-) 1(-) 7(1)
1
 Origin of algal samples: H-1 to H-3 Helgoland, CT 195 D to CT 195 Y Tenerife; for
details about the taxonomy see 3.1.2.
2
 - no isolates obtained.
3
 Numbers in paragraphs indicate portion of isolates obtained after surface sterilisation.
The results are not differentiated as to the media used, because no significant
selectivity was observed. The greatest number of isolates (> 25) and the greatest
diversity of genera (> 12) was obtained from the samples H-3, CT 195 I and
CT 195 Y. Most other samples yielded only single representatives of one to four
fungal genera. Only one obligate marine fungus, Varicosporina ramulosa from a
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sample of a Cytoseira sp., was obtained. If the taxonomy of the fungi obtained from
sponges and algae from the same geographic origin is compared, some correlations are
obvious. This is most significant for the fungal strains obtained from samples from
Helgoland. Representatives of all genera of Mitosporic fungi which were encountered
in the algal samples were also isolated from sponges (see 4.1.1).
About half of the fungal strains (47.6 %) was obtained after employing a surface
sterilisation. Some algae proved to be very sensitive against EtOH, e.g. the red alga
H-3 which lost colour within several seconds. Therefore sterilisation time had to be
reduced for some samples, and was not sufficient to destroy fungal spores adhaerent to
the surface of the algae. In general, the numbers of fungal strains isolated were too low
to reveal significant differences as to the pattern and number of genera/species isolated
from a selected sample with or without surface sterilisation.
4.2 Biological activity of extracts of selected fungal strains
4.2.1 Biological activity of extracts of fungal isolates from sponges
4.2.1.1 Antimicrobial activity in agar diffusion assays
Of the 681 fungal strains isolated, only some could be further evaluated for the
production of biologically active metabolites. The major criteria for selection were the
taxonomy of the isolates, and the diversity of secondary metabolite chemistry of the
relevant genera, as found in the Chapman & Hall database. Strains of ubiquitous
genera with well known secondary metabolism were not further investigated, isolates
of less well investigated genera and genera known to possess marine representatives
were prefered. Thus, 92 strains were selected and grown on two, and in some cases
three different media (see 8.3 for details).
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Table 5. Antimicrobial activity of sponge-derived fungal strains, monitored by
the activity of EtOAc extracts from fungal cultures in agar diffusion assays.1
Genus Number
of strains
tested
E.
c.2
B.
m.
M.
v.
E.
r.
F.
o.
M.
m.
C.
f.
total no.
of active
strains
Aplosporella (D)3 2 -4 1 1 2 - 1 1 2
Asteromyces (H) 1 - - - - - - 1 1
Beauveria (D) 1 - - - - - - - -
Beauveria (H) 2 - 1 - - - - - 1
Cladosporium (D) 1 - - - - - - - -
Coniothyrium (D) 8 1 3 6 8 2 2 6 8
Coniothyrium (H) 9 - 2 8 5 - - 6 9
Drechslera (H) 2 - - 2 2 1 1 2 2
Emericellopsis (H) 1 - 1 1 1 - - 1 1
Gliocladium (D) 1 1 1 1 1 1 1 1 1
Gonatobotrys (H) 1 - - - - - - - -
Leptosphaeria (D) 1 - 1 1 - - 1 - 1
Microascus (H) 1 - - 1 1 - 1 - 1
Microascus (M) 1 - 1 1 1 - - - 1
Microsphaeropsis (H) 1 - 1 1 1 - - 1 1
Monascus (M) 1 - - 1 1 - - 1 1
Monochaetia (D) 3 - 1 1 1 1 1 - 1
Myrothecium (D) 3 - 3 2 1 - 2 1 2
Myxotrichum (M) 1 - 1 - 1 1 1 1 1
Niesslia (H) 1 - 1 1 1 - - - 1
Phoma (D) 10 - 1 4 4 - 2 2 7
Phoma (H) 11 2 3 6 8 - 3 7 11
Preussia (H) 1 - 1 1 1 - - 1 1
Scopulariopsis (H) 1 - 1 1 1 - 1 - 1
Sporormiella (A) 1 - - - - - - 1 1
Sporothrix (D) 1 - 1 1 1 - - - 1
Stachylidium (A) 1 - - - 1 - - - 1
Ulocladium (D) 2 - 2 1 - - 1 - 2
Mycelia sterilia (A) 4 1 1 2 2 2 1 - 2
Mycelia sterilia (D) 18 1 5 7 5 2 5 4 13
total 92 6 33 51 50 10 24 37 75
1
 Extracts from fungal cultures on two or three different media were tested. If one of
the extracts was active, the corresponding strain was regarded as active.
2
 Test organisms: E.c. Escherichia coli, B.m. Bacillus megaterium, M.v.
Microbotryum violaceum, E.r. Eurotium repens, F.o. Fusarium oxysporum, M.m.
Mycotypha microspora, C.f. Chlorella fusca.
3
 Origin of the sponge samples from which the strains were isolated: (A) Australia, (D)
Dominica, (H) Helgoland, (M) Malta.
4
 Isolates whose extracts produced an inhibition zone ≥ 3 mm or a complete inhibition
≥ 1 mm were regarded as active; - no such activity.
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Resultant cultures were extracted with EtOAc to yield a total of 256 extracts. In agar
diffusion assays for antibacterial, antifungal and antialgal activity, 161 extracts
(62.9 %) resulting from 75 strains (81.5 %) proved to be active (growth inhibition
zone ≥ 3 mm, or complete inhibition ≥ 1 mm) against at least one test organism
(Table 5).
Antifungal activity was the most common inhibitory effect: at least one extract of 63 %
of the fungal strains tested exhibited antifungal properties. The sensitivity of fungi used
as test organisms in the agar diffusion assays varied greatly. The growth of E. repens
and M. violaceum was inhibited by extracts of 54 and 55 % of the tested strains,
respectively, whereas M. microspora was inhibited by extracts of 26 %, and
F. oxysporum by extracts of only 11 % of the tested strains.
Antibacterial activity was found for extracts of 40 % of the selected strains. Extracts of
only six strains (7 %) were found to be active against the gram-negative bacterium
E. coli, whereas extracts of 33 strains (36 %) were found to be active against the
gram-positive bacterium, B. megaterium. Extracts of 37 strains (42 %) were found to
be active against the green alga, C. fusca.
The largest number of strains investigated for antimicrobial activity belonged to the
genera Coniothyrium (17 strains) and Phoma (21 strains), or to the Mycelia sterilia
(22 strains). The agar diffusion assays demonstrated that all 17 strains of the genus
Coniothyrium, 18 of 21 tested strains of the genus Phoma, and 15 of 22 tested strains
of the Mycelia sterilia showed antimicrobial activity. For the genera Coniothyrium and
Phoma, the collection site, e.g., Dominica or Helgoland, appeared to have negligible
influence on the activity of the strains.
Extracts of 19 strains selectively inhibited only one test organism (Table 6). A broad
spectrum of antimicrobial activity towards all test organisms was observed for extracts
of one Coniothyrium and one Gliocladium strain, both from Dominica. The extracts of
most strains, however, showed antimicrobial activity towards only some of the test
organisms of each group or towards organisms of one or two groups of test
organisms. Extracts from 19 strains were found to be both antibacterial and antifungal,
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extracts from 22 strains were found to be antifungal and antialgal, extracts from two
strains were found to be antibacterial and antialgal. The extracts of 16 strains inhibited
members of all three groups of test organisms.
Table 6: Selectivity of the antimicrobial activity of culture extracts of sponge-
derived fungi in the agar diffusion assays.
Number of strains of which the extracts were found to be exclusively active
against:1
E. coli 1 (1.2 %)
B. megaterium 6 (7.2 %)
E. repens 2 (2.4 %)
M. violaceum 5 (6.0 %)
C. fusca 5 (6.0 %)
Number of strains of which the extracts were found to be active against two or
more groups of test organisms:
antibacterial and antifungal 19 (22.9 %)
antifungal and antialgal 22 (26.5 %)
antibacterial and antialgal 2 (2.4 %)
antibacterial, antifungal and antialgal 16 (19.3 %)
1
 Extracts of none of the strains were found to be selectively active against
M. microspora or F. oxysporum; extracts which produced an inhibition zone with a
radius ≥ 3 mm or a complete inhibition ≥ 1 mm were regarded as active.
4.2.1.2 Inhibition of tyrosine kinase and HIV-1 reverse transcriptase
Inhibition of HIV-1 reverse transcriptase and tyrosine kinase was measured using
ELISA based systems (Eberle & Seibl, 1992). For lack of other criteria, the selection
of strains to be tested was mainly based on their TLC profile and on their antimicrobial
activity (growth inhibition zone > 10 mm or prominent complete inhibition zone) in the
agar diffusion assays. These criteria for the choice of isolates assume that a strain is
likely either to produce a large number of metabolites, some of which are active in one,
and others in another assay, or that a metabolite is likely to be inhibitory in more than
one assay system. Additionally, the two obligate marine fungi were tested. Thus,
27 strains, representing 15 genera and four Mycelia sterilia were cultured and extracted
for the enzyme assays (strains tested and media used are indicated in section 8.3).
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From the resulting 48 EtOAc and n-BuOH extracts, eight were found to be active in
the HIV-1 RT assay and seven in the TK assay (Table 7), with extracts from five
strains inhibiting both enzymes. With the exception of two n-BuOH extracts from a
Coniothyrium and a Phialophorophoma strain, respectively, the enzyme inhibiting
activity was always associated with the EtOAc extracts. From the three Phoma strains
tested, two extracts were active. Only one extract from the six Coniothyrium strains
investigated was active.
Table 7. Culture extracts of sponge-derived fungi with significant activity in the
enzyme assays for HIV-1 reverse transcriptase and tyrosine kinase inhibition.
Fungal strain and code number Extract
HIV-1
reverse
transcriptase
activity1
Tyrosine
kinase
activity1
Ulocladium botrytis (193A4, D)2 EtOAc 7 4
Mycelia sterilia (193I36, D) EtOAc 36 16
Phoma sp. (H4-77, H) EtOAc 77 21
Preussia sp. (H5-73, H) EtOAc 79 23
Leptosphaeria sp. (195-43, T) EtOAc n.a.3 37
Coniothyrium sp. (193H44, D) n-BuOH n.a. 37
Microsphaeropsis sp. (H5-50, H) EtOAc 77 38
Phoma sp. (H6-51, H) EtOAc 54 n.a.
Phialophorophoma litoralis (195-40, T) n-BuOH 64 n.a.
Microascus sp. (K14, M) EtOAc 80 n.a.
1
 Percentage of enzyme activity observed relative to a negative control (100 % HIV-1
RT or TK activity). Reduction of enzyme activity to 80% or less (HIV-1 RT) or 40%
or less (TK) was regarded as a significant inhibition. Piceatannol (3 mM, rest activity
of TK 2.3 %) and phosphonoformic acid (10 µM, rest activity of HIV-1 RT 23.5 %)
were used as positive controls.
2
 Origin of the sponge samples from which the strains were isolated: (D) Dominica,
(H) Helgoland, (M) Malta, (T) Tenerife.
3
 n.a. not active.
4.2.1.3 Cytotoxicity and inhibition of Mycobacterium tuberculosis
Extracts of selected strains were tested for cytotoxic effects towards KB cells and
inhibitory activity against M. tuberculosis. In these assays the same fungal strains as
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outlined in 4.2.1.2 were investigated. The results for the active extracts are given in
Table 8.
Table 8. Activity of culture extracts from sponge-derived fungi towards KB cells
and M. tuberculosis.
Fungal strain
and code
number
Culture
medium
Extract IC50
against
KB cells
(µg/mL)1
Inhibition
(%) of M.
tuberculosis
(300 µg/mL)2
Inhibition
(%) of M.
tuberculosis
(100 µg/mL)2
Gliocladium sp. BIO n-BuOH 3.9 n.a.3 n.a.
193H15 BIO EtOAc 0.23 n.a. n.a.
MS EtOAc 6.0 n.a. n.a.
Mycelia sterilia
193H60 BIO n-BuOH n.a. 98 96
Mycelia sterilia BIO EtOAc 2.7 99 100
293K9 BIO n-BuOH n.a. 99 99
Phoma sp. BIO EtOAc 1.4 n.a. n.a.
H4-77 MS EtOAc 12.6 n.a. n.a.
Drechslera sp. BIO EtOAc n.a. 96 89
H5-28 BIO n-BuOH n.a. 96 85
MS EtOAc n.a. 96 n.a.
Microsphaerop-
sis sp. H5-50 BIO n-BuOH n.a. 92 5
Gonatobotrys sp. BIO EtOAc n.a. 99 93
H6-51 BIO n-BuOH n.a. 95 73
Emericellopsis BIO n-BuOH 7.5 n.a. n.a.
minima MS n-BuOH 15.6 91 81
H7-65 MS EtOAc 2.2 98 94
Coniothyrium BIO EtOAc 13.4 99 100
sp. BIO n-BuOH n.a. 99 99
H8-57 MS EtOAc n.a. 95 89
Microascus sp. BIO EtOAc 8.8 n.a. n.a.
K14 MS EtOAc 18.7 n.a. n.a.
1
 An IC50 ≥ 20 µg/mL was not determined, such extracts were regarded as not active.
2
 Results are shown only for extracts which caused an inhibition of 90 % or more at
300 µg/mL and/or 25 % or more at 100 µg/mL.
3
 n.a. not active.
Results 47
4.2.2 Biological activity of extracts of fungal isolates from algae
Of the 105 strains obtained from the different algae, 22 were selected for further
investigation. Selection criteria were the same as those for the sponge-derived isolates.
Strains obtained after surface sterilisation were preferred. Cultivation and extraction
was performed as for the sponge isolates. For an overview of all strains tested and the
media used, see section 8.3. Extracts from cultures of 14 strains (63.6 %) showed a
significant activity against at least one test organism (Table 9).
Table 9. Antimicrobial activity of algal-derived fungal strains, monitored by the
activity of EtOAc extracts from fungal cultures in agar diffusion assays.1
Genus No. of
strains
tested
E.
c.2
B.
m.
M.
v.
E. r. F. o. M.
m.
C. f. total no.
of active
strains
Alternaria (T)3 1 -4 - 1 1 - - - 1
Curvularia (T) 1 - - - - - - - -
Chrysosporium (T) 1 - - - - - - - -
Drechslera (T) 1 - - - 1 - 1 - 1
Gymnoascus (H) 1 - 1 1 - - 1 1 1
Leptosphaeria (T) 1 - - 1 1 - 1 1 -
Phoma (H) 2 - - 1 1 - - 1 2
Phoma (T) 2 - 1 1 - - - - 2
Scolecobasidium (T) 2 - - - - - - - -
Ulocladium (T) 1 - - - - - - - -
Varicosporina (T) 1 - - - 1 - - - 1
Westerdykella (H) 1 - 1 - - - - - 1
Mycelia sterilia (H) 2 - - 1 1 - - - 1
Mycelia sterilia (T) 5 1 4 - 1 - 1 - 4
total 22 1 7 6 7 - 4 3 14
1
 Extracts from fungal cultures on two or three different media were tested. If one of
the extracts was active, the corresponding strain was regarded as active.
2
 Test organisms: E.c. Escherichia coli, B.m. Bacillus megaterium, M.v.
Microbotryum violaceum, E.r. Eurotium repens, F.o. Fusarium oxysporum, M.m.
Mycotypha microspora, C.f. Chlorella fusca.
3
 Origin of the algal samples from which the strains were isolated: (H) Helgoland,
(T) Tenerife.
4
 Isolates whose extracts produced an inhibition zone ≥ 3 mm or a complete inhibition
≥ 1 mm were regarded as active; - no such activity.
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With the exception of inhibitory activity against B. megaterium, the percentage of
strains with active extracts was lower compared to the sponge-derived strains. These
antibacterial extracts mainly resulted from Mycelia sterilia from Tenerife. Extracts of
about 30 % of all isolates inhibited M. violaceum and E. repens, 18.1 %
M. microspora and 13.6 % C. fusca, whereas F. oxysporum was inhibited by none of
the extracts.
Results 49
4.3 Chemical investigation of sponge samples
Three sponge samples, Callyspongia sp. cf. C. flammea, Ircinia oros and
Leucosolenia challengeri, parts of which had been used for the isolation of fungal
strains, were investigated for secondary metabolites. This resulted in the isolation of
eight pure compounds, including 22-O-methyl derivatives of the two new sesterterpene
tetronic acids (8Z,13Z,18S,20Z)-strobilinin (2a) and (7E,12Z,18S,20Z)-variabilin (3a)
from I. oros. The isolated secondary metabolites proved to be typical sponge
metabolites, and were distinct from known fungal metabolites.
4.3.1 Callyspongia sp. cf. C. flammea (CT 293 K)
Frozen sponge tissue was freeze-dried and exhaustedly
extracted with DCM followed by MeOH. While the MeOH
was removed under reduced pressure, compound 1
precipitated as colourless crystals (11.6 mg). DCM and
MeOH extracts are currently under investigation for their biological properties. Both
extracts were not further investigated chemically. The crystals precipitated from the
MeOH extract could be identified as taurine by combined elemental analysis, FAB-MS,
and 1H and 13C NMR spectroscopy.
Taurine (1): colourless crystals (11.6 mg); IR (film) νmax 3435, 3210, 3050, 2984, 2970, 1615, 1585,
1510, 1460, 1425, 1390, 1345, 1305, 1250, 1215, 1180, 1110, 1100, 1045, 1040, 960, 895, 740, 600,
535, 525, 465 cm-1; 1H NMR (DMSO-d6, 200 MHz) δ 2.71 (2H, t, J = 6.1 Hz), 3.04 (2H, t,
J = 6.1 Hz), 7.67 (2H, brs); 13C NMR (D2O, 75.5 MHz) δ 38.3 (t), 50.4 (t); FAB-MS (glycerol,
negative mode) m/z [M-H]- 124; anal. C 18.75%, H 5.47%, N 10.71%, S 24.46%, calcd for
C2H7NO3S, C 19.20%, H 5.64%, N 11.19%, S 25.62%.
4.3.2 Ircinia oros (CT 912 J)
Frozen sponge tissue was freeze-dried (88.0 g) and successively extracted with DCM
(5 x 1 L) and MeOH to give 2.0 g (DCM extract) and 12 g (MeOH extract),
H2N
S
O
O OH1
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respectively. The DCM extract was fractionated by normal-phase VLC (gradient
hexane/EtOAc/MeOH) to yield five fractions. Fraction 2 (hexane/EtOAc 50/50)
contained sesterterpene tetronic acids as monitored by 1H NMR spectroscopy. These
compounds are known for their instability, especially in the presence of oxygen
(Barrow, Blunt & Munro, 1989). To avoid their decomposition, as well as to improve
chromatographic behaviour through prevention of keto-enol-tautomerism, the fraction
(250 mg) was methylated using diazomethane (Ngan & Toofan, 1991). Separation of
the products by reversed-phase (C-18) VLC (MeOH), followed by normal-phase
HPLC (EtOAc/hexane 20/80) gave 173 mg of the 22-OCH3 and 50 mg of 24-OCH3
derivatives. The 22-OCH3 derivatives were further purified using reversed-phase
(C-18) HPLC (CH3CN/MeOH/H2O 42/43/15, photodiode array detection
210-400 nm) to give compound 4 (44.4 mg) and two mixtures. The latter were
separated using reversed-phase (C-18) HPLC (MeOH/H2O 83/17, photodiode array
detection 210-400 nm) to yield compounds 2 (4.1 mg), 3 (7.0 mg) and 5 (8.7 mg), and
3.0 mg of a mixture containing 6 and another unidentified sesterterpene tetronic acid.
The other fractions from the DCM extract, and the MeOH extract proved to be not
interesting as judged by their 1H NMR spectra and were not further investigated.
The molecular formula of 2 was established as C26H36O4 by accurate mass
measurement. 1H NMR spectroscopic measurements revealed signals at δ 6.26 (brs),
7.21 (brs) and 7.34 (m) for a 3-substituted furan moiety, four resonances for methyl
groups (δ 1.65, d, J = 1 Hz; 1.67, s; 1.03, d, J = 6.5 Hz and 2.06, s), a signal for a
methoxyl function (δ 4.11, s), and three resonances for olefinic protons (δ 5.13, m;
5.09, t, J = 7.0 Hz, and δ 5.15, d, J = 9.7 Hz). These data together with the observed
UV maximum at 263 nm, IR absorptions at 1640 and 1760 cm-1 for carbon-carbon
double-bonds and a lactone moiety suggested, when compared with literature data,
that 2 was a sesterterpene tetronic acid (Rothberg & Shubiak, 1975; Gonzáles,
Rodríguez & Barrientos, 1983; Barrow et al., 1988). After assignment of all protons
to their directly bonded carbon atoms via a 1H-13C 2D NMR shift correlated
measurement (HMQC), it was possible to deduce two major molecular fragments from
the 1H-1H COSY spectrum of 2. Thus, coupling was observed from H-1 (δ 7.34, m) to
H-2 (δ 6.26, brs), H-2 to H-4 (δ 7.21, brs) and H-4 to H2-5 (δ 2.39, dd, J = 7.6,
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8.1 Hz). Further, H2-5 coupled to H2-6 (δ 1.63, m), which in turn coupled with H2-7
(δ 2.05, m), clearly delineating the first molecular fragment; the furan moiety through
to C-7. Coupling of H3-19 (δ 1.03, d, J = 6.5 Hz) to H-18 (δ 2.77, m), H-18 to H-20
(δ 5.15, d, J = 9.7 Hz) and to H2-17 (δ 1.37, brm), H2-17 to H2-16 (δ 1.94, m), and
H2-16 to H-15 (δ 5.09, tq, J = 7.0, 1.0), which further coupled to H3-14 (q,
J = 1.0 Hz), characterised a second major fragment of the molecule; C-20 to C-13.
1H-1H couplings from other proton resonances could not be interpreted unambiguously
due to signal overlapping.
Figure 5: 1H-13C long-range (HMBC) NMR spectrum of 2; CDCl3, 400 MHz for
1H, 100 MHz for 13C.
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A long-range 1H-13C 2D NMR shift correlated measurement (HMBC) made with 2
permitted the molecule to be further elaborated. Thus, long-range couplings from C-21
(142.8 ppm) to H-20 and to H3-25 (δ 2.06, s), and between C-22 (162.0 ppm) and
H-20, the methoxyl protons (δ 4.11, s), and H3-25, as well as between C-24
(171.0 ppm) and H3-25 clearly established, together with the C-20 to C-13 fragment,
the C-25 to C-13 part of 2. Remaining to be accounted for were two methylene
groups, CH2-11 and CH2-12, both with identical chemical shift in the 1H NMR
spectrum (δ 2.00, m), and a double-bond (δ 5.13, m), substituted with a methyl group
(δ 1.67, s). Through detailed analysis of all homo- and heteronuclear NMR correlation
spectra it was evident that the two methylene groups are adjacent, as are H2-11 and
H-10. With the major part of the molecule established the C-9 to C-12 fragment had
thus to be located between C-7 and C-13, giving rise to a the basic structure of a
strobilinin derivative.
Depending on the geometry of the double-bond, methyl groups on isolated double-
bonds in sesterterpene tetronic acids show characteristic 1H NMR chemical shifts:
δ > 1.6 for the Z- and δ < 1.6 for the E-isomer, the corresponding 13C NMR chemical
shifts being > 20 ppm and < 20 ppm, respectively, for the equivalent carbon atoms
(Gonzáles, Rodríguez & Barrientos, 1983; Barrow et al., 1988). Thus, 1H NMR shifts
of δ 1.65 and δ 1.67 for H-14 and H-9 and 23.4 ppm for C-9 and C-14 established the
Z-configuration at both ∆8,10 and ∆13,15. NOE difference measurements (600 MHz),
with irradiation at the resonances for the olefinic protons (δ 5.1), led to the
enhancement of the signals for both CH3-9 and CH3-14, clearly confirming the 8Z,13Z
geometry of both ∆8,10 and ∆13,15. The geometry of ∆20, 21 was also determined as Z by
comparison of the 13C chemical shifts for C-17 to C-23 with published data for
(7E,12E,20Z)-22-O-methylvariabilin (Barrow et al., 1988).
The absolute configuration at C-18 in related sesterterpene tetronic acids was
determined by degradation studies and shown to be S in (7E,12E,20Z)-variabilin from
an Amphimedon sp., and Ircinia variabilis and found to be R in (8E,13Z,20Z)- and
(8Z,13E,20Z)-strobilinin (Ishibashi et al., 1993; Capon, Dargaville & Davies, 1994).
Although literature data differ markedly, a negative optical rotation, e.g., -36° for
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(18S)-variabilin (Capon, Dargaville & Davies, 1994) seems to be typical for the 18S
isomers, with a positive rotation, e.g., +36° for (18R)-strobilinin acetates (Capon,
Dargaville & Davies, 1994) for the 18R isomers. In the case of 2 an optical rotation of
-43.7° suggests it to be 18S. Compound 2 is thus (8Z,13Z,18S,20Z)-22-O-
methylstrobilinin, indicating 2a to be the new natural product (8Z,13Z,18S,20Z)-
strobilinin.
Compound 3 was shown by accurate mass measurement to have the identical
molecular formula as 2, C26H36O4. The 1H-13C short-range (HMQC) spectrum of 3
permitted correlation of all proton and carbon resonances of directly bonded atoms. By
comparing these NMR data of 3 with those for 2, it was evident that the C-16 to C-25
part of 3 was identical to that of 2. Strobilinin derivatives such as 2 show characteristic
chemical shifts for the C-5 and C-6 methylene groups in their 1H NMR spectra at δ 2.4
and δ 1.6, whereas these protons in variabilins resonate at δ 2.4 and δ 2.2. The
characteristic 1H NMR chemical shifts for the methylene groups H2-5 and H2-6 at
δ 2.45 (dd, J = 7.1, 7.6 Hz) and δ 2.24 (ddd, J = 7.1, 7.1, 7.6 Hz) respectively, thus
suggested 3 to be, in contrast to 2, a variabilin derivative. 1H-1H COSY and 1H-13C
heteronuclear long-range (HMBC) measurements established the connectivities
between H2-5 and H2-6, and between H2-6 and C-7. From the 1H-1H COSY it was also
clear that H-7 coupled with H3-9 (δ 1.58, s), the resonance of which showed a cross
peak to C-10 (39.9 ppm) in the HMBC spectrum. C-10 in turn had an HMBC
correlation to H-12 (δ 5.08, brt, J = 6.1 Hz), which further coupled to H2-11 (δ 2.00,
m) and H3-14 (δ 1.64, s). From H3-14 heteronuclear coupling to C-13 (135.1 ppm),
and to C-15 (31.7 ppm) was seen in the HMBC spectrum. H-15 (δ 2.00, m) then
coupled to H2-16 (δ 1.35, m), as is evidenced by the relevant cross-peaks in the
1H-1H COSY of 3. The geometry of double-bonds was determined as outlined for 2.
Chemical shifts of δ 1.58 for H3-9 and of 16.0 ppm for C-9, and δ 1.64 for H3-14 and
23.3 ppm for C-14 suggested the 7E,12Z configuration. This was confirmed by NOE
difference measurements: irradiation at δ 5.16 (H-7) did not affect the intensity of the
signal for H3-9, whereas irradiation at δ 5.08 resulted in an enhancement of the
1H NMR signal of H3-14. On the basis of almost identical 13C NMR chemical shifts of
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compounds 2 and 3 in the region of the tetronic acid moiety it was concluded that 3
also has the 20Z-configuration. The optical rotation of 3 (-33.1°) suggested the
absolute configuration at C-18 to be S on the same grounds as discussed for 2. Thus,
compound 3 is (7E,12Z,18S,20Z)-22-O-methylvariabilin, indicating 3a to be the new
natural product (7E,12Z,18S,20Z)-variabilin.
O
O
O
O
O
O
O
O
O O
O
O
O
O
O
O
O
O
O
O R
R
R
R
R
2   R = CH3
2a R = H
3   R = CH3
3a R = H
4   R = CH3
4a R = H
6   R = CH3
6a R = H
5   R = CH3
5a R = H
1
4 9
14
19 24
Compounds 4, 5 and 6 were identified as the 22-O-methyl derivatives of
(7E,12E,18S,20Z)-variabilin (4a), (7E,13Z,18S,20Z)-variabilin (5a) and (7Z,12Z,20Z)-
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variabilin (6a) by comparison of their 1H and 13C NMR spectroscopic data and their
optical rotations with published values (Gonzáles, Rodrígues & Barrientes, 1983;
Barrow et al., 1988).
After completion of the present investigation, five sesterterpene tetronic acid acetates,
derivatives of (8Z,13Z,20Z)-strobilinin, (7Z,13Z,20Z)-felixinin, (8E,13Z,20Z)-
strobilinin, (7E,13Z,20Z)-felixinin and (7E,12E,20Z)-variabilin, have been reported
from Ircinia felix, I. strobilina and I. campana from the Colombian Caribbean
(Martinez et al., 1997). Despite derivatisation only one of the compounds was
obtained in a pure form, the others were analysed as mixtures. In this work the C-18
was tentatively assigned as having the R absolute configuration based on the optical
rotations recorded from the mixtures (ratio 1:1), +34.8° and +45.6°, respectively. This
assignment may indeed be correct since the stereo- and regiochemistry of the carbon-
carbon double bonds and/or methylation or acetylation of the tetronic acid moiety
appears to have only a modest affect on the optical rotation of this class of compounds
(Ishibashi et al., 1993; Capon, Dargaville & Davies, 1994). Compound 2 of the present
study has the same basic structure as (8Z,13Z,18R,20Z)-strobilinin acetate isolated by
Martinez et al. (1997), as part of a mixture. Optical rotation comparisons, however,
indicated 2a to be the enantiomer of (8Z,13Z,18R,20Z)-strobilinin.
(8Z,13Z,18S,20Z)-22-O-Methyl-strobilinin (2): Colourless oil (4.1 mg, 0.005 %); [α]20D -43.7o
(c 0.4, CHCl3); UV (EtOH) λmax 263 nm (ε 19900); IR (film) νmax 2927, 1760, 1640, 1453, 1356,
1060, 982 cm-1; 1H NMR (CDCl3, 600 MHz) δ 1.03 (3H, d, J = 6.5 Hz, H-19), 1.37 (2H, brm, H-17),
1.63 (2H, m, H-6), 1.65 (3H, d, J = 1.0 Hz, H-14), 1.67 (3H, s, H-9), 1.94 (2H, m, H-16), 2.00 (4H,
m, H-11, H-12), 2.05 (2H, m, H-7), 2.06 (3H, s, H-25), 2.39 (2H, dd, J = 7.6, 8.1 Hz, H-5), 2.77 (1H,
m, H-18), 4.11 (3H, s, OCH3), 5.09 (1H, tq, J = 7.0, 1.0 Hz, H-15), 5.13 (1H, m, H-10), 5.15 (1H, d,
J = 9.7 Hz, H-20), 6.26 (brs, H-2), 7.21 (brs, H-3), 7.34 (m, H-1); 13C NMR (CDCl3, 100 MHz) δ 8.6
(q, C-25), 20.6 (q, C-19), 23.4 (q, C-9, C-14), 24.7 (t, C-5), 25.8 (t, C-16), 26.3 (t, C-11), 28.3 (t,
C-6), 30.7 (d, C-18), 31.4 (t, C-7), 32.1 (t, C-12), 37.5 (t, C-17), 58.8 (q, OCH3), 99.0 (s, C-23), 110.9
(d, C-2), 115.1 (d, C-20), 124.9 (d, C-15), 125.1 (s, C-3), 125.2 (d, C-10), 135.0 (s, C-8), 135.3 (s,
C-13), 138.7 (d, C-4), 142.6 (d, C-1), 142.8 (s, C-21), 162.0 (s, C-22), 171.0 (s, C-24); EIMS m/z
[M]+ 412 (6), 397 (1), 223 (13), 205 (10), 167 (17), 149 (100), 135 (19), 111 (16),109 (10); HREIMS
m/z 412.261 (calcd for C26H36O4, 412.261).
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(7E,12Z,18S,20Z)-22-O-Methyl-variabilin (3): Colourless oil (7.0 mg, 0.008 %); [α]20D -33.1o
(c 0.7, CHCl3); UV (EtOH) λmax 263 nm (ε 12100); IR (film) νmax 2926, 1759, 1638, 1451, 1356,
1060, 1028, 981 cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.04 (3H, d, J = 6.6 Hz, H-19), 1.35 (4H, m,
H-16, H-17), 1.58 (3H, s, H-9), 1.64 (3H, s, H-14), 2.00 (6H, m, H-10, H-11, H-15), 2.06 (3H, s,
H-20), 2.24 (2H, ddd, J = 7.1, 7.1, 7.6 Hz, H-6), 2.45 (2H, dd, J = 7.1, 7.6 Hz, H-5), 2.77 (1H, m,
H-18), 4.11 (3H, s, OCH3), 5.08 (1H, brt, J = 6.1 Hz, H-12), 5.15 (1H, d, J = 9.7 Hz, H-20), 5.16 (1H,
t, J = 7.1 Hz, H-7), 6.27 (1H, brs, H-2), 7.21 (1H, brs, H-4), 7.33 (1H, brs, H-1); 13C NMR (CDCl3,
100 MHz) δ 8.6 (q, C-25), 16.0 (q, C-9), 20.7 (q, C-19), 23.3 (q, C-14), 25.0 (t, C-5), 25.7 (t, C-16),
26.4 (t, C-11), 28.4 (t, C-6), 30.9 (d, C-18), 31.7 (t, C-15), 36.9 (t, C-17), 39.9 (t, C-10), 58.8 (q,
OCH3), 99.1 (s, C-23), 111.1 (d, C-2), 115.1 (d, C-20), 123.8 (d, C-7), 125.0 (s, C-3), 125.0 (d, C-12),
135.1 (s, C-13), 135.7 (s, C-8), 138.8 (d, C-4), 142.5 (d, C-1), 142.7 (s, C-21), 162.0 (s, C-22), 171.0
(s, C-24); EIMS m/z [M]+ 412 (24), 397 (7), 331 (3), 318 (4), 207 (15), 204 (19), 193 (24), 181 (33),
167 (100), 149 (42), 141 (61), 135 (60), 123 (46), 109 (34), 81 (80); HREIMS m/z 412.261 (calcd for
C26H36O4, 412.261).
(7E,12E,18S,20Z)-22-O-Methyl-variabilin (4): Colourless oil (44.4 mg, 0.05 %); [α]20D -40.8o
(c 0.7, CHCl3); 1H NMR (CDCl3, 400 MHz) δ 1.03 (3H, d, J = 6.6 Hz, H-19), 1.35 (4H, m, H-16,
H-17), 1.55 (3H, s, H-14), 1.58 (3H, s, H-9), 1.94 (2H, m, H-15), 1.99 (2H, m, H-10), 2.06 (2H, m,
H-11), 2.06 (3H, s, H-20), 2.24 (2H, ddd, J = 7.1, 7.1, 7.6 Hz, H-6), 2.44 (2H, t, J = 7.6 Hz, H-5),
2.76 (1H, m, H-18), 4.11 (3H, s, OCH3), 5.07 (1H, brt, J = 6.6 Hz, H-12), 5.15 (1H, d, J = 10.2 Hz,
H-20), 5.16 (1H, m, H-7), 6.27 (1H, brs, H-2), 7.20 (1H, brs, H-4), 7.33 (1H, brs, H-1); 13C NMR
(CDCl3, 100 MHz) δ 8.5 (q, C-25), 15.8 (q, C-14), 16.0 (q, C-9), 20.7 (q, C-19), 25.0 (t, C-5), 25.7 (t,
C-16), 26.5 (t, C-11), 28.4 (t, C-6), 30.8 (d, C-18), 36.7 (t, C-17), 39.5 (t, C-10), 39.7 (t, C-15), 58.8
(q, OCH3), 99.0 (s, C-23), 111.1 (d, C-2), 115.2 (d, C-20), 123.7 (d, C-7), 124.3 (d, C-12), 125.0 (s,
C-3), 134.9 (s, C-13), 135.7 (s, C-8), 138.8 (d, C-4), 142.5 (d, C-1), 142.7 (s, C-21), 162.0 (s, C-22),
171.1 (s, C-24); EIMS m/z [M]+ 412 (44), 397 (12), 331 (7), 203 (26), 181 (38), 174 (34), 167 (96),
149 (42), 141 (52), 136 (74), 135 (70), 123 (55), 109 (30), 81 (100).
(7E,13Z,18S,20Z)-22-O-Methyl-variabilin (5): Colourless oil (8.7 mg, 0.01 %); [α]20D -47.2o (c 0.9,
CHCl3); UV (EtOH) λmax 263 nm (ε 13600); IR (film) νmax 2926, 1760, 1640, 1453, 1356, 1060,
982 cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.04 (3H, d, J = 7.1 Hz, H-19), 1.40 (4H, m, H-11/17), 1.58
(3H, s, H-9), 1.66 (3H, d, J = 1.5 Hz, H-14), 1.94 (6H, m, H-10/12/16), 2.06 (3H, s, H-25), 2.24 (2H,
ddd, J = 7.1, 7.1, 7.6 Hz, H-6), 2.45 (2H, dd, J = 7.1, 7.6 Hz, H-5), 2.78 (1H, m, H-18), 4.11 (3H, s,
OCH3), 5.09 (1H, dd, J = 6.6, 7.1 Hz, H-15), 5.16 (1H, m, H-7), 5.16 (1H, d, J = 10.2 Hz, H-20), 6.27
(1H, brs, H-2), 7.21 (1H, brs, H-4), 7.33 (1H, t, J = 1.5 Hz, H-1); 13C NMR (CDCl3, 100 MHz) δ 8.6
(q, C-25), 15.9 (q, C-9), 20.6 (q, C-19), 23.4 (q, C-14), 25.1 (t, C-5), 25.7 (t, C-16), 26.3 (t, C-11),
28.4 (t, C-6), 30.7 (d, C-18), 31.4 (t, C-12), 37.5 (t, C-17), 39.6 (t, C-10), 58.8 (q, OCH3), 99.0 (s,
C-23), 111.1 (d, C-2), 115.1 (d, C-20), 123.7 (d, C-7), 124.6 (d, C-15), 125.0 (s, C-3), 135.7a (s,
Results 57
C-13), 135.8a (s, C-8), 138.8 (d, C-4), 142.5 (d, C-1), 142.8 (s, C-21), 162.0 (s, C-22), 171.0 (s,
C-24), a assignments may be interchanged; EIMS m/z [M]+ 412 (35), 397 (13), 331 (10), 318 (10),
208 (44), 207 (43), 203 (44), 181 (38), 167 (81), 141 (39), 135 (86), 122 (38), 109 (33), 81 (100).
(7Z,12Z,20Z)-22-O-Methyl-variabilin (6): Colourless oil (approx. 0.005 %); 13C NMR (CDCl3,
100 MHz) δ 8.6 (q, C-25), 20.7 (q, C-19), 23.3 (2C, q, C-9 and 14), 25.3 (t, C-6), 25.8 (t, C-16), 26.3
(t, C-11), 28.3 (t, C-5), 30.9 (d, C-18), 31.6 (t, C-15), 32.3 (t, C-10), 37.0 (t, C-17), 58.8 (q, OCH3),
99.1 (s, C-23), 111.1 (d, C-2), 115.1 (d, C-20), 124.0 (d, C-7), 124.6 (d, C-12), 125.0 (s, C-3), 135.2
(s, C-13), 135.8 (s, C-8), 138.8 (d, C-4), 142.5 (d, C-1), 142.8 (s, C-21), 162.0 (s, C-22), 171.0 (s,
C-24).
4.3.3 Leucosolenia challengeri (CT 293 T)
Frozen sponge tissue was freeze-dried (125 g) and subsequently extracted with DCM
and MeOH. The DCM fraction (2.5 g of a brown oil) was fractionated by normal-
phase VLC (gradient hexane-EtOAc-MeOH) to yield five fractions. Fraction 3
(EtOAc/hexane 75/25, 46 mg) was separated by normal-phase HPLC (EtOAc/hexane
75/25) to yield compound 7 (5 mg). Fraction 4 (EtOAc, 109 mg) was separated with
the same HPLC system to yield compound 8 (5.5 mg). All other fractions did not
contain metabolites in amounts worthwhile further investigation as monitored by
1H NMR spectroscopy.
Compound 7 was obtained as a slightly yellow solid (5.5 mg). The molecule was found
to consist of two, or a multitude of two, adjacent methylene groups both substituated
with one electronegative atom or moiety, by 1H and 13C NMR spectroscopy.
Unfortunately, no reasonable MS data was obtained by EIMS, CIMS (NH3), and
GC-MS. Finally, compound 7 decomposed and its structure thus remained unresolved.
Compound 8 was an orange-yellow solid. From its DCI-MS (i-butane) spectrum the
presence of one zinc atom within the molecule could be deduced from the
characteristic molecular ion cluster. A literature search (Chapman & Hall database)
revealed natural products containing zinc to be quite rare. A molecular ion at m/z
[M]+ 745 suggested 8 to be a known clathridine zinc complex, which could be
confirmed by comparison of its 1H and 13C NMR data with literature values (Ciminiello
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et al., 1989; He et al., 1992). In this respect, it is interesting to note that the 1H NMR
signal of the protons of the dioxymethylene-moiety (δ 5.89, 2H, dd, J = 1.1, 8.3 Hz,
H-7’), is not the expected singlet. This effect might be due to the spatial orientation of
the two clathridine molecules forming the complex, resulting in both hydrogen atoms
not being equivalent.
O
O N
N
N
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Unknown 1 (7): slightly yellow solid (5 mg); UV (EtOH) no significant adsorption above 210 nm; IR
(film) νmax 3310, 3050, 3020, 2990, 1415, 1335, 1300, 1250, 1210, 1175, 1155, 1110, 960, 760, 670,
615, 465 cm-1; 1H NMR (CDCl3, 400 MHz) δ 3.89 (2H (?), ddd, J = 4.1, 7.1, 7.1 Hz, JCH = 155 Hz),
4.30 (2H (?), dt, J = 2.0, 7.1 Hz, JCH = 149 Hz), 5.26 (1H, brs); 13C NMR (CDCl3, 100 MHz)
δ 28.2 (t), 61.0 (t).
Clathridine Zn complex (8): orange-yellow solid (5.5 mg); 1H NMR (CDCl3, 300 MHz) δ 3.03 (3H,
s, H-13), 3.36 (1H, d, J = 16.6 Hz, H-14a), 3.50 (1H, d, J = 16.6 Hz, H-14b), 3.80 (3H, s, H-12), 5.89
(2H, dd, J = 1.1, 8.3 Hz, H-7’), 6.24 (1H, s, H-2’), 6.26 (1H, d, J = 7.5 Hz, H-6’), 6.50 (1H, d,
J = 7.5 Hz, H-5’), 6.63 (1H, s, H-5); 13C NMR (CDCl3, 300 MHz) δ 24.6 (q, C-13), 32.6 (q, C-12),
33.1 (t, C-14), 101.1 (t, C-7’), 107.7 (d, C-5’), 108.4 (d, C-2’), 117.5 (d, C-5), 121.1 (d, C-6’), 131.1
(s, C-1’), 136.3 (s, C-4), 146.1 (s, C-4’), 147.6 (s, C-3’), 148.6 (s, C-2), 154.5 (s, C-7), 161.4 (s, C-11),
164.6 (s, C-9); DCI-MS (i-butane) m/z 752 (1), 751 (4), 750 (14), 749 (42), 748 (30), 747 (62),
746 (38), 745 (100) [M(64Zn)+H]+, 744 (6), 342 (28), 246 (12).
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4.4 Chemical investigation of extracts from selected fungal strains
Extracts of ten sponge-derived and one algal-derived fungi, including the two obligate
marine mitosporic fungi Asteromyces cruciatus and Varicosporina ramulosa, were
investigated chemically. Most strains were selected because of prominent activity of
their extracts in the biological screening assays. This led to the isolation of 30 pure
secondary metabolites. Six compounds, (+)-2,4-dimethyl-4,5-dihydrofuran-3-
carbaldehyde (10) from A. cruciatus, (3S)-(3’,5’-dihydroxyphenyl)butan-2-one (16) and
2-((1’E)-propenyl)-octa-(4E,6Z)-diene-1,2-diol (17) from a Coniothyrium sp.,
microsphaeropsisin (26) from a Microsphaeropsis  sp, ulocladol (39) from Ulocladium
botrytis and 9,10-dihydro-(6R,11R,12R,14R)-colletodiol (46) from V. ramulosa,
proved to be new structures, and further three compounds, (3S,5R)-dimethyl-
dihydrofuran-2-one (11) from A. cruciatus, 5,7-dimethoxy-4,6-dimethylphthalide (33)
from a Monochaetia sp. and 9,10-dihydro-(6R,11S,12S,14R)-colletodiol (45) from
V. ramulosa were for the first time obtained as natural products.
4.4.1 Acremonium sp. H5-65
The stock cultures of strain H5-65 produced orange-yellow crystals in the initial test
tubes at 4ºC. They could be separated from the attached agar and turned out to be
pure 9 (7.1 mg).
Compound 9 was shown to possess the molecular formula
C10H12O4 by HREIMS, indicating five elements of
unsaturation within the molecule. Its 1H NMR spectrum
consisted of only two singlets (δ 2.01 and 3.99), most
probably representing two methyl groups and two methoxyl
groups, respectively. The 13C NMR spectra (1H decoupled
and DEPT) revealed additionally to the signals expected for
the carbon atoms of the methyl (12.1 ppm) and the methoxyl
(61.1 ppm) groups three signals representing sp2-hybridized carbon atoms (138.9,
O
O
O
O
9
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144.4 and 184.3 ppm) one of them possessing a chemical shift typical for carbon atoms
of the carbonyl moieties in quinones (184.3 ppm). Together with the molecular
formula deduced from the HREIMS, this meant that all signals observed in the NMR
spectra accounted for two moieties or atoms, implying a high degree of symmetry
within the molecule. These findings corresponded best with tetra-substituted quinones,
leaving three possible structures: 2,6-dimethoxy-3,5-dimethylquinone, 2,5-dimethoxy-
3,6-dimethylquinone and 2,3-dimethoxy-5,6-dimethylquinone. A literature search
(Beilstein data base) revealed these three quinones all to be known; compound 9 could
then shown to be 2,3-dimethoxy-5,6-dimethylquinone (aurantiogliocladin) by
comparison of its spectroscopic data with published values (Perri & Moore, 1990).
Aurantiogliocladin (9): orange-yellow crystals (7.1 mg); mp 63°C; UV (EtOH) λmax 270 nm; IR
(film) νmax 2965, 2665, 2650, 1610, 1455, 1385, 1330, 1270, 1205, 1090, 1050, 940, 925, 865, 735,
545 cm-1; 1H NMR (CDCl3, 300 MHz) δ 2.01 (6H, s, 2 × CH3), 3.99 (6H, s, 2 × OCH3); 13C NMR
(CDCl3, 100 MHz) δ 12.1 (2C, q, 2 × CH3), 61.1 (2C, q, 2 × OCH3), 138.9 (2C, s, 2 × C-OCH3),
144.4 (2C, s, 2 × C-CH3), 184.3 (2C, s, 2 × C=O); EIMS m/z [M]+ 196 (100), 181 (50), 173 (25),
167 (14), 153 (33), 151 (71), 125 (30), 123 (64), 97 (40); HREIMS m/z 196.0716 (calcd for C10H12O4,
196.0736).
4.4.2 Asteromyces cruciatus H5-81
A. cruciatus was one of the obligate marine fungi obtained during this study. On all
media tested, it produced abundant brownish-black conidia, which could easily be
separated together with the mycelium from the growth medium by scraping them off.
Thus, fungus and medium were investigated separately. The two different growth
media were combined for extraction and yielded 473 mg of a brown oil (EtOAc
extract). Subsequent normal-phase VLC (gradient hexane-EtOAc-MeOH) yielded four
fractions. Fractions 1 (hexane/EtOAc 50/50, 352 mg) and 2 (EtOAc, 31 mg) were
further separately purified by normal-phase HPLC (hexane/EtOAc 75/25) to give
compounds 10 (6.1 mg), 11 (5.3 mg) and 12 (6.1 mg, fraction 2). Mycelium and
conidia were freeze-dried (23 g), crushed in a mortar and subsequently extracted with
hexane (500 ml) and MeOH (3 × 500 ml). The MeOH extract was suspended in
EtOAc and the residue subjected to reversed-phase VLC (MeOH) giving 4.09 g of a
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gum. Further normal-phase VLC (EtOAc/MeOH/H2O/HOAc 60/15/15/10) yielded
compounds 13-15.
Compound 10 was obtained as a colourless oil, and proved to be
too volatile for direct EIMS analysis. GC-EIMS however,
resulted in the detection of its molecular ion [M]+ at m/z 126. The
13C NMR spectra of 4 (1H decoupled and DEPT) revealed signals
for seven carbon atoms, including one aldehyde moiety
(185.0 ppm, d, CHO-3), two quaternary sp2-hybridized carbon atoms (120.5 ppm, s,
C-3; 174.6 ppm, s, C-2), two methyl groups (12.5 ppm, q, CH3-2; 19.3 ppm, q,
CH3-4), one methylene group adjacent to an oxygen (79.3 ppm, t, C-5), and one
methine group (34.8 ppm, d, C-4). From the 1H NMR spectrum the molecular
fragment from CH3-4 (δ 1.21, d, J = 6.6 Hz) to H-4 (δ 3.34, m) and H2-5 (δ 4.06, dd,
J = 5.1, 9.2 Hz and δ 4.54, dd, J = 9.2, 9.7 Hz) could be established. Thus, CH3-2,
CHO-3, C-4 and OCH2-5 (via the oxygen) had to be connected to the carbon-carbon
double bond. 1H-13C long-range (HMBC) correlations between CHO-3, and both C-3
and C-4, and both CH3-4 and H-4, and C-3, respectively, connected CHO and C-4 to
C-3. CH3-2 and the oxomethylene group had therefore to be the other substituents on
the double bond. 10 is the new compound (+)-2,4-dimethyl-4,5-dihydrofuran-3-
carbaldehyde.
From the 1H and 13C NMR spectra of compound 11 the
presence of two methyl groups, two methine groups, one of
which had to be further connected to an oxygen atom, one
methylene group, and one carboxyl moiety could be
deduced. The 1H-1H COSY NMR spectrum revealed the
connectivity of all hydrogen-bearing moieties. GC-MS resulted in a molecular ion at
m/z [M]+ 114, suggesting a molecular formula of C6H10O2. Thus, the carboxyl group
had to be part of a lactone moiety, completing the basic structure of 11. By
comparison of the NMR data and its optical rotation of +3.8° with published values
(Davies, Polywka & Warner, 1990; Chu, Negrete & Konopelski, 1991) 11 was found
to be (3S,5R)-dimethyl-dihydrofuran-2-one. This is the first report of this compound as
a natural product.
O
OHC
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The 1H NMR spectrum of compound
12 revealed signals typical for the
glycerol-part of triglycerides (δ 4.14,
2H, dd, J = 5.8, 12.0 Hz, H-1a/H-3a;
δ 4.29, 2H, dd, J = 4.3, 12.0 Hz,
H-1b/H-3b, and δ 5.25, m, H-2).
Additionally to the two expected
signals due to the three carbon atoms of the glycerol-moiety (62.3 and 69.1 ppm), the
13C NMR spectrum revealed for the acid-part of the molecule only signals attributable
to the carbon atoms of three methyl groups and three ester moieties. Thus, 12 was
presumed to be tri-O-acetyl-glycerol. This could be confirmed by comparison of the
spectroscopic data with literature values (Numata et al., 1990).
Investigation of the conidia and mycelium extract by 1H NMR spectroscopy revealed it
to consist mainly of sugars and polyols. Three main compounds could be separated,
and were identified as D-arabitol (13), D-mannitol (14) and D-trehalose (15) by GC and
NMR spectroscopy by comparison with authentic material. Not all of the extract was
separated, total amounts were estimated to be 3.7 g D-arabitol, 2.8 g D-mannitol and
10.8 g D-trehalose per 100 g freeze-dried mycelium.
CH2OH
HO H
H OH
H OH
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(+)-2,4-Dimethyl-4,5-dihydrofuran-3-carbaldehyde (10): colourless oil (6.1 mg; 1.2 mg/L
medium), [α]20D +38.9° (c 0.61, CHCl3); UV (EtOH) λmax 272 nm (ε 2570); IR (film) νmax 2930, 2740,
2730, 1730, 1635, 1625, 1455, 1395, 1240, 1120, 1035 cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.21 (3H,
d, J = 6.6 Hz, CH3-4), 2.16 (3H, brs, CH3-2), 3.34 (1H, m, H-4), 4.06 (1H, dd, J = 5.1, 9.2 Hz, H-5),
4.54 (1H, dd, J = 9.2, 9.7 Hz, H-5), 9.71 (1H, s, CHO); 13C NMR (CDCl3, 100 MHz) δ 12.5 (q,
O
O
O
O
O
O
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CH3-2), 19.3 (q, CH3-4), 34.8 (d, C-4), 79.3 (t, C-5), 120.5 (s, C-3), 174.6 (s, C-2), 185.0 (d, CHO);
GC-EIMS m/z [M]+ 126 (100), 111 (80), 83 (97), 55 (68), 43 (98); HRMS, sample decomposed prior
to this measurement.
(3S,5R)-Dimethyl-dihydrofuran-2-one (11): colourless oil (5.3 mg; 1.1 mg/L medium); [α]20D +3.8°
(c 0.53, CHCl3); 1H NMR (CDCl3, 400 MHz) d 1.26 (3H, d, J = 7.1 Hz, CH3-3), 1.41 (3H, d,
J = 6.1 Hz, CH3-5), 1.46 (1H, m, H-4a), 2.51 (1H, m, H-4b), 2.67 (1H, m, H-3), 4.46 (1H, m, H-5);
13C NMR (CDCl3, 100 MHz) d 15.1 (q, CH3-3), 20.9 (q, CH3-5), 36.4 (d, C-3), 39.1 (t, C-4), 74.9 (d,
C-5), 179.5 (s, C-2); GC-EIMS m/z [M]+ 114 (3), 70 (66), 55 (96), 45 (22), 42 (100).
Tri-O-acetyl-glycerol (12): colourless oil (6.1 mg;1.2 mg/L medium); 1H NMR (CDCl3, 300 MHz)
δ 2.08 (6H, s, 2 × CH3), 2.09 (3H, s, CH3), 4.14 (2H, dd, J = 5.8, 12.0 Hz, H-1a/H-3a), 4.29 (2H, dd,
J = 4.3, 12.0 Hz, H-1b/H-3b), 5.25 (1H, m, H-2); 13C NMR (CDCl3, 75.5 MHz) δ 20.7 (q, 2 × CH3),
20.9 (q, CH3-2'), 62.3 (t, C-1/C-3), 69.1 (d, C-2), 170.1 (s, C=O), 170.5 (s, 2 × C=O)
D-Arabitol (13): [α]20D +9.5° (c 0.26, H2O); 1H NMR (D2O, 400 MHz) δ 3.64 (1H, m), 3.72 (2H, m),
3.81 (1H, m), 3.86 (1H, m), 3.91 (1H, m), 3.99 (1H, m); 13C NMR (D2O, 100 MHz) δ 63.3 (t),
63.5 (t), 70.7 (d), 70.9 (d), 71.4 (d).
D-Mannitol (14): [α]20D +10.9° (c 0.11, H2O); 1H NMR (D2O, 200 MHz) δ 3.50 - 3.95 (8H, m).
D-Trehalose (15): [α]20D +129.1° (c 0.44, H2O); 1H NMR (D2O, 400 MHz) δ 3.49 (2H, brt,
J = 9.2 Hz), 3.69 (2H, brdd, J = 3.6, 10.2 Hz), 3.81 (2H, m), 3.88 (6H, m), 5.24 (2H, brd, J = 4.1 Hz);
13C NMR (D2O, 100 MHz) δ 60.9 (t), 70.1 (d), 71.4 (d), 72.5 (d), 72.9 (d), 93.6 (d).
4.4.3 Coniothyrium sp. 193H77
Culture extracts of Coniothyrium strain 193H77 showed prominent inhibition of
several test-organisms in the initial screening for antimicrobial activity in agar diffusion
assays: inhibition zones (extract from culture in liquid Biomalt-ASW-medium) against
B. megaterium 0.2 cm, M. violaceum and E. repens 1.0 cm, M. microspora 0.5 cm
and C. fusca 0.8 cm. These results, together with the presence of 7-10 major
compounds in the extract as monitored by TLC, promoted further chemical
investigation. The EtOAc extract (1.75 g of a brown oil) of a new, upscaled cultivation
was fractionated by normal-phase VLC (gradient hexane-EtOAc) to yield five
fractions. Fractions 3 (hexane/EtOAc 75/25, 250 mg) and 4 (hexane/EtOAc 50/50,
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149 mg) were further separated by normal-phase HPLC (hexane/EtOAc 80/20) to
yield 18 (5 mg), 21 (12 mg), and 23 (17 mg). Further purification of one previous
HPLC fraction with reversed-phase (C-18) HPLC (MeOH/H2O 70/30) yielded 20
(5.1 mg). Fraction 5 (EtOAc, 75 mg) was separated by normal-phase HPLC
(hexane/EtOAc 70/30) to yield 16 (1.2 mg), 17 (1.3 mg), 19 (7.0 mg) and 22 (3.0 mg).
The molecular formula of 16 was established as C10H12O3
by accurate mass measurement, indicating the molecule to
have five elements of unsaturation. 1H NMR
measurements revealed the presence of two methyl
groups (δ 1.35, d, J = 6.8 Hz, H3-4 and δ 2.08, s, H3-1),
the first with an adjacent methine group (δ 3.63, q,
J = 6.8 Hz, H-3), and the other connected to a double
bond, two hydroxyl groups (δ 5.19, brs), and three
aromatic hydrogens (δ 6.27, m). From the 13C NMR and DEPT spectra a carbonyl
group (209.3 ppm, s, C-2) and three quaternary aromatic carbons (143.2 and
2 × 157.3 ppm), were deduced. These findings, together with UV maxima at 217 and
280 nm suggested the presence of a 1,3,5-trisubstituted aromatic ring. The 13C NMR
chemical shifts of the ring carbons, ranging from 101.8 to 157.3 ppm, showed the
typical influence of electronegative ring substituents. Thus, the two OH-groups had to
be phenolic, accounting for two of the three substituents on the aromatic ring. The
1H NMR signal for the methyl group H3-1 (δ 2.08) appeared as a singlet, indicating it
to be adjacent to the carbonyl group C-2, leaving the methine group to be positioned
between it and the aromatic ring, thus giving 16. Comparison of the 1H NMR shifts of
16 with published values for the di-methoxy-derivative clearly substantiated the
structure proposed for 16 (Cristol, Mahfuza & Sankar, 1989). The absolute
configuration at C-3 was determined as S by comparison of the optical rotation of 16
(+124.0o) to those of similar 3-phenylbutan-2-ones, e.g., -350o for (3R)-phenylbutan-2-
one, +340o for (3S)-phenylbutan-2-one (Fuganti et al., 1984), and +218o for
(3S)-(p-methoxyphenyl)butan-2-one (Collins & Hobbs, 1970). Thus, 16 is the new
compound (3S)-(3’,5’-dihydroxyphenyl)butan-2-one.
OHHO
O
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Compound 17 was obtained as a clear
oil. CIMS with NH3 gave ions at m/z
182 [M]+ and 200 [M + NH4]+. CIMS
with i-butane resulted in ions at m/z
182 [M]+ and 165 [MH - H2O]+, while
GC-EIMS yielded fragment ions at m/z
101 [M - C6H9]+ and 151 [M -
CH2OH]+; the molecular formula of 17 is C11H18O2. From a 1H-13C 2D NMR shift
correlated measurement (HMQC) 16 hydrogens could be assigned to their directly
bonded carbon atoms, revealing the presence of two methyl groups (13.3 ppm, C-8
and 17.8 ppm, C-3’), one methylene group (41.2 ppm, C-3), one methylene group
adjacent to an oxygen (68.8 ppm, C-1), six olefinic methine groups (125.6 ppm, C-7;
126.5 ppm, C-2’; 127.4 ppm, C-4; 129.0 ppm, C-6; 129.7 ppm, C-5 and 133.3 ppm,
C-1’) and one quaternary carbon atom (74.8 ppm, C-2) adjacent to oxygen. Thus, two
hydroxyl groups had to be present within the molecule. From the 1H-1H COSY
spectrum the molecular fragments from C-3 to C-8 and C-1’ to C-3’ could be
established. Coupling was observed between H-1’ (δ 5.47, dd, J = 1.6, 15.7 Hz) and
H-2’ (δ 5.77, dq, J = 6.8, 15.7 Hz), H-2’ and H3-3’ (δ 1.75, brd, J = 6.8 Hz). Further,
H2-3 (δ 2.40, m) coupled with H-4 (δ 5.62, ddd, J = 7.6, 7.6, 15.2 Hz), H-4 with H-5
(δ 6.45, dd, J = 11.4, 15.2 Hz), H-5 with H-6 (δ 5.99, brdd, J = 10.8, 11.4 Hz), H-6
with H-7 (δ 5.45, dq, J = 6.8, 10.8 Hz) and H-7 with H3-8 (δ 1.75, brd, J = 6.8 Hz).
HMBC 1H-13C long-range correlations observed between H2-3, H-4, H-1’ and C-2
linked both these fragments to the quaternary carbon atom C-2. The hydrogens of the
remaining hydroxymethyl group C-1, showed long-range correlations to C-3, thus, also
had to be connected to C-2. The configurations of the double bonds were determined
to be 4E,6Z,1’E on the basis of the 1H-1H spin coupling constants (J = 15.2, 10.8 and
15.7 Hz, respectively), and confirmed by NOE difference measurements. Irradiation at
the 1H NMR frequency of H3-8 and H3-3’ enhanced the signals of both H-5 and H-1’,
confirming the Z-configuration at ∆6,7 and the E-configuration at ∆1’,2’. Thus, 17 is the
new compound 2-((1’E)-propenyl)-octa-(4E,6Z)-diene-1,2-diol.
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The 1H NMR spectra of compounds 18 and 19
revealed signals typical for mellein derivatives (cf.
4.4.6; compounds 27-29): one methyl group
(δ 1.54, d, J = 6.4 Hz) adjacent to a methine
group (around δ 4.75, m) substituted with oxygen
and a methylene group (around δ 2.85); and one
hydroxyl group with a hydrogen atom (around
δ 11.5, s) deshielded due to a hydrogen bond to a
carbonyl moiety. The 1H NMR spectra of 18 and
19 additionally contained signals due to one methoxyl group and two, respectively one
(19), hydrogen atom(s) on an aromatic ring. In compound 18 these two hydrogen
atoms were located meta to each other as judged by the value of their 1H-1H spin
coupling constant (J = 2.3 Hz), suggesting the methoxyl group to be positioned in
between, and thus giving 6-methoxymellein. In compound 19 the remaining substituent
of the aromatic ring was obviously a chlorine atom, the presence of which could be
clearly derived from the molecular ion cluster in the EIMS spectrum. By comparison of
the spectroscopic data with published values, 19 could be shown to be 6-methoxy-7-
chloromellein (MacGahren & Mitcher, 1968). The stereochemistry at C-3 of both
compounds was established as R by comparison of their optical rotations with
published values (McGahren & Mitcher, 1968).
EIMS revealed for compound 20 a molecular ion at
m/z [M]+ 266, and proved two chlorine atoms to be
present within the molecule. From the 1H NMR
spectrum the presence of one methyl group (δ 1.81,
d, J = 4.9 Hz) and one methoxyl group (δ 3.91, s)
could be deduced. Additionally, two broad singlets
(δ 2.97 and δ 3.97, 1H each), presumably
accounting for the hydrogen atoms of two
OH-groups, and two multiplets at δ 4.47 and δ 6.20, each accounting for two
hydrogen atoms, were observed. The 13C NMR spectrum revealed signals due to 10
carbon atoms, including five sp2-hybridised carbon atoms of double-bonds, one of
O
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R
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them involved in a carboxyl moiety. Further structure elucidation by 1H-1H COSY and
1H-13C long-range (HMBC) correlation NMR measurements was hindered due to the
overlapping signals of four hydrogen atoms. A literature search (Chapman & Hall
database) for molecules containing two chlorine atoms and possessing a molecular
mass around 266 resulted in cryptosporiopsinol as the most probable structure for 20.
This could then be confirmed by comparison of 1H and 13C NMR data and optical
rotation with published values (Giles & Turner, 1969; Holker & Young, 1975).
O
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Compounds 21-23 were identified as 2-phenylethanol, 2-(p-hydroxyphenyl)ethanol and
2-(hydroxymethyl)furan by NMR spectroscopy and MS.
(3S)-(3’,5’-Dihydroxyphenyl)butan-2-one (16): colourless oil (1.2 mg, 0.16 mg/L medium); [α]20D
+124.0° (c 0.12, CHCl3); UV (EtOH) λmax 217 nm (ε 27900) and 280 nm (ε 1170); IR (film) νmax
3250, 2920, 2850, 1670, 1605, 1455, 1155 cm-1; 1H NMR (CDCl3, 300 MHz) δ 1.35 (3H, d,
J = 6.8 Hz, H-4), 2.08 (3H, s, H-1), 3.63 (1H, q, J = 6.8 Hz, H-3), 5.19 (2H, brs, OH-3’/5’), 6.27 (3H,
m, H-2’/H-4’/H-6’); 13C NMR (CDCl3, 75.5 MHz) δ 16.9 (q, C-4), 28.3 (q, C-1), 53.5 (d, C-3), 101.8
(d, C-4’), 107.4 (d, C-2’/C-6’), 143.2 (s, C-1’), 157.3 (s, C-3’/C-5’), 209.3 (s, C-2); EIMS m/z [M]+
180 (55), 149 (45), 137 (100); HREIMS m/z 180.078 (calcd for C10H12O3, 180.079).
2-((1’E)-Propenyl)-octa-(4E,6Z)-diene-1,2-diol (17): colourless oil (1.3 mg, 0.17 mg/L medium);
[α]20D -13.8° (c 0.13, CHCl3); UV (EtOH) λmax 235 nm (ε 12600); IR (film) νmax 3385, 2925, 2855,
1675, 1450, 1440, 1375, 1055, 1035, 985, 970 cm-1; 1H NMR (CDCl3, 600 MHz) δ 1.75 (6H, brd,
J = 6.8 Hz, H-8/H-3’), 2.40 (2H, m, H-3), 3.48 (2H, m, H-1), 5.45 (1H, dq, J = 6.8, 10.8 Hz, H-7),
5.47 (1H, dd, J = 1.6, 15.7 Hz, H-1’), 5.62 (1H, ddd, J = 7.6, 7.6, 15.2 Hz, H-4), 5.77 (1H, dq, J = 6.8,
15.7 Hz, H-2’), 5.99 (1H, brdd, J = 10.8, 11.4 Hz, H-6), 6.45 (1H, dd, J = 11.4, 15.2 Hz, H-5);
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13C NMR (CDCl3, 100 MHz) δ 13.3 (q, C-8), 17.8 (q, C-3’), 41.2 (t, C-3), 68.8 (t, C-1), 74.8 (s, C-2),
125.6 (d, C-7), 126.5 (d, C-2’), 127.4 (d, C-4), 129.0 (d, C-6), 129.7 (d, C-5), 133.3 (d, C-1’); CIMS
(NH3) m/z 200 (100) [M + NH4]+, 182 (15) [M]+; CIMS (i-butane) m/z 182 (15) [M]+, 165 (100)
[MH - H2O]+; GC-EIMS m/z 151 (8) [M - CH2OH]+, 101 (100) [M - C6H9]+, 83 (92), 69 (62), 55 (86);
HRMS, sample decomposed prior to this measurement.
(3R)-6-Methoxymellein (18): colourless oil (5 mg, 0.67 mg/L medium); [α]20D -18° (c 0.5, CHCl3);
1H NMR (CDCl3, 200 MHz) δ 1.54 (3H, d, J = 6.4 Hz, CH3-3), 2.88 (2H, m, H-4), 3.87 (3H, s,
OCH3), 4.80 (1H, m, H-3), 6.23 (1H, d, J = 2.3 Hz), 6.43 (1H, d, J = 2.3 Hz), 11.33 (1H, s, OH).
(3R)-6-Methoxy-7-chloromellein (19): white solid (7 mg, 0.93 mg/L medium); [α]20D -47° (c 0.3,
CHCl3); 1H NMR (CDCl3, 300 MHz) δ 1.53 (3H, d, J = 6.0 Hz, CH3-3), 2.91 (2H, m, H-4), 3.96 (3H,
s, OCH3), 4.70 (1H, m, H-3), 6.33 (1H, s, H-5), 11.69 (1H, s, OH-8); 13C NMR (CDCl3, 75.5 MHz)
δ 20.6 (q, CH3-3), 34.8 (t, C-4), 56.5 (q, OCH3), 75.7 (d, C-3), 101.1 (d, C-5), 102.9 (s, C-8a), 108.3
(s, C-7), 138.9 (s, C-4a), 159.2a (s, C-6), 160.8a (s, C-8), 169.5 (s, C-1), a assignments may be
interchanged; EIMS m/z 244 (32), 242 (100) [M]+, 226 (10), 224 (30), 200 (23), 198 (66).
Cryptosporiopsinol (20): white solid (5.1 mg, 0.68 mg/L medium); [α]20D -25.5° (c 0.26, CHCl3);
1H NMR (CDCl3, 300 MHz) δ 1.81 (3H, d, J = 4.9 Hz, H-1), 2.97 (1H, brd, J = 11.0 Hz, OH-6), 3.91
(3H, s, OCH3), 3.97 (1H, brs, OH-8), 4.47 (2H, m, H-7/H-8), 6.20 (2H, m, H-2/H-3); 13C NMR
(CDCl3, 75.5 MHz) δ 19.4 (q, C-1), 54.5 (q, OCH3), 66.0 (d, C-7), 75.5 (d, C-6), 87.2 (s, C-8), 120.6
(d, C-3), 133.1 (s, C-5), 134.4 (d, C-2), 137.0 (s, C-4), 172.1 (s, COO); EIMS m/z 270 (<1), 268 (5),
266 (9) [M]+, 252 (2), 250 (11), 248 (16), 215 (16), 213 (48), 209 (64), 207 (100), 197 (19), 195 (29),
187 (6), 185 (20), 173 (15), 171 (35), 161 (10), 159 (19), 145 (10), 143 (30).
2-Phenylethanol (21): colourless oil (12 mg, 1.6 mg/L medium); 1H NMR (CDCl3, 200 MHz) δ 2.87
(2H, t, J = 6.5 Hz), 3.86 (2H, t, J = 6.5 Hz), 7.25 (5H, m); GC-EIMS m/z [M]+ 112 (100), 97 (7),
84 (20), 83 (25), 69 (39), 55 (37).
2-(p-Hydroxyphenyl)ethanol (22): colourless oil (3.0 mg, 0.4 mg/L medium); 1H NMR (acetone-d6,
200 MHz) δ 2.65 (2H, t, J = 7.1 Hz), 3.62 (2H, brt, J = 7.1 Hz), 6.68 (2H, m), 6.99 (2H, m); EIMS
m/z [M]+ 138 (34), 107 (100).
2-(Hydroxymethyl)furan (23): colourless oil (17 mg, 2.3 mg/L medium); 1H NMR (CDCl3,
300 MHz) δ 4.61 (2H, brs), 6.29 (1H, dd, J = 0.7, 3.4 Hz), 6.34 (1H, dd, J = 1.9, 3.4 Hz), 7.40 (1H,
dd, J = 0.7, 1.9 Hz); 13C NMR (CDCl3, 75.5 MHz) δ 57.5 (t), 107.8 (d), 110.3 (d), 142.6 (d),
153.9 (s).
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4.4.4 Emericellopsis minima H7-65
The isolate of E. minima was chosen for further chemical investigation because of
prominent antimicrobial activity of its extracts as observed in preliminary agar diffusion
assays: inhibition zones (extract from culture on Biomalt medium) against
B. megaterium 0.6 cm, M. violaceum 1.5 cm, E. repens 0.8 cm, F. oxysporum 0.2 cm,
C. fusca 0.5 cm. Although the EtOAc extract obtained from the up-scaled recultivation
of the strain proved to be inactive in the same assays, it was further investigated
chemically. Thus, the extract (1.06 g of a brown oil) was fractionated by normal-phase
VLC (gradient hexane-EtOAc-MeOH) to yield 14 fractions. Fraction 4 (hexane/EtOAc
70/30, 67.7 mg) was further separated by normal-phase HPLC (hexane/EtOAc 75/25)
to yield compound 24 (19.6 mg).
The 13C NMR spectrum of 24 revealed signals for 16
aliphatic carbon atoms and one carbon atom of a
carboxyl moiety (170.5 ppm, s). By DEPT and 1H-13C
shift correlated (HMQC) NMR measurements, the 16
aliphatic moieties could be shown to consist of five
methyl groups, three methylene groups, one of them
presumably connected to an oxygen atom, five
methine groups (two of them adjacent to an oxygen
atom) and three quaternary carbon atoms (one of
them adjacent to an oxygen atom). The 1H NMR
spectrum additionally revealed the presence of two hydroxyl groups. By 1H-1H COSY
NMR measurements, the molecular part from CH3-11 and CHOH-10 to CH-5 could
be established. The structure was further elaborated by interpretation of the 1H-13C
long-range (HMBC) NMR spectrum of 24. Long-range correlations observed between
both H-4 and the hydrogens (δ 2.02) of one methyl group, and the carbon atom of the
carboxyl moiety revealed an acetate as substituent at C-4. Further long-range
correlations between both CH3-12 and CH3-13, and C-5, C-6 and C-7, and between
CH3-14 and C-7, C-8, C-9 and C-15 established the molecular part from CH-5 to C-9
and to CH2-15. Additional long-range correlations between both H-5 and H-1, and
C-9, and between CH2-15 and C-10 connected the molecular fragments to a three ring
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system, leaving the remaining OH-group to be positioned at C-9. A literature search
(Chapman & Hall database) revealed compound 24 to possess an identical basic
structure as dihydrobotrydial (Fehlhaber et al., 1974). It could be shown to be identical
with this metabolite by comparing the NMR data and optical rotation with published
values.
Dihydrobotrydial (24): colourless crystals (19.6 mg; 2.2 mg/L medium); mp. 164°C; [α]20D +36.7°
(c 0.39, CHCl3); 1H NMR (CDCl3, 400 MHz) δ 0.98 (3H, d, J = 6.1 Hz, H-11), 1.07 (1H, m, H-3a),
1.11 (3H, s, H-12 or H-13), 1.17 (1H, d, J = 11.7 Hz, H-7a), 1.26 (3H,s, H-12 or H-13), 1.28 (3H, s,
H-14), 1.64 (1H, d, J = 12.7 Hz, H-1), 1.80 (1H, m, H-2), 1.88 (1H, d, J = 11.7 Hz, H-7b), 1.90 (1H,
d, J = 10.7 Hz, H-5), 2.02 (3H, s, CH3CO), 2.06 (1H, m, H-3b), 3.25 (1H, d, J = 10.7 Hz, H-15a),
3.52 (1H, brs, OH-9 or OH-10), 3.60 (1H, s, OH-9 or OH-10), 4.19 (1H, d, J = 10.7 Hz, H-15b), 5.08
(1H, ddd, J = 5.1, 10.7, 11.2 Hz, H-4), 5.33 (1H, brs, H-10); 13C NMR (CDCl3, 100 MHz) δ 20.1 (q,
C-11), 21.4 (q, CH3CO), 25.3 (q, C-14), 27.3 (q, C-12 or C-13), 28.7 (d, C-2), 35.9 (q, C-12 or C-13),
38.8 (s, C-6), 39.9 (t, C-3), 45.4 (s, C-8), 50.4 (t, C-7), 55.0 (d, C-1), 60.0 (d, C-5), 67.6 (t, C-15),
72.7 (d, C-4), 83.4 (s, C-9), 92.5 (d, C-10), 170.5 (s, CH3CO); EIMS m/z [M - H2O]+ 294 (11),
252 (9), 235 (16), 234 (20), 175 (52), 86 (67), 84 (100).
4.4.5 Microascus sp. K14
The Microascus strain K 14 had been chosen for further chemical investigation
because of prominent antifungal activity observed in agar diffusion assays: inhibition
zones (extract from culture on Biomalt medium) against B. megaterium 0.1 cm,
M. violaceum 0.2 cm, E. repens 1.3 cm. 0.5 g of the EtOAc extract of a recultivation
was fractionated by normal-phase VLC (gradient petrol ether-EtOAc-MeOH) to yield
four fractions. Fraction 3 (MeOH/EtOAc 50/50) was further fractionated by normal-
phase HPLC (petrol ether/acetone 50/50). The major compound remained on the
column and was eluted with pure acetone to give 25 (5 mg).
The 1H NMR spectrum of 25 revealed the presence of two methyl groups on double
bonds (δ 1.72, s, 3H and δ 1.75, s, 3H), two methyl groups attached to electro-
negative atoms such as oxygen or nitrogen (δ 3.62, s, 3H and δ 3.72, s, 3H), one
E substituted double bond (δ 6.70 and δ 7.56; 1H each, J = 15.4 Hz), one methylene
group (δ 3.42, d, J = 6.8 Hz), and two methine groups (δ 5.01, m and δ 7.99, brs).
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From the 13C NMR spectra (1H decoupled and DEPT)
the additional presence of four sp2-hybridised
quaternary carbon atoms could be deduced, one of
them most probably part of an ester moiety. After
assignment of all protons to their directly bonded
carbon atoms via a 1H-13C 2D NMR shift correlated
measurement (HMQC), the structure of 25 was
further elaborated by interpretation of its 1H-13C
longe-range (HMBC) NMR spectrum. Long-range
coupling was observed between both the hydrogen
atoms of the methoxyl group and and those of the E
substituted double-bond, and the carbon atom of the ester moiety, establishing the
molecular part from the methoxyl group to C-3. Further long-range correlations
between both CH3-12, CH3-13 and CH2-9, and both C-10 and C-11 established a
second fragment of the molecule. Both fragments were connected via the two
sp2-hybridised carbon atoms C-4 and C-8: thus long-range correlations between both
H-3 and CH2-9, and C-4 and C-8 were observed. This left only one methyl group and
the methine group C-6 to be positioned. The chemical shifts of this methyl group
(δ 3.62 and 32.2 ppm) suggested it to be attached to a nitrogen atom. The
corresponding protons showed long-range correlations only with C-8 and C-6, thus the
N-methyl group had to be positioned in between these two carbon atoms. The methine
group CH-6 had further to form a double-bond with a hetero-atom due to the absence
of additional carbon atoms, and thus giving an N-methylimidazole structure for the
central part of 25. The positioning of the N-methyl group and the assignment of C-4
and C-8 was so far only tentative, it could have been proven by difference NOE
measurements. A literature search (Beilstein database), however, revealed both
possible isomers to be known. A closer inspection showed them to be isolated from
two different Fusarium spp., and to be published with almost identical NMR data (the
5-NCH3 isomer as visoltricin: Visconti & Solfrizzo, 1994; the 7-NCH3 isomer as
fungerin: Kato et al., 1996), both data sets being in good agreement with the data
obtained in this study. A recent total sythesis (Benhida, Lezama & Fourrey, 1998)
confirmed the structure proposed by Kato et al. Thus, 25 is fungerin.
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Fungerin (25): colourless solid (5 mg; 3.3 mg/L medium); 1H NMR (CDCl3, 300 MHz) δ 1.72 (3H,
brs, H-12), 1.75 (3H, brs, H-13), 3.42 (2H, d, J = 6.8 Hz, H-9), 3.62 (3H, s, NCH3), 3.76 (3H, s,
OCH3), 5.01 (1H, m, H-10), 6.70 (1H, d, J = 15.4 Hz, H-2), 7.56 (1H, d, J = 15.4 Hz, H-3), 7.99 (1H,
brs, H-6); 13C NMR (CDCl3, 75.5 MHz) δ 18.0 (q, C-13), 22.3 (t, C-9), 25.5 (q, C-12), 32.2 (q,
NCH3), 51.5 (q, OCH3), 116.4 (d, C-2), 118.5 (d, C-10), 132.0 (s, C-4), 132.9 (d, C-3), 134.1 (s, C-8),
135.1 (s, C-11), 138.1 (d, C-6), 168.0 (s, C-1).
4.4.6 Microsphaeropsis sp. H5-50
The Microsphaeropsis strain H5-50 had been chosen for further chemical investigation
because of prominent antimicrobial activity of its extracts as observed in preliminary
agar diffusion assays: inhibition zones (extract from culture on Biomalt medium)
against B. megaterium 0.3 cm, M. violaceum 1.0 cm, E. repens 0.5 cm, C. fusca
0.3 cm). TLC investigation of this extract revealed at least five main components. The
EtOAc extract of a recultivation (0.93 g of brown oil) was fractionated by normal-
phase VLC (gradient hexane-EtOAc) to yield 4 fractions. Fraction 2 (145 mg) was
further fractionated by normal-phase HPLC (hexane/EtOAc 70/30) to yield
26 (1.3 mg), 27 (20.8 mg), 28 (425 mg), and 29 (51 mg). Further purification of one
previous HPLC fraction with reversed-phase (C-18) HPLC (MeOH/H2O 75/25)
yielded 30 (5 mg) and 31 (0.5 mg).
The molecular formula of 26 was determined as C16H22O4 by accurate mass
measurement. 13C NMR spectroscopy (1H decoupled and DEPT) showed that three of
the six elements of unsaturation, as indicated by the molecular formula of 26, could be
attributed to two carbon-carbon double bonds (126.3 ppm, d, C-2; 126.9 ppm, d, C-9;
140.9 ppm, s, C-10 and 143.9 ppm, d, C-1), and a carbonyl group (204.2 ppm, s, C-3);
the molecule is thus tricyclic. After association of all 1H NMR resonances with the
13C NMR resonances of the directly bonded carbon atoms via a 1H-13C 2D NMR
shift-correlated measurement (HMQC), the presence of a single OH-group was evident
(δ 3.03, d, J = 1.9 Hz). 1H and 13C NMR spectra further revealed the presence of one
methoxyl group (48.3 ppm), two methylene groups (42.1 ppm, t, C-6 and 72.8 ppm, t,
C-12), one of which had to be attached to oxygen, two methine groups (δ 2.10, m,
H-11 and δ 2.27, q, J = 7.3 Hz, H-4) with adjacent methyl groups (δ 0.98, d,
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J = 7.3 Hz, H3-15 and δ 1.05, d,
J = 7.3 Hz, H3-13), one quaternary methyl
group (δ 1.39, s, H3-14), and three
quaternary carbon atoms (39.7 ppm, s, C-5;
78.2 ppm, s, C-7 and 101.3 ppm, s, C-8),
including one substituted with an oxygen
containing functionality and one as part of
an acetal moiety. From the 1H-1H COSY of
26 three fragments of the molecule could be deduced. Thus, coupling was observed
between H3-15 and H-4, H3-13 and H-11, and further to H2-12. The only other 1H-1H
spin system involved the methine protons H-1 (δ 6.89, d, J = 9.9 Hz) and H-2 (δ 5.90,
d, J = 9.9 Hz), and left C-9 and C-10 to form the second carbon-carbon double bond.
An UV maximum at λ = 280 nm suggested the double bonds and the carbonyl group
to be conjugated. This deduction was confirmed via a 1H-13C HMBC measurement
which revealed the carbonyl group (C-3) and the ∆9,10 double bond both to be
connected to the ∆1,2 double bond. Long-range correlations between both H-4 and
H3-15 and C-3 established the connectivity between C-3 and C-4. Correlations
between H3-14 and C-4, C-5, C-6 and C-10 showed that C-14 was bound to C-5, and
further C-5 to C-4, C-10 and C-6, thus establishing the first of the three rings.
Further, long-range correlations between the hydrogens of the hydroxyl and the
methoxyl group and C-7 and C-8, respectively, located the hydroxyl group at C-7 and
the methoxyl group at C-8. As C-8, evidenced by its 13C NMR chemical shift
(101.3 ppm) is the carbon atom involved in the acetal moiety, it had to be further
connected to the methylene group C-12 via the remaining oxygen atom. Further long-
range correlations between the 7-OH and C-6, and between both H3-13 and H-11 and
C-7 connected both C-6 and C-11 to C-7, leaving the acetal moiety (C-8) to be bound
to both C-7 and C-9, thus completing the planar structure of 26.
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Figure 6: 1H-1H COSY NMR spectrum of 26; CDCl3, 300 MHz.
The relative configurations at the five chiral centres were established by NOE
difference measurements. Irradiation at the resonance frequency of H3-15 (δ 0.98) only
enhanced the signal of H-6α, whereas irradiation at δ 1.39 (H3-14) enhanced the
signals of H-4, H-6β and 7-OH. Irradiation at δ 1.87 (H-6α) enhanced the signals of
H-11 and H3-15; irradiation at δ 3.03 (7-OH) enhanced the signals of H3-13, H3-14
and the methoxyl group. Further, irradiation at the resonance frequency of H3-13
(δ 1.05) enhanced the signals of H-12β and 7-OH. Thus, H-4, H-6β, 7-OH, H-12β,
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H3-13, H3-14 and the methoxyl group had to be on the same side of the molecule, and
H-6α and H3-15 on the other side. Finally, irradiation at δ 6.24 (H-9) enhanced the
signal of H-1, confirming the double bond assignments. Compound 26 is thus a new
natural product of the eremophilane type for which the trivial name microsphaeropsisin
is suggested.
The 1H NMR spectrum of compound 27 showed signals
typical for the hydrogen atoms of a 1,2,3-trisubstituted
aromatic ring (δ 6.68, 1H, dd, J = 0.9, 7.4 Hz, δ 6.88,
1H, d, J = 8.3 Hz, and δ 7.42, 1H, dd, J = 7.4, 8.3 Hz),
a methyl group (δ 1.54, d, J = 6.3 Hz) adjacent to a
methine group (δ 4.73, dq, J = 6.3, 7.3 Hz) substituted
with an oxygen atom, a methylene group (δ 2.92, d,
J = 7.3 Hz) adjacent to the aromatic ring and a hydroxyl
group (δ 11.07, s) involved in a hydrogen bond to a carbonyl moiety. Together with its
characteristic smell, compound 27 was presumed to be the widespread fungal
metabolite mellein. The 1H NMR spectra of compounds 28 and 29 revealed in
comparison to mellein, that one hydrogen atom of the methylene group was substituted
for an oxygen, the rest of the molecule seemed to be unaltered. Compounds 27-29
were then identified by comparison of their spectroscopic data and optical rotations
with published values as the known fungal metabolites R-mellein (Holker & Simpson,
1981; Garson, Staunton & Jones, 1984), (3R,4S)-hydroxymellein (Devys et al., 1992;
Izawa et al., 1989), and (3R,4R)-hydroxymellein (Izawa et al., 1989; Aldridge et al.,
1971).
Compound 30 appeared to be similar to 28 and 29 as judged
by interpretation of its 1H NMR spectrum, except for the
methyl group and one aliphatic methine group, which were
obviously replaced in 30 by two methylene groups. EIMS
revealed a molecular ion at m/z [M]+ 178. With this
information, a literature search (Chapman & Hall database)
showed compound 30 to be 4,8-dihydroxy-3,4-dihydro-2H-
O
OOH
R1R2
27  R1 = R2 = H 
28  R1 = OH, R2 = H
29  R1 = H, R2 = OH
OOH
OH
30
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naphthalene-1-one (Findlay & Kwan, 1973; Talapatra et al., 1988). The observed
optical rotation of zero for 30 suggested the isolate to be racemic.
The 1H NMR spectrum of compound 31 was
similar to that of 30. A corresponding CH2-CH2-
CHO-fragment could be deduced. Only one signal
due to a hydrogen atom on an aromatic ring was
present, instead a signal due to one additional
methyl group on a double bond was observed, and
the signal of the hydrogen atom of the OH-group
at δ 12.41 was replaced by two signals further
downfield (δ 14.34 and δ 14.98), each representing one hydrogen atom. Unfortunately,
compound 31 was too scarce for recording a 13C NMR spectrum. NOE difference
measurements with irradiation at the resonance frequency of the hydrogen atom on the
aromatic ring resulted in an enhancement of the signal of the hydrogen atom of the
other methine group, whereas irradiation at the resonance frequency of the hydrogens
of the methyl group gave no positive NOE. EIMS revealed a molecular ion at m/z
[M]+ 236, suggesting in combination with the NMR data a molecular formula of
C12H12O5. A fragment ion at m/z 221 most probably resulted from the loss of the
methyl group. Taking these results into account and presuming for 31 a basic structure
similar to that of 30, the only differences were likely to be the substituents at C-6 and
C-7. These substituents may consist of one acetyl moiety and one OH-group.
Unfortunately, compound 31 decomposed before further measurements could be
performed. A literature search (Chapman & Hall and Beilstein databases) with the
confirmed structural fragments revealed no structure to fit the described data.
Microsphaeropsisin (26): colourless solid (1.3 mg, 0.29 mg/L medium); mp 152-154°C; [α]20D
-97.7° (c 0.13, CHCl3); UV (EtOH) λmax 223 nm (ε 2250) and 280 nm (ε 8560); IR (film) νmax 3515,
2925, 1665, 1245, 1205, 1180, 1025 cm-1; 1H NMR (CDCl3, 300 MHz) δ 0.98 (3H, d, J = 7.3 Hz,
H-15), 1.05 (3H, d, J = 7.3 Hz, H-13), 1.39 (3H, s, H-14), 1.68 (1H, d, J = 14.2 Hz, H-6β), 1.87 (1H,
brd, J = 14.2 Hz, H-6α), 2.10 (1H, ddq, J = 6.5, 7.3, 8.4 Hz, H-11), 2.27 (1H, q, J = 7.3 Hz, H-4),
3.03 (1H, d, J = 1.9 Hz, OH-7), 3.43 (3H, s, OCH3), 3.50 (1H, dd, J = 6.5, 8.8 Hz, H-12β), 4.13 (1H,
dd, J = 8.4, 8.8 Hz, H-12α), 5.90 (1H, d, J = 9.9 Hz, H-2), 6.24 (1H, s, H-9), 6.89 (1H, d, J = 9.9 Hz,
OH
O
HO
OH
31 (tentative structure)
O
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H-1); 13C NMR (CDCl3, 75.5 MHz) δ 14.4 (q, C-13), 14.6 (q, C-15), 27.4 (q, C-14), 39.7 (s, C-5),
42.1 (t, C-6), 42.9 (d, C-11), 48.3 (q, OCH3), 53.5 (d, C-4), 72.8 (t, C-12), 78.2 (s, C-7), 101.3 (s,
C-8), 126.3 (d, C-2), 126.9 (d, C-9), 140.9 (s, C-10), 143.9 (d, C-1), 204.2 (s, C-3); EIMS m/z [M]+
278 (100), 247 (56), 221 (56), 203 (94), 162 (54), 134 (70); HREIMS m/z 278.151 (calcd for
C16H22O4 278.152).
R-Mellein (27): white solid (20.8 mg, 4.6 mg/L medium); mp. 52-54°C; [α]20D -76° (c 1.04, CHCl3);
1H NMR (CDCl3, 200 MHz) δ 1.54 (3H, d, J = 6.3 Hz), 2.92 (2H, d, J = 7.3 Hz), 4.73 (1H, dq,
J = 6.3, 7.3 Hz), 6.68 (1H, dd, J = 0.9, 7.4 Hz), 6.88 (1H, brd, J = 8.3 Hz), 7.42 (1H, dd, J = 7.4,
8.3 Hz), 11.07 (1H, s).
(3R,4S)-Hydroxymellein (28): white crystals (425 mg, 94 mg/L medium); mp. 132-136°C; [α]20D
-13° (c 0.53, CHCl3); IR (film) νmax 3400, 3200, 2985, 1655, 1465, 1425, 1400, 1365, 1310, 1280,
1235, 1215, 1110, 1090, 1070, 1050, 985, 955, 820, 790, 745, 695, 590, 470 cm-1; 1H NMR (CDCl3,
300 MHz) δ 1.52 (3H, d, J = 6.1 Hz), 2.35 (1H, brs), 3.49 (1H, brs), 4.61 (2H, m), 6.99 (1H, d,
J = 7.5 Hz), 7.02 (1H, d, J = 6.5 Hz), 7.56 (1H, dd, J = 6.5, 7.5 Hz), 11.01 (1H, brs); 13C NMR
(CDCl3, 75.5 MHz) δ 17.9 (q), 69.1 (d), 80.0 (d), 106.7 (s), 116.3 (d), 117.8 (d), 136.9 (d), 141.1 (s),
161.9 (s), 168.5 (s); EIMS m/z [M]+ 194 (60), 150 (100), 122 (73), 121 (97).
(3R,4R)-Hydroxymellein (29): white crystals (51 mg, 11 mg/L medium); mp. 113-114°C; [α]20D
-39.6° (c 0.59, MeOH); 1H NMR (CDCl3, 300 MHz) δ 1.61 (3H, d, J = 6.6 Hz), 2.04 (1H, brs), 4.58
(1H, d, J = 1.8 Hz), 4.72 (1H, dq, J = 1.8, 6.6 Hz), 6.94 (1H, d, J = 7.4 Hz), 7.04 (1H, dd, J = 1.0,
8.5 Hz), 7.54 (1H, dd, J = 7.4, 8.5 Hz), 11.02 (1H, brs); 13C NMR (CDCl3, 75.5 MHz) δ 16.0 (q),
67.2 (d), 78.2 (d), 106.8 (s), 118.3 (d), 118.5 (d), 136.8 (d), 140.5 (s), 162.0 (s), 169.2 (s).
4,8-Dihydroxy-3,4-dihydro-2H-naphthalene-1-one (30): white solid (5 mg, 1.1 mg/L medium);
[α]20D 0° (c 0.13, MeOH); 1H NMR (CDCl3, 300 MHz) δ 1.84 (1H, brs, OH-4), 2.19 (1H, m, H-3a),
2.35 (1H, m, H-3b), 2.65 (1H, ddd, J = 4.9, 8.3, 17.9 Hz, H-2a), 3.01 (1H, ddd, J = 4.9, 8.3, 17.9 Hz,
H-2b), 4.92 (1H, m, H-3), 6.93 (1H, d, J = 8.3 Hz), 7.02 (1H, d, J = 7.2 Hz), 7.50 (1H, dd, J = 7.2,
8.3 Hz, H-6), 12.41 (1H, s, OH-8); 13C NMR (CDCl3, 75.5 MHz) δ 31.2 (t), 34.6 (t), 67.7 (d),
115.3 (s), 117.3 (d), 117.8 (d), 137.0 (d), 145.8 (s), 162.7 (s), 204.2 (s); EIMS m/z [M]+ 178 (100),
160 (12), 150 (30), 122 (39), 121 (87).
Unknown 2 (31): white solid (0.5 mg, 0.1 mg/L medium); 1H NMR (CDCl3, 300 MHz) δ 2.13 (1H,
m), 2.32 (1H, m), 2.65 (1H, ddd, J = 4.9, 9.8, 18.1 Hz), 2.77 (3H, s), 2.92 (1H, ddd, J = 4.9, 6.8,
18.1 Hz), 4.80 (1H, dd, J = 3.8, 8.7 Hz), 6.63 (1H, brs), 14.34 (1H, brs), 14.98 (1H, s); EIMS m/z
[M]+ 236 (64), 221 (100).
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4.4.7 Monochaetia sp. 193A20
Extracts of small scale cultures of Monochaetia strain 193A20 possessed significant
antifungal, and to a lesser degree, antibacterial activity: inhibition zones (extract from
fungal culture on MS-ASW medium) against B. megaterium 0.3 cm, M. violaceum
0.8 cm, E. repens 1.4 cm, F. oxysporum 0.4 cm, M. microspora 0.4 cm). These
findings together with the fact that this genus had not been investigated chemically thus
far as judged by a literature search (Chapman & Hall and Beilstein databases) seemed
to warrant further chemical investigation. The EtOAc extract of an up-scaled
recultivation (4.6 g of brown oil) was fractionated by normal-phase VLC (gradient
hexane-EtOAc-MeOH) to yield five fractions. Agar diffusion assays revealed the
previously observed antimicrobial activity against B. megaterium and M. violaceum to
be concentrated in fractions 3 and 4. Both fractions were separated by normal-phase
HPLC; only fraction 3 yielded pure compounds in amounts allowing further structure
elucidations. Thus, fraction 3 (EtOAc/hexane 75/25, 200 mg) was separated by
normal-phase HPLC (petrol ether/acetone 70/30) to give compounds 32 and 33, and a
mixture of fatty acid monoglycerides. This mixture was further separated by reversed-
phase HPLC (MeOH/H2O 81/15) to yield compounds 34 and 35.
O
OO
O
O
OOH
O
32 33
Compound 32 had a molecular formula of C11H12O4 as determined by HREIMS,
indicating six elements of unsaturation within the molecule. The 13C NMR spectrum
revealed the presence of seven quaternary sp2-hybridised carbon atoms (106.1, 116.5,
118.5, 143.4, 153.8, 163.8 and 173.0 ppm), probably part of an aromatic ring and one
carboxyl moiety. In combination with the 1H NMR spectrum two methyl (δ 2.16, s and
δ 2.21, s), one methoxyl (δ 3.78, s) and one methylene group (δ 5.22, s) adjacent to
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oxygen could be deduced, representing four of the six substituents on the aromatic
ring. Thus, the signal in the 1H NMR spectrum at δ 7.70 was due to the hydrogen atom
of an OH group, deshielded due to a weak hydrogen bond to the carboxyl moiety,
suggesting both groups to be adjacent substituents on the aromatic ring. The carboxyl
moiety then further had to form a lacton via the methylene group, the structure of 32
being a substituted phthalide. The substitution pattern of the two methyl and the one
methoxyl group on the aromatic ring was established by comparing the spectroscopic
data of 32 with literature values for different phthalides (see below). The 1H and
13C NMR spectra of compound 33 were closely similar to those of 32 except for the
lack of a signal due to a hydrogen atom of an OH group, and the presence of a signal
due to an additional methoxyl group. This suggested 33 to be the methoxyl derivative
of 32. Thus, 32 turned out to be the known fungal metabolite 7-hydroxy-5-methoxy-
4,6-dimethylphthalide, first isolated from a Hansfordia sp. (Schneider, Anke &
Sterner, 1997), and 33 to be 5,7-dimethoxy-4,6-dimethylphthalide, previously only
reported as a methylation product of 5,7-dihydroxy-4,6-dimethylphthalide (Achenbach,
Mühlenfeld & Brillinger, 1985).
The HPLC separations further resulted in the isolation
of two fatty acid monoglycerides (34 and 35), as
judged by their 1H NMR spectra. The signal due to
hydrogen atom at position 2 of the glycerol-part of
the molecules had a chemical shift of δ 3.93. Thus, the
corresponding OH-2 group was not esterified, because this would result in a
deshielding of the hydrogen atom at C-2, in which case it resonates around δ 5.0.
Therefore the esterification had to be at position 1. A structure elucidation of long-
chain fatty acids by NMR spectroscopy is often hindered due to overlapping resonance
signals of methylene groups. The structure of the fatty acids was therefore further
elucidated by EIMS. Typical fragment ions at m/z 264 (for compound 34) and 262 (for
compound 35), resulting from the cleavage of the ester between the carbon atom of the
carboxyl moiety and the oxygen atom of the ester bond, revealed both fatty acids to
possess 18 carbon atoms, and one respectively two double bonds within the chain.
Compounds 34 and 35 could then be determined as 1-O-oleyl-glycerol and
OH
O
R
34 R = oleyl 
35 R = linoleyl
HO
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1-O-linoleyl-glycerol by comparison of the spectroscopic data with literature values
(Mistry & Min, 1987; Zhang, Xing & Zhang, 1997). An optical rotation of zero,
respectively, suggests both compounds to be racemic.
7-Hydroxy-5-methoxy-4,6-dimethylphthalide (32): white solid (3 mg; 0.5 mg/L medium); 1H NMR
(CDCl3, 300 MHz) δ 2.16 (3H, s, CH3-4), 2.21 (3H, s, CH3-6), 3.78 (3H, s, OCH3), 5.22 (2H, s, H-3),
7.70 (1H, s, OH); 13C NMR (CDCl3, 75.5 MHz) δ 8.5 (q, CH3-6), 11.4 (q, CH3-4), 60.3 (q, OCH3),
70.0 (t, C-3), 106.1 (s, C-7a), 116.5 (s, C-4), 118.5 (s, C-6), 143.4 (s, C-3a), 153.8 (s, C-7), 163.8
(C-5), 173.0 (s, C-1); EIMS m/z [M]+ 208 (100), 193 (14), 190 (22), 179 (75); HREIMS m/z 208.0735
(calcd for C11H12O4, 208.0736).
5,7-Dimethoxy-4,6-dimethylphthalide (33): white solid (2 mg; 0.3 mg/L medium); 1H NMR
(CDCl3, 300 MHz) δ 2.19 (3H, s, CH3-4), 2.25 (3H, s, CH3-6), 3.78 (3H, s, OCH3-5), 4.05 (3H, s,
OCH3-7), 5.15 (2H, s, H-3); 13C NMR (CDCl3, 75.5 MHz) δ 9.3 (q, CH3-6), 11.3 (q, CH3-4), 60.2 (q,
OCH3-5), 62.2 (q, OCH3-7), 68.3 (t, C-3), 112.5 (s, C-7a), 119.9 (s, C-4), 125.3 (s, C-6), 146.1 (s,
C-3a), 156.7 (s, C-7), 162.9 (s, C-5), 169.0 (s, C-1); EIMS m/z [M]+ 222 (100), 207 (21), 204 (38),
193 (64), 176 (73).
1-O-Oleyl-glycerol (34): colourless oil (5.3 mg; 0.9 mg/L medium); 1H NMR (CDCl3, 400 MHz)
δ 0.88 (3H, t, J = 6.9 Hz), 1.29 (20H, m), 1.63 (2H, m), 2.01 (4H, m), 2.35 (2H, m), 3.60 (1H, dd,
J = 5.6, 11.4 Hz), 3.69 (1H, dd, J = 4.1, 11.4 Hz), 3.93 (1H, dddd, J = 4.1, 4.6, 5.6, 6.1 Hz), 4.15 (1H,
dd, J = 6.1, 11.7 Hz), 4.21 (1H, dd, J = 4.6, 11.7 Hz), 5.34 (2H, m); 13C NMR (CDCl3, 100 MHz)
δ 14.1 (q), 22.7 (t), 24.9 (t), 27.1 (t), 27.2 (t), 29.07 (2C, t), 29.13 (t), 29.3 (2C, t), 29.5 (t), 29.7 (t),
29.8 (t), 31.9 (t), 34.1 (t), 63.3 (t), 65.2 (t), 70.3 (d), 129.7 (d), 130.0 (d), 174.3 (s); EIMS m/z [M]+
356 (5), 338 (10), 264 (75), 55 (100).
1-O-Linoleyl-glycerol (35): colourless oil (6.5 mg; 1.1 mg/L medium); 1H NMR (CDCl3, 400 MHz)
δ 0.89 (3H, t, J = 6.9 Hz), 1.31 (14H, m), 1.63 (2H, m), 2.05 (4H, m), 2.35 (2H, m), 2.77 (2H, m),
3.59 (1H, dd, J = 6.1, 11.7 Hz), 3.69 (1H, dd, J = 4.1, 11.7 Hz), 3.93 (1H, dddd, J = 4.1, 4.6, 6.1,
6.1 Hz), 4.15 (1H, dd, J = 6.1, 11.7 Hz), 4.20 (1H, dd, J = 4.6, 11.7 Hz), 5.35 (4H, m); 13C NMR
(CDCl3, 100 MHz) δ 14.1 (q), 22.6 (t), 24.9 (t), 25.6 (t), 27.17 (t), 27.20 (t), 29.08 (2C, t), 29.13 (t),
29.3 (t), 29.6 (t), 31.5 (t), 34.1 (t), 63.3 (t), 65.2 (t), 70.3 (d), 127.9 (d), 128.1 (d), 130.0 (d),
130.2 (d), 174.3 (s); EIMS m/z [M]+ 354 (4), 352 (7), 336 (4), 262 (30), 55 (100).
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4.4.8 Phoma sp. H4-77
Strain H4-77 was selected for further chemical investigations because of the significant
activity of its culture extracts in both agar diffusion and ELISA based assays. The
EtOAc extract of a recultivation of the strain (0.2 g of a green-brown oil) was
subjected to VLC (sephadex, MeOH) to yield five fractions. Fractions 2 (50 mg) and
3 (70 mg) were further separated by reversed-phase HPLC (MeOH/H2O 85/15,
UV-detection 210-400 nm) to yield 36 as pale yellow crystals.
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Compound 36 seemed to represent a relatively large molecule as judged by its complex
1H NMR spectrum. Additionally, the signals in the downfield region (δ 6.5 to 7.5)
underwent some slight shifts during the separation process, as obvious when
comparing 1H NMR spectra from the crude extract, the fractions and the pure
compound. 13C NMR spectroscopy revealed the presence of 33 carbon atoms, and by
EIMS a molecular ion at [M]+ m/z 548 was observed. A literature search (Chapman &
Hall database) for natural products with a corresponding mass showed such
compounds to be quite rare and revealed two possible structures, pycnidione (Harris
et al., 1993) isolated from a Phoma sp., and its C-8 epimer eupenifeldin (Mayerl et al.,
1993) isolated from Eupenicillium brefeldianum. Comparison of 1H and 13C NMR
data and the optical rotation of 36 with published values for these two compounds
revealed it to be pycnidione.
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Pycnidione (36): pale yellow crystals (9.3 mg; 6.2 mg/L medium); mp. 190°C (decomp.); [α]20D
+207.7° (c 0.31, DCM/MeOH 2/1); 1H NMR (400 MHz, CDCl3) δ 1.07 (3H, s), 1.10 (3H, s),
1.10 - 1.35 (2H, m), 1.22 (3H, s), 1.27 (3H, s), 1.65 (2H, m), 1.85 (1H, m), 2.15-2.55 (4H, m), 2.39
(6H, 2s), 2.69 (2H, m), 3.00 (1H, dd), 3.65 (1H, d), 5.41 (2H, m), 6.94 (1H, s), 7.00 (1H, s), 7.10 (1H,
s), 7.12 (1H, s); 13C NMR (CDCl3, 100 MHz) δ 15.9 (q, C-35), 18.6 (q, C-33), 21.9 (q, C-31), 27.1 (q,
C-30), 27.2 (q, C-34), 31.2 (q, C-31), 31.4 (d, C-8), 33.5 (t, C-25), 33.9 (t, C-23), 34.1 (t, C-7), 36.7
(s, C-10), 39.5 (d, C-24), 46.1 (t, C-9), 48.7 (t, C-13), 76.2 (d, C-26), 81.6 (s, C-14), 83.8 (s, C-27),
112.8 (d, C-1), 113.7 (d, C-17), 120.3 (s, C-6), 121.9 (d, C-22), 122.3 (s, C-12), 124.0 (d, C-20),
124.5 (d, C-4), 143.7 (d, C-11), 149.5 (s, C-21), 149.7 (s, C-5), 159.9 (s, C-29), 160.6 (s, C-16),
163.5 (s, C-2), 164.0 (s, C-18), 171.5 (s, C-19), 172.4 (s, C-3); EIMS m/z [M]+ 548 (100).
4.4.9 Scopulariopsis candida H7-19
The isolate of S. candida was chosen for further chemical investigations because of
prominent antifungal activity of extracts of small scale cultivations (Biomalt medium,
inhibition zones against M. violaceum 2.5 cm, E. repens 2.0 cm, M. microspora
1.3 cm). The EtOAc extract of a recultivation (6.15 g of a yellow oil) was extracted
with MeOH to separate the more polar components from the dominating fat fraction.
After removing the MeOH under reduced pressure, the residue was fractionated by
normal-phase VLC (gradient hexane-EtOAc-MeOH) to give five fractions. Fraction 3
(EtOAc) was further separated by normal-phase HPLC (EtOAc/hexane 50/50; DAD
detection 210-400 nm) to yield 14 fraction. After removing the eluent, each fraction
was redissolved in 3 mL eluent and subjected to agar diffusion assays for inhibition of
E. repens and M. violaceum. Antifungal activity could be shown to be most
pronounced in fraction 7 (2.7 mg of a white solid). During the structure elucidation,
this fraction was found to be a 2:1 M/M mixture of 37 and 2-(p-hydroxyphenyl)ethanol
(22), which was further separated by reversed-phase HPLC (MeOH/H2O 65/35;
UV detection 272 nm) to yield pure 37 (2.3 mg). Fraction 4 (EtOAc/MeOH 50/50)
was further separated by reversed-phase VLC (MeOH/H2O 75/25) to yield five
fractions; fractions 4 and 5 were subjected to reversed-phase HPLC with the same
eluent (DAD detection 210-400 nm) to yield 11 further fractions. The corresponding
fractions 2-4 of each separation, as judged by reversed-phase TLC with the same
eluent, were subjected to preparative normal-phase VLC (eluent a: acetone, 16.5 cm;
eluent b: acetone/MeOH containing 2% NH3 50/50, 12.5 cm) yielding four bands
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(UV 254 nm). Bands 1 and 2 (6.5 - 10.5 cm; 17.8 mg) were purified by reversed-phase
HPLC (MeOH/H2O 25/75, DAD 210-400 nm) to yield 38 (6.1 mg).
OO
OH
O
OH
37
14
1
By 1H and 13C NMR spectroscopy (1H decoupled and DEPT), compound 37 could be
shown to contain two carboxyl moieties, further two sp2-hybridised quaternary
carbons, two olefinic methine groups, three methyl groups, two of them located on
double bonds and one adjacent to a methine group, six methylene groups, including
one hydroxymethyl group, and three aliphatic methine groups, one of which had to be
attached to an oxygen atom. By interpretation of the 1H-1H COSY NMR spectrum of
37, the molecular part from the CH2OH group to CH2-9 could be established. An
UV maximum at λ = 260 nm suggested the two double bonds and one carboxyl group
to be conjugated, forming the molecular part from C-10 to C-14 (without
stereochemistry at the double-bonds). By interpretation of the 1H-13C long-range
(HMBC) NMR spectrum, a connectivity between C-9 and C-10 could be established
(correlation between CH2-9 and C-10). Additionally, the second carboxyl moiety had
to be connected to C-2 and formed a lactone via C-3, as obvious by the downfield shift
of the signal of the hydrogen atom at C-3, thus giving the basic structure of 37. 37
could then be identified as the known fungal metabolite 1233A by comparison of its
spectral data and optical rotation with published values (Aldridge, Giles & Turner,
1971; Kumagai, Tomoda & Omura, 1992).
Compound 38 appeared to possess a structure similar to that of 37 as judged by
comparison of their 1H NMR spectra. Nevertheless, 38 was substantially more polar
than 37, suggesting it to be an "open lactone" derivative of 37. This could be
confirmed by comparing 13C NMR data of both compounds, and by interpretation of
the 1H-1H COSY NMR spectrum of 38. A literature search (Beilstein database)
revealed two compounds with this basic structure to be reported. One of them
Results84
(1233B) had been isolated from cultures of the same fungus which produced 1233A,
the other had been obtained by alkaline hydrolysis of 1233A (Aldridge, Giles &
Turner, 1971). Both compounds were presumed to differ in the stereochemistry at
C-3, with 1233A possessing a stereochemistry at C-3 opposite to that of 1233B.
Unfortunately no 13C NMR spectroscopic data were reported for both isomers, the
1H NMR values did not allow to determine the identity of the metabolite isolated in
this study with one of the compounds described in literature. The production of 37 and
38 by the same fungal strain, however, suggested the stereochemistry at C-2 and C-8
to be identical with that of the lactone (1233A), and the stereochemistry at C-3 to be
identical with that of 1233B.
HO
O
OH
O
OH
OH
38 (tentative stereochemistry)
1 3
1233A (37): white solid (2.3 mg; 0.3 mg/L medium); mp. 62-63°C; [α]20D +24.3° (c 0.23, CHCl3);
UV (EtOH) λmax 260 nm; IR (film) νmax 3400, 2930, 1810, 1695, 1615, 1515, 1455, 1375, 1245, 1170,
1045 cm-1; 1H NMR (CDCl3, 300 MHz) δ 0.84 (3H, d, J = 6.8 Hz, CH3-8), 1.12 (1H, m, H-7a), 1.32
(1H, m, H-7b), 1.38 (2H, m, H-6), 1.42 (2H, m, H-5), 1.67 (1H, m, H-8), 1.78 (1H, m, H-4a), 1.81
(3H, s, CH3-10), 1.86 (1H, dd, J = 9.0, 13.5 Hz, H-9a), 1.91 (1H, m, H-4b), 2.09 (1H, dd, J = 6.8,
13.5 Hz, H-9b), 2.24 (3H, s, CH3-12), 3.40 (1H, ddd, J = 4.1, 4.1, 4.9 Hz, H-2), 3.89 (1H, dd, J = 4.1,
11.7 Hz, CH2O), 4.05 (1H, dd, J = 4.9, 11.7 Hz, CH2O), 4.58 (1H, ddd, J = 4.1, 6.0, 10.1 Hz, H-3),
5.69 (1H, s, H-12), 5.73 (1H, s, H-13); 13C NMR (CDCl3, 75.5 MHz) δ 18.5 (q, CH3-10), 19.4 (q,
CH3-8), 20.0 (q, CH3-12), 25.2 (t, C-5), 26.6 (t, C-6), 30.9 (d, C-8), 34.0 (t, C-4), 36.6 (t, C-7), 49.0
(t, C-9), 58.1 (t, CH2O), 58.6 (d, C-2), 74.9 (d, C-3), 116.5 (d, C-13), 129.5 (d, C-11), 142.1 (s,
C-10), 157.1 (s, C-12), 169.8 (s, C-1), 171.0 (s, C-14); CIMS (NH3, negative mode) m/z [M]+
324 (100), 308 (9), 280 (34).
(38): colourless solid (6.1 mg; 0.8 mg/L medium); 1H NMR (CD3OD, 300 MHz) δ 0.88 (3H, d,
J = 6.3 Hz, CH3-10), 1.18 (1H, m, H-7a), 1.40 (1H, m, H-7b), 1.40 (2H, m, H-6), 1.49 (2H, m, H-5),
1.57 (2H, m, H-4), 1.71 (1H, m, H-8), 1.83 (3H, d, J = 1.2 Hz, CH3-10), 1.85 (1H, m, H-9a), 2.13
(3H, d, J = 1.0 Hz, CH3-12), 2.15 (1H, m, H-9b), 2.47 (1H, m, H-2), 3.84 (3H, m, H-3, CH2O), 5.71
(1H, brs, H-13), 5.74 (1H, brs, H-11); 13C NMR (CD3OD, 100 MHz) δ 18.3 (q, CH3-10), 19.6 (q,
CH3-8), 19.8 (q, CH3-12), 27.5 (t, C-5), 28.2 (t, C-6), 32.2 (d, C-8), 37.1 (t, C-4), 38.2 (t, C-7), 49.9
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(t, C-9), 56.2 (d, C-2), 62.7 (t, CH2OH), 70.9 (d, C-3), 125.2 (d, C-13), 131.0 (d, C-11), 139.6 (s,
C-10), 146.7 (s, C-12), 175.5 (s, C-14), 181.1 (s, C-1).
4.4.10 Ulocladium botrytis 193A4
In the preliminary screening for inhibition of tyrosine kinase, extracts of strain 193A4
showed a complete inhibition at 200 µg/mL. In an attempt to isolate the active
component(s) the fungus was recultivated. The EtOAc extract (366 mg of a brown oil)
was separated by normal-phase VLC (gradient hexane-EtOAc-MeOH) to give
6 fractions. ELISA’s showed that the TK inhibitory activity was concentrated in
fractions 4 (EtOAc/hexane 75/25) and 5 (EtOAc). These fractions were further
purified by normal-phase HPLC (hexane/EtOAc 75/25) to give 39 (5.4 mg),
41 (6.0 mg), and a fraction presumably containing 40.
The molecular formula of 39 was
determined as C16H14O7 by
accurate mass measurement,
indicating 10 elements of
unsaturation within the molecule.
From the 1H NMR spectrum of 39
signals for two methoxyl groups
(δ 3.87, s, OCH3-2 and δ 3.95, s,
OCH3-9), two meta-coupled
aromatic protons (δ 6.55, d, J = 2.5 Hz, H-3 and δ 6.92, d, J = 2.5 Hz, H-1), one not
further coupled aromatic proton (δ 6.57, s, H-8), three phenolic hydroxyl groups
(δ 5.68 and 5.77, each brs, OH-10/OH-11) including one (δ 10.29, s, OH-4)
deshielded due to a hydrogen bonding with a carbonyl moiety, and one methylene
group attached to oxygen (δ 4.79 and 5.11, each 1H, d, J = 11.7 Hz, H2-7) could be
deduced. The 13C NMR spectrum revealed signals for 13 sp2-hybridized carbon atoms,
(six carbon-carbon double bonds, one carbon-oxygen double bond), accounting for 7
of the 10 elements of unsaturation, and suggesting the presence of two separate
O
O
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aromatic rings. The third ring had thus to be a lactone due to signals in the
IR spectrum at ν 1650 and 1660 cm-1, and involving the only methylene group.
 Figure 7: 1H-13C long-range (HMBC) NMR spectrum of 39; CDCl3, 300 MHz
for 1H, 75.5 MHz for 13C.
The three hydroxyl groups, two methoxyl groups, and one lactone moiety together
with three olefinic hydrogens accounted for 10 of the possible 12 substituents on the
aromatic rings, both rings thus had to be directly connected via a carbon-carbon bond.
After correlating all carbons with their directly bonded hydrogens via a 1H-13C shift
correlated NMR measurement (HMQC), the structure was further elaborated by
interpretation of the 1H-13C long-range (HMBC) spectrum.
Long-range correlations between each H-1, H-3 and OCH3-2 to C-2 connected each
C-1, C-3 and the methoxyl group to C-2. Further OH-4 showed long-range
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3
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correlations to C-3, C-4 and C-4a establishing the molecular fragment from C-1 to
C-4a. The signal of OH-4 appeared as a singlet at δ 10.29, deshielded due to a
hydrogen bond to a carbonyl moiety, thus the carbon of the lactone moiety C-5 had to
be connected to C-4a. Long-range correlations between OCH2-7 and each C-5, C-7a,
C-8 and C-11a established a further major part of the molecule, revealing that the two
aromatic rings had to be connected via the two quaternary carbon atoms C-11a and
C-11b.The remaining two hydroxyl groups, and one methoxyl group were the other
substituents, still to be placed. The regio-chemistry of the molecular fragment from
C-8 to C-11 was established by difference NOE measurements. Irradiations at the
resonance frequencies of OCH3-9 (δ 3.95, s) and OCH2-7 (δ 4.79 and 5.11, each 1H,
d, J = 11.7 Hz) respectively, both enhanced the signal of H-8 (δ 6.57, s). Thus,
OCH2-7 and OCH3-9 had to be attached to carbon atoms adjacent to C-8, leaving the
two hydroxyl groups to be positioned at C-10 and C-11. Compound 39 is the new
compound 4,10,11-trihydroxy-2,9-dimethoxy-7H-dibenzo[c,e]oxepin-5-one for which
the trivial name ulocladol is proposed.
It is interesting to note that a similar
compound, botrallin (40), formally
derived from a common polyketide
precursor by closure of the lactone at
different sites, has been reported from
Botrytis allii (Kameda et al., 1974).
It was tentatively identified in a
fraction of the current investigation by
1H NMR spectroscopy and EIMS, but
material was too scarce to be further characterised.
The 1H NMR spectrum of compound 41 revealed two spin systems characteristic for
1,2,3 and 1,3 respectively substituated aromatic rings. Additionally, one methyl group
on an aromatic ring, one methylene group adjacent to oxygen, and one phenolic
OH-group, deshielded due to a hydrogen bond to a carbonyl moiety could be deduced.
O O
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O
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The DEPT spectrum of 41 revealed the
expected five signals for the carbon atoms of
the aromatic methine groups; no other
methine group was present. Thus, the triplet
in the 1H NMR spectrum at δ 4.35 had to
account for an aliphatic OH-group, and
revealed the presence of a hydroxylmethylene
moiety. From the 13C NMR spectrum the additional presence of one carbonyl moiety
(184.3 ppm), and seven sp2-hybridised quaternary aromatic carbon atoms could be
deduced. These NMR spectroscopic data suggested the presence of a xanthone
derivative. The phenolic OH group and the CH2OH group had then to be adjacent to
the carbonyl moiety at positions 1 and 8, leaving the methyl group to be positioned
either at position 3 or 6. By comparing its 1H NMR data with published values (Ayer
& Taylor, 1976) 41 was identified as 1-hydroxy-6-methyl-8-hydroxymethylxanthone,
first reported from the Basidiomycete Cyathus intermedius. 13C NMR data were not
reported, all carbon atoms could be assigned by interpretation of the 1H-13C long-range
(HMBC) NMR spectrum of 41.
Ulocladol (39): white solid (5.4 mg; 5.4 mg/L medium); mp 110-111°C; UV (EtOH) λmax 251
(ε 12900), 299 (ε 3500) nm; IR (film) νmax 3440, 2930, 1660, 1650, 1615, 1345, 1155, 1095 cm-1;
1H NMR (CDCl3, 400 MHz) δ 3.87 (3H, s, OCH3-2), 3.95 (3H, s, OCH3-9), 4.79 (1H, d, J = 11.7 Hz,
H-7a), 5.11 (1H, d, J = 11.7 Hz, H-7b), 5.68 (1H, brs, OH-10 or 11), 5.77 (1H, brs, OH-10 or 11),
6.56 (1H, d, J = 2.5 Hz, H-3), 6.57 (1H, s, H-8), 6.92 (1H, d, J = 2.5 Hz, H-1), 10.29 (1H, s, OH-4);
13C NMR (CDCl3, 100 MHz) δ 55.5 (q, OCH3-2), 56.3 (q, OCH3-9), 70.3 (t, C-7), 100.8 (d, C-3),
103.1 (d, C-8), 106.9 (s, C-4a), 110.2 (d, C-1), 118.8 (s, C-11a), 127.1 (s, C-7a), 133.8 (s, C-10),
135.9 (s, C-11)a, 142.1 (s, C-11b)a, 146.3 (s, C-9), 163.0 (s, C-4), 163.2 (s, C-2), 172.5 (s, C-5),
a
 assignments may be interchanged; EIMS m/z [M]+ 318 (100), 300 (70), 282 (20), 254 (30); HREIMS
m/z 318.073 (calcd for C15H14O7, 318.074).
Botrallin (40): 1H NMR (CDCl3, 200 MHz) δ 1.76 (3H, s, CH3), 3.80 (3H, s, OCH3), 3.90 (3H, s,
OCH3), 6.13 (1H, s), 6.53 (1H, d, J = 2.4 Hz), 7.34 (1H, d, J = 2.4 Hz), 11.32 (1H, s).
1-Hydroxy-6-methyl-8-hydroxymethylxanthone (41): white crystals (6.0 mg; 6.0 mg/L medium);
mp. 175-177°C; 1H NMR (CDCl3, 400 MHz) δ 2.50 (3H, s, CH3-6), 4.35 (1H, t, J = 7.6 Hz, CH2OH),
4.96 (2H, d, J = 7.6 Hz, CH2OH), 6.81 (1H, dd, J = 1.0, 8.1 Hz, H-2), 6.92 (1H, dd, J = 1.0, 8.7 Hz,
O
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H-4), 7.16 (1H, d, J = 1.0 Hz, H-5), 7.27 (1H, d, J = 1.0 Hz, H-7), 7.60 (1H, dd, J = 8.1, 8.7 Hz, H-3),
12.64 (1H, s, OH-1); 13C NMR (CDCl3, 75.5 MHz) δ 21.9 (q, CH3), 65.2 (t, CH2OH), 106.6 (d, C-4),
109.4 (s, C-9a), 110.6 (d, C-2), 116.5 (s, C-8a), 118.0 (d, C-5), 127.2 (d, C-7), 136.9 (d, C-3), 142.6
(s, C-8), 147.5 (s, C-6), 155.7 (s, C-4a), 158.1 (s, C-10a), 161.9 (s, C-1), 184.3 (s, C-9); EIMS m/z
[M]+ 256 (100), 238 (58), 227 (43), 210 (75).
4.4.11 Varicosporina ramulosa 195-31
The isolate of V. ramulosa represented one of the few obligate marine fungi isolated in
this study, and was therefore selected for further chemical investigations. The EtOAc
extract (3.85 g of a yellow oil) of a recultivation was subjected to normal-phase VLC
(gradient hexane-EtOAc) to give six fractions, fraction 5 (hexane/EtOAc 50/50)
containing pure 44 (680 mg). Fraction 3 (hexane/EtOAc 25/100, 65 mg) was purified
by normal-phase HPLC (hexane/EtOAc 90/10) to yield 47 (8 mg). Fraction 4
(hexane/EtOAc 50/50, 380 mg) was purified by normal-phase HPLC (EtOAc/hexane
25/75) to give 42 (24 mg) and 43 (168 mg), fraction 6 was purified by normal-phase
HPLC (EtOAc/hexane 50/50) to give 45 (23 mg) and 46 (12.7 mg).
Compounds 42-46 seemed to possess similar basic structures as judged by their 1H and
13C NMR spectra. Structure elucidation started with the most abundant compound 44.
By interpretation of the 1H-1H COSY NMR spectrum of 44, the two major molecular
fragments from C-3 to CH3-6 and from C-9 to CH3-14 could be established. Both
fragments were further connected via ester moieties, thus forming a di-lactone, as
deduced from the 1H-13C long-range (HMBC) NMR spectrum, which revealed
correlations between H-6 and C-8, and H-14 and C-1, respectively. A literature search
(Chapman & Hall database) revealed a couple of such macrodiolides to be known.
Compounds 42, 44 and 45 were then identified by comparing their spectroscopic data
and optical rotations with published values as grahamimycin A1 (42, Bestmann &
Schobert, 1987), (6R,11R,12R,14R)-colletodiol (44, MacMillan & Simpson, 1973;
Amstutz, Hungerbühler & Seebach, 1981; Keck, Boden & Wiley, 1989) and 9,10-
dihydro-(6R,11S,12S,14R)-colletodiol (45, Ohta et al., 1993). Compound 45 was
originally described under its systematic name (3E,6R,11S,12S,14R)-11,12-dihydroxy-
6,14-dimethyl-1,7-dioxa-3-cyclotetradecene-2,8-tetrone (Ohta et al., 1993). To show
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the relationship of 45 and 46 to (6R,11R,12R,14R)-colletodiol (44), here they are
referred to as 9,10-dihydro-(6R,11S,12S,14R)-colletodiol and 9,10-dihydro-
(6R,11R,12R,14R)-colletodiol. 45 had originally been obtained during a total synthesis
of 44, but as yet not as a fungal metabolite.
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43  R1, R2 = O
44 R1 = OH; R2 = H
O
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42 R1, R2 = O;  R3, R4 = O
45 R1 = R4 = H;  R2 = R3 = OH
46 R1 = R4 = OH;  R2 = R3 = H
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Compound 43 was found to have the same basic structure as both colletoketol
(MacMillan & Simpson, 1973) and grahamimycin A (Gurusiddaiah & Ronald, 1981;
Gurusiddaiah et al., 1981) on the ground of extensive 1D and 2D NMR studies. The
configuration of colletoketol is 6R,12R,14R, with that of grahamimycin A being
6R,12R,14S. The 13C NMR data for 43 were found to be in good agreement with
values published for grahamimycin A, even though the 1H NMR data differed
(Gurusiddaiah et al., 1981). There appeared to be no reported 13C NMR data for
colletoketol, and other physical properties as melting point and optical rotation proved
in this investigation to be insufficient to determine unambigouasly if 43 was identical
with one of the two compounds in question. To resolve these issues a single crystal
X-ray analysis of 43 was performed, which established the relative stereochemistry
(Figure 8).
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Figure 8: Result of the single crystal X-ray analysis of 43 (provided by Prof.
Jones). Ellipsoids represent 50% probability levels. H atom radii are arbitrary.
The absolute configuration at C-6 was determined as R by alkaline hydrolysis of 43
resulting in (-)-5-hydroxy-(2E)-hexenoic acid (43a) of known configuration as one
product (MacMillan & Simpson, 1973). Thus, 43 could be shown to possess
6R,12R,14R configuration and is identical with colletoketol.
OH
OOH 43a
Compound 46 appeared to be closely similar to 45 by comparing their EIMS, 1H and
13C NMR spectroscopic data. After assigning all hydrogens to their directly bonded
carbons via a 1H-13C shift correlated NMR measurement (HMQC), 46 was shown to
be a stereoisomer of 45, differing in the configuration at one or more of the four chiral
centres. The conformational flexibility of these 14-membered rings usually means the
stereochemistry of each individual chiral centre has to be determined separately, e.g. by
degradation studies. Attempts to produce crystals of 46 suitable for a X-ray
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crystallographic analysis proved unsuccessful. Therefore, the
11,12-di-(p-bromobenzoate)-derivative of 46 (46a) was synthezised, unfortunately this
compound was a clear oil. Its CD-spectrum showed for the two p-bromobenzoate
units a negative (∆ε255.2 nm -8.4), and a positive (∆ε241.2 nm +7.8) cotton effect implying a
negative chirality. MacMillan & Simpson (1973) calculated similar values for the two
benzoate-units of the dibenzoate-derivative of 44, and established the configuration at
C-11 as S by degradation studies. This led in the initial determination of the absolute
stereochemistry of colletodiol to the assignment of the 11S,12R configurations
(MacMillan & Simpson, 1973). Although this assignment was later revised to 11R,12R
after a X-ray crystallographic analysis (Amstutz, Hungerbhler & Seebach, 1981),
both an 11R,12R- and an 11S,12R-configuration have to be in agreement with the
observed cotton effect of the two benzoate units. This finding suggested one of these
configurations also for 46. As all other four isolated isolated (42-45) possessed the
R-configuration at C-6 and C-14, 46 was likely also to have the 6R,14R-configuration.
Taking this possibility into account, 46 was then possibly the 9,10-dihydro-derivative
of (6R,11R,12R,14R)-colletodiol. Hydrogenation of 44 and 46 should then lead to
identical products. The 3,4,9,10-tetrahydro-derivative of 44 (44a) was known and
readily accessible by hydrogenation with H2 over Pd/charcoal (MacMillan & Simpson,
1973).
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The 9,10-dihydro-derivative of 46 (46b) was prepared analogously. The hydrogenation
products of both reactions proved to be unstable, and their spontanous
decomposition/rearrangement started during the reaction and continued in the CDCl3
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solution during NMR measurements. Nevertheless, 44a and 46b could be shown to
have identical 1H NMR spectra, indicating the configurations of 46 at C-6, C-11, C-12
and C-14 to be either all R as in 44 or all S. The R-configuration, however, would be in
accordance with the negative chirality observed for 46a. The R-configurations could be
further substantiated by a closer inspection of one major decomposition product of
44a, which was shown to be (5R)-((1’R,3’R)-dihydroxybutyl)-dihydrofuran-2-one
(44b), (MacMillan & Simpson, 1973). The identical compound (46c) was obtained
from the decomposition of 46b. Thus, 46 is 9,10-dihydro-(6R,11R,12R,14R)-
colletodiol.
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Additionally, the common fungal sterol ergosterol (47) was identified by 1H NMR
spectroscopy and MS (Shirane et al. 1996).
Grahamimycin A1 (42): yellow solid (24 mg; 3.7 mg/L medium); mp. 68-70°C; [α]20D -5.5° (c 0.50,
CHCl3); 1H NMR (CDCl3, 300 MHz) δ 1.31 (3H, d, J = 6.4 Hz, CH3-14), 1.38 (3H, d, J = 6.4 Hz,
CH3-6), 2.30 (1H, dddd, J = 1.1, 7.2, 10.2, 13.6 Hz, H-5a), 2.42 (1H, dddd, J = 1.1, 3.8, 8.5, 13.6 Hz,
H-5b), 2.46 (1H, ddd, J = 2.6, 10.2, 15.5 Hz, H-9a), 2.69 (1H, ddd, J = 3.0, 7.9, 15.5 Hz, H-9b), 2.73
(1H, dd, J = 6.0, 12.1 Hz, H-13a), 2.81 (1H, ddd, J = 3.0, 10.2, 19.6 Hz, H-10a), 3.29 (1H, dd,
J = 5.3, 12.1 Hz, H-13b), 3.43 (1H, ddd, J = 2.6, 7.9, 19.6 Hz, H-10b), 4.95 (1H, ddq, J = 3.8, 10.2,
6.4 Hz, H-6), 5.26 (1H, ddq, J = 5.3, 6.0, 6.4 Hz, H-14), 5.68 (1H, dt, J = 15.8, 1.1 Hz, H-3), 6.58
(1H, ddd, J = 7.2, 8.5, 15.8 Hz, H-4); 13C NMR (CDCl3, 75.5 MHz) δ 19.8 (q, CH3-6), 20.6 (q,
CH3-14), 28.4 (t, C-9), 31.3 (t, C-10), 38.1 (t, C-5), 39.3 (t, C-13), 68.7 (d, C-14), 70.6 (d, C-6),
123.4 (d, C-3), 144.9 (d, C-4), 164.3 (s, C-2), 171.1 (s, C-8), 196.4 (s, C-11 or C-12), 197.3 (s, C-11
or C-12); EIMS m/z [M]+ 282 (<1), 254 (15), 181 (15), 154 (32), 139 (26), 125 (13), 113 (100),
100 (22), 96 (40), 95 (51), 81 (31), 69 (78), 68 (76).
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Colletoketol (43): light yellow crystals (EtOAc, 168 mg; 26 mg/L medium); mp 142-143°C; [α]D20
-24.0° (c 0.68, CHCl3); IR (film) νmax 3460, 2980, 2935, 1725, 1715, 1705, 1650, 1630, 1445, 1320,
1290, 1240, 1175, 1120, 1050, 985 cm-1; 1H NMR (300 MHz, CDCl3) δ 1.29 (3H, d, J = 6.4 Hz,
CH3-14), 1.38 (3H, d, J = 6.4 Hz, CH3-6), 1.85 (1H, ddd, J = 3.0, 7.2, 15.6 Hz, H-13), 2.07 (1H, ddd,
J = 2.6, 5.7, 15.6 Hz, H-13), 2.27 (1H, ddd, J = 10.9, 11.5, 12.8 Hz, H-5), 2,49 (1H, dddd, J = 1.1,
3.0, 5.1, 12.8 Hz, H-5), 3.70 (1H, brs, OH-12), 4.46 (1H, dd, J = 3.0, 5.7 Hz, H-12), 5.09 (1H, ddq,
J = 3.0, 11.5, 6.4 Hz, H-6), 5.31 (1H, ddq, J = 2.6, 7.2, 6.4 Hz, H-14), 5.76 (1H, brd, J = 15.8 Hz,
H-3), 6.67 (1H, d, J = 15.8 Hz, H-9), 6.68 (1H, ddd, J = 5.1, 10.9, 15.8 Hz, H-4), 7.12 (1H, d,
J = 15.8 Hz, H-10); 13C NMR (75.5 MHz, CDCl3) δ 18.8 (q, CH3-14), 20.3 (q, CH3-6), 40.2 (t, C-13),
40.3 (t, C-5), 66.6 (d, C-14), 70.6 (d, C-6), 73.0 (d, C-12), 126.8 (d, C-3), 132.2 (d, C-9), 134.2 (d,
C-10), 143.7 (d, C-4), 165.4 and 165.8 (s, C-2/C-8), 201.3 (s, C-11); EIMS m/z [M]+ 284 (2), 282 (2),
280 (3), 256 (16), 194 (18), 113 (100), 96 (56), 95 (86), 82 (78), 69 (62), 68 (84).
(5R)-Hydroxy-(2E)-hexenoic acid (43a): clear oil (10.5 mg); [α]20D -11.6° (c 1.05, EtOH); 1H NMR
(CDCl3, 300 MHz) δ 1.25 (3H, d, J = 6.2 Hz, H-6), 2.40 (2H, ddt, J = 1.1, 6.2, 7.5 Hz, H-4), 3.99
(1H, tq, J = 6.2, 6.2 Hz, H-5), 5.91 (1H, dt, J = 15.7, 1.1 Hz, H-2), 5.51 (2H, brs, OH-5, COOH-1),
7.07 (1H, dt, J = 15.7, 7.5 Hz, H-3); 13C NMR (CDCl3, 75.5 MHz) δ 23.2 (q, C-6), 41.8 (t, C-4), 66.8
(d, C-5), 123.2 (d, C-2), 147.7 (d, C-3), 170.8 (s, C-1); FAB-MS (glycerol, negative mode) m/z
[M - H]- 129 (100).
(6R,11R,12R,14R)-Colletodiol (44): colourless crystals (680 mg; 105 mg/L); mp. 164°C; [α]20D
+27.3° (c 0.41, CHCl3); UV (EtOH) λmax 214 nm (ε 1000); IR (film) νmax 3440, 2980, 2935, 1720,
1655, 1450, 1350, 1315, 1265, 1230, 1175, 1110, 1055, 1025, 990 cm-1; 1H NMR (CDCl3, 300 MHz)
δ 1.34 (6H, d, J = 6.4 Hz, CH3-14/CH3-6), 1.49 (1H, ddd, J = 1.9, 6.0, 15.8 Hz, H-13a), 2.00 (1H,
ddd, J = 1.1, 4.5, 15.8 Hz, H-13b), 2.16 (1H, ddd, J = 11.1, 11.1, 11.1 Hz, H-5a), 2.50 (1H, dddd,
J = 1.1, 3.0, 4.9, 11.1 Hz, H-5b), 3.21 (2H, brs, OH-11/OH-12), 3.63 (1H, ddd, J = 1.1, 5.7, 8.3 Hz,
H-12), 4.05 (1H, dd, J = 5.7, 9.0 Hz, H-11), 5.15 (1H, ddq, J = 1.9, 4.5, 6.4 Hz, H-14), 5.25 (1H, ddq,
J = 3.0, 6.4, 11.1 Hz, H-6), 5.71 (1H, d, J = 15.8 Hz, H-3), 6.18 (1H, dd, J = 1.1, 15.8 Hz, H-9), 6.68
(1H, ddd, J = 4.9, 11.1, 16.0 Hz, H-4), 6.73 (1H, dd, J = 5.7, 15.8 Hz, H-10); 13C NMR (CDCl3,
75.5 MHz) δ 18.1 (q, CH3-14), 20.3 (q, CH3-14), 36.2 (t, C-13), 41.1 (t, C-5), 68.1 (d, C-14), 68.7 (d,
C-6), 71.8 (d, C-11), 73.8 (d, C-12), 123.7 (d, C-9), 125.6 (d, C-3), 144.2 (d, C-4), 146.6 (d, C-10),
165.2 (s, C-2), 166.7 (s, C-8); EIMS m/z [M]+ 284 (<1), 280 (8), 113 (100).
3,4,9,10-Tetrahydro-(6R,11R,12R,14R)-colletodiol (44a/46b): white solid (8.0 mg); 1H NMR
(300 MHz, CDCl3) δ 1.22 (3H, d, J = 6.4 Hz), 1.27 (3H, d, J = 6.4 Hz), 1.50-2.50 (12H, m), 3.58 (1H,
ddd, J = 3.8, 4.9, 8.7 Hz), 3.72 (1H, ddd, J = 3.8, 3.8, 7.9 Hz), 5.04 (1H, ddq, J = 3.0, 12.4, 6.4 Hz),
5.15 (1H, ddq, J = 2.3, 13.2, 6.4 Hz).
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(5R)-((1’R,3’R)-Dihydroxybutyl)-dihydrofuran-2-one (44b/46c): clear oil (8.9 mg); [α]20D -57.1°
(c 0.45, CHCl3); IR (film) νmax 3440, 2965, 2920, 1765, 1645, 1455, 1420, 1375, 1195, 1135, 1035,
920 cm-1; 1H NMR (CDCl3, 300 MHz) δ 1.24 (3H, d, J = 6.4 Hz, H-4'), 1.59 (1H, dt, J = 14.5, 2.8 Hz,
H-2'), 1.72 (1H, dt, J = 14.5, 10.0 Hz, H-2'), 2.13 (1H, dddd, J = 6.6, 7.9, 10.2, 13.0 Hz, H-4), 2.25
(1H, dddd, J = 6.0, 7.5, 9.8, 13.0 Hz, H-4), 2.50 (1H, ddd, J = 7.9, 9.8, 17.7 Hz, H-3), 2.64 (1H, ddd,
J = 6.0, 10.2, 17.7 Hz, H-3), 3.04 (2H, brs, OH), 3.89 (1H, ddd, J = 2.8, 4.3, 10.0 Hz, H-1'), 4.09 (1H,
ddd, J = 2.8, 6.4, 10.0 Hz, H-3'), 4.42 (1H, ddd, J = 4.3, 6.6, 7.5 Hz, H-5); 13C NMR (CDCl3,
75.5 MHz) δ 23.7 (t), 24.2 (q), 28.5 (t), 40.0 (t), 68.3 (d), 74.0 (d), 82.8 (d), 177.5 (s); FAB-MS
(glycerol, negative mode) m/z 173 (100) [M - H]-.
9,10-Dihydro-(6R,11S,12S,14R)-colletodiol (45): colourless crystals (23 mg; 3.5 mg/L medium); mp.
152-154°C; [α]20D -39.1° (c 0.46, CHCl3); 1H NMR (CDCl3, 400 MHz) δ 1.30 (3H, d, J = 6.1 Hz,
CH3-6), 1.33 (3H, d, J = 6.1 Hz, CH3-14), 1.73 (1H, ddd, J = 7.1, 11.2, 14.8 Hz, H-13a), 1.80 (1H,
dddd, J = 6.6, 14.2 Hz, H-10a), 1.90 (1H, dddd, J = 14.2 Hz, H-10b), 1.95 (1H, ddd, J = 2.5, 7.1,
14.8 Hz, H-13b), 2.30 (1H, ddd, J = 17.3 Hz, H-9a), 2.31 (1H, ddd, J = 3.1, 8.1, 12.9 Hz H-5a), 2.40
(1H, ddd, J = 8.1, 11.2, 12.9 Hz H-5b), 2.47 (1H, ddd, J = 2.0, 6.6, 17.3 Hz, H-9b), 3.30 (1H, brdd,
J = 7.1, 7.1 Hz, H-12), 3.43 (1H, ddd, J = 1.0, 5.1, 7.1 Hz, H-11), 5.06 (1H, ddq, J = 2.5, 6.1,
11.2 Hz, H-14), 5.19 (1H, ddq, J = 3.1, 6.1, 11.2 Hz, H-6), 5.80 (1H, d, J = 16.0 Hz, H-3), 6.78 (1H,
ddd, J = 8.1, 8.1, 16.0 Hz, H-4); 13C NMR (CDCl3, 100 MHz), δ, 21.0 (q, 2C, CH3-6/CH3-14), 27.8 (t,
C-10), 30.2 (t, C-9), 39.2 (t, C-5), 40.5 (t, C-13), 68.4 (d, C-11), 69.7 (d, C-14), 70.3 (d, C-6), 73.2
(d, C-12), 124.2 (d, C-3), 144.6 (d, C-4), 166.1 (s, C-2), 174.2 (d, C-8); EIMS m/z [M]+ 286 (<1),
268 (3), 242 (5), 215 (12), 197 (7), 18 4 (9), 157 (23), 139 (25), 113 (100).
9,10-Dihydro-(6R,11R,12R,14R)-colletodiol (46): colourless crystals (12.7 mg; 2.0 mg/L medium);
mp 146-147°C; [α]20D -5.0° (c 0.42, CHCl3); IR (film) λmax 3330, 2975, 2920, 1725, 1705, 1655,
1450, 1415, 1380, 1350, 1325, 1265, 1230, 1185, 1140, 1070, 1050, 1005 cm-1; 1H NMR (CDCl3,
400 MHz) δ 1.28 (3H, d, J = 6.6 Hz, CH3-14), 1.31 (3H, d, J = 6.1 Hz, CH3-6), 1.61 (1H, dddd,
J = 4.6, 4.6, 11.1, 13.7 Hz, H-10), 1.83 (1H, ddd, J = 3.1, 9.0, 15.3 Hz, H-13), 1.94 (1H, ddd, J = 2.1,
5.6, 15.3 Hz, H-13), 1.97 (1H, dddd, J = 4.8, 5.6, 7.4, 13.7 Hz, H-10), 2.28 (1H, dddd, J = 1.0, 8.1,
11.4, 13.2 Hz, H-5), 2.39 (1H, ddd, J = 4.6, 4.8, 13.2 Hz, H-9), 2.42 (1H, ddd, J = 3.0, 8.1, 13.2 Hz,
H-5), 2.52 (1H, ddd, J = 5.6, 11.1, 13.2 Hz, H-9), 3.43 (1H, ddd, J = 4.6, 7.4, 10.7 Hz, H-11), 3.61
(1H, ddd, J = 3.1, 5.6, 10.7 Hz, H-12), 5.16 (1H, ddq, J = 3.0, 11.4, 6.1 Hz, H-6), 5.30 (1H, ddq,
J = 2.1, 9.0, 6.6 Hz, H-14), 5.79 (1H, brd, J = 15.8 Hz, H-3), 6.73 (1H, ddd, J = 8.1, 8.1, 15.8 Hz,
H-4); 13C NMR (CDCl3, 100 MHz) δ 20.8 (q, CH3-14), 21.1 (q, CH3-6), 28.0 (t, C-10), 30.4 (t, C-9),
37.6 (t, C-13), 39.0 (t, C-5), 66.7 (d, C-14), 69.2 (d, C-6), 70.5 (d, C-11), 71.7 (d, C-12), 125.0 (d,
C-3), 143.4 (d, C-4), 165.3 (s, C-2), 173.1 (s, C-8); EIMS m/z [M]+ 286 (<1), 242 (5), 215 (10),
157 (15), 139 (20), 113 (100).
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9,10-Dihydro-(11R,12R)-di-(p-bromobenzoate)-(6R,14R)-colletodiol (46a): colourless oil (8.8 mg);
[α]20D +3.6° (c 0.29, CHCl3); UV (EtOH) λmax 245 (ε 28800), 280 (sh, ε 900) nm; CD (EtOH)
∆ε255.2 nm -8.4, ∆ε241.2 nm +7.8; IR (film) νmax 2955, 2925, 1725, 1590, 1260, 1170, 1120, 1100, 1010,
755 cm-1; 1H NMR (CDCl3, 300 MHz) δ 1.30 (3H, d, J = 6.4 Hz, CH3-14), 1.30 (3H, d, J = 6.0 Hz,
CH3-6), 1.99 (1H, m, H-13), 2.03 (2H, m, H-10), 2.14 (1H, m, H-13), 2.33 (1H, m, H-5), 2.44 (2H, m,
H-9), 2.49 (1H, m, H-5), 5.12 (1H, m, H-14), 5.15 (1H, m, H-6), 5.33 (1H, ddd, J = 4.9, 7.2, 7.2 Hz,
H-11), 5.56 (1H, ddd, J = 4.5, 4.5, 7.2 Hz, H-12), 5.93 (1H, d, J = 15.8 Hz, H-3), 6.93 (1H, ddd,
J = 7.2, 8.7, 15.8 Hz, H-4), 7.54 (2H, m), 7.57 (2H, m), 7.86 (2H, m), 7.87 (2H, m); 13C NMR
(CDCl3, 75.5 MHz) δ 20.2 (q, CH3- 14), 20.8 (q, CH3-6), 25.7 (t, C-10), 29.5 (t, C-9), 35.9 (t, C-13),
39.3 (t, C-5), 67.2 (d, C-14), 69.5 (d, C-6), 70.7 (d, C-12), 71.6 (d, C-11), 124.4 (d, C-3), 128.2 (s),
128.4 (s), 128.6 (s), 128.7 (s), 131.1 (d, 2 × C), 131.2 (d, 2 × C), 131.7 (d, 2 × C), 131.9 (d, 2 × C),
144.8 (d, C-4), 164.5 (s), 165.0 (s), 165.2 (s), 171.1 (s, C-8); EIMS m/z [M]+ 654 (1), 652 (3),
650 (1), 610 (<1), 608 (1), 606 (<1), 543 (1), 541 (2), 539 (1), 469 (5), 467 (5), 452 (3), 450 (3),
350 (4), 348 (4), 341 (12), 339 (12), 297 (3), 295 (3), 185 (98), 183 (100); HREIMS m/z 652.013
(calcd for C28H28O879Br81Br, 652.013).
Ergosterol (47): white solid (8 mg; 1.2 mg/L medium); 1H NMR (CDCl3, 200 MHz) δ 0.63 (3H, s);
0.82 (3H, d, J = 6.7 Hz), 0.83 (3H, d, J = 6.7 Hz), 0.91 (3H, d, J = 6.9 Hz), 0.95 (3H, s), 1.03 (3H, d,
J = 6.6 Hz), 1.24 - 2.10 (19H, m), 2.20 - 2.50 (2H, m), 3.64 (1H, m), 5.20 (2H, m), 5.37 (1H, m), 5.57
(1H, m); GC-EIMS m/z [M]+ 396 (75), 363 (100), 337 (40).
4.5 Biological activity of pure compounds
Most secondary metabolites obtained in this study were evaluated for their
antimicrobial activity in agar diffusion assays, the observed activities are summarised in
Table 10. The same compounds, except 25 and 32 - 35, were further investigated for
inhibititory activity in ELISAs towards HIV-1 reverse transcriptase and tyrosine kinase
at a test concentration of 0.2 µg/µL (TK) and 0.066 µg/µL (RT), respectively.
Ulocladol (39) showed a complete inhibition of TK at this concentration. At a test
concentration of 0.02 µg/µL a reduction of TK activity by 93% was observed. All
other compounds did not significantly inhibit one of the enzymes tested.
Compounds 24, 28, 36, 43 and 44 were further tested for their in vitro activity against
three different Plasmodium falciparum clones; compounds 36 (pycnidione) and 43
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(colletoketol) proved to be active. The results of the investigations of the active
compounds are given in Table 11.
Table 10: Antimicrobial activity of pure compounds in agar diffusion assays.1
Compound
Nr.
Inhibition zone (cm) against test organism
50 µg compound / test disk
E.c.2 B.m. M.v. E.r. F.o. M.m. C.f.
9 n.a.3 0.4 0.1 n.a. n.a. 0.1 n.a.
16 n.a. n.a. 0.1 n.a. n.a. 0.1 n.a.
18 n.a. n.a. n.a. 0.3 n.a. n.a. n.a.
19 n.a. n.a. 0.2 0.1 n.a. n.a. 0.1
20 n.a. n.a. n.a. n.a. n.a. n.a. n.a.
21 n.a. n.a. 0.2 0.2 n.a. n.a. n.a.
22 n.a. n.a. n.a. 0.2 n.a. n.a. n.a.
23 n.a. 0.3 n.a. n.a. n.a. n.a. n.a.
24 n.a. n.a. 0.1 n.a. n.a. 0.1 n.a.
25 n.a. n.a. 0.2 0.7 n.a. n.a. n.a.
26 n.a. n.a. 0.1 0.1 n.a. n.a. n.a.
27 n.a. n.a. n.a. 0.3 n.a. n.a. n.a.
28 n.a. n.a. 0.1 n.a. n.a. n.a. n.a.
29 n.a. n.a. 0.1 0.1 n.a. n.a. n.a.
30 n.a. n.a. 0.1 0.1 n.a. n.a. n.a.
32 n.a. n.a. 0.3 0.3 n.a. n.a. 0.4
33 n.a. n.a. 0.2 n.a. n.a. n.a. n.a.
34 n.a. n.a. 0.5 0.3 n.a. n.a. n.a.
35 n.a. n.a. 0.3 0.3 n.a. n.a. n.a.
36 n.a. 0.1 n.a. n.a. n.a. n.a. n.a.
37 n.a. n.a. 1.0 2.5 n.a. 1.8 n.a.
39 n.a. n.a. n.a. n.a. n.a. n.a. n.a.
41 n.a. n.a. 0.2 0.2 n.a. n.a. n.a.
42 n.a. n.a. n.a. n.a. n.a. n.a. n.a.
43 n.a. n.a. 0.2 0.2 n.a. n.a. n.a.
44 n.a. n.a. n.a. n.a. n.a. n.a. n.a.
45 n.a. n.a. n.a. 0.2 n.a. n.a. n.a.
46 n.a. n.a. n.a. 0.1 n.a. n.a. n.a.
1
 The following compounds were not tested: 1 - 8, 10 -15, 17, 31, 38, 40, 47.
2
 E.c. Escherichia coli, B.m. Bacillus megaterium, M.v. Microbotryum violaceum,
E.r. Eurotium repens, F.o. Fusarium oxysporum, M.m. Mycotypha microspora,
C.f. Chlorella fusca.
3
 n.a. not active.
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Table 11. Antimalarial activity (IC50) of compounds 36 and 43 against
P. falciparum strains FCR3F86, D6 and W2.
Inhibitor P. falciparum strain tested
FCR3F86 W2 D6
atovaquone
(ng/mL)
0.4 ± 0.3 (n = 5) 0.8 (n = 2) 0.2 (n = 2)
36 (µg/mL) 0.3 (n = 2) 0.2 (n = 2) 0.4 (n = 2)
43 (µg/mL) 2.3 (n = 2) 3.1 (n = 1) 7.0 (n = 1)
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5 Discussion
This study mainly aimed at the isolation of higher filamentous fungi from marine
sponges and algae, investigation of their taxonomy, and evaluation of the biological
activity of their extracts and secondary metabolite production. Both sponge- and algal-
derived fungi only recently received broader interest in the natural products chemists
community as producers of new and biologically active metabolites (cf. the reviews of,
e.g., König & Wright, 1996; Pietra, 1997; Biabani & Laatsch, 1998). In this study, it
could be shown that especially in sponges a great taxonomical variety of fungi is
encountered, although it seemed doubtful that the majority of these isolates was
actively growing in their hosts. Biological investigations of culture extracts of selected
isolates suggested a high biosynthetic potential, especially for the production of
antimicrobial metabolites. The corresponding chemistry turned out to be structurally
diverse, and although obviously related to that of terrestrial fungi, several new natural
products have been isolated. The interesting and biologically active metabolites already
published from marine fungi (cf. 1.3.2 and reviews cited above) suggested them to be a
prolific source for new compounds, which is clearly underlined by the present results.
5.1 Isolation and taxonomy of higher filamentous fungi from marine sponges
Two of the primary goals of the current study were to investigate the diversity of
higher filamentous fungi associated with marine sponges, and to examine to what
extent they produce biologically active secondary metabolites. It was therefore
attempted to isolate species adapted to the marine environment, in particular to
sponges, while trying to exclude ubiquitous, chemically well investigated, fast growing,
and presumably terrestrial fungi. This was tried by either destroying fungal
contaminants adherent to the surface of the sponges chemically or by inhibiting their
growth by the use of selective isolation media. Literature data indicated, that to date
no comparable studies about sponge-derived fungi were published.
The application of a surface sterilisation method using EtOH, analogously to methods
established for terrestrial plants (Schulz et al., 1993), was found to be not applicable to
sponges. The EtOH could not be quickly and completely removed from the sponge
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tissue, and thus damaged it already after a time insufficient to destroy most surface
fungal spores (Schulz et al., 1993). It therefore proved to be impossible to exclude
fungi which were merely present by chance in sponge samples, such as inactive
propagules filtered by the sponge from the water.
The exclusion of ubiquitous fungi was attempted further by the use of different
isolation media. On nutrient rich agar media, fungi isolated were mostly members of
genera well known from terrestrial habitats, e.g., Acremonium, Fusarium and
Penicillium. Even though species of some of these genera have previously been
observed to occur in sponges (Siepmann & Höhnk, 1962; Höhnk & Ulken, 1979; see
also 1.3.3, Table 2), they were not desired in the present study due to the high
possibility that these strains were terrestrial contaminants. Additionally, they were fast
growing and quickly dominated on the agar plates, preventing the detection and
isolation of slow growing species. The use of media supplemented with ASW did not
significantly inhibit their growth. This finding is consistent with those of physiological
studies (e.g., Jones & Byrne, 1976; Molitoris & Schaumann, 1986) which showed that
the growth of many terrestrial fungi is not inhibited by salt concentrations equal to
those found in the marine environment. Since a selective medium could not be obtained
by adding salt, media poor in nutrients, and media supplemented with cyclosporine A
(Dreyfuss, 1986) were used. These conditions hindered fast-growing isolates and led
to the isolation of slow growing fungi otherwise not obtained.
5.1.1 Taxonomy of the fungal isolates
The majority of fungi isolated belonged to genera of mitosporic fungi. The number of
strains identified as Ascomycetes was considerably lower, despite the fact that to date
higher filamentous marine fungi have been reported primarily to be members of genera
of the Ascomycetes (Kohlmeyer & Volkmann-Kohlmeyer, 1991). Although it can be
assumed that most of the mitosporic fungi isolated are in effect Ascomycetes, the
taxonomy of the isolates suggests that these are not obligate marine fungi. The only
two obligate marine fungi, Asteromyces cruciatus and Phialophorophoma litoralis,
obtained during this part of the current study were mitosporic fungi. The fact that not
more obligate marine fungi have been obtained may be due to one or more of the
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following reasons: 1) The obligate marine fungi described so far have been rarely
isolated from the substrate sponge. 2) Marine Ascomycetes are best isolated using
direct isolation methods, e.g., searching for ascomata which have developed on natural
substrates, predominately wood (Kohlmeyer & Kohlmeyer, 1979). 3) In pure culture,
as is the case for many terrestrial Ascomycetes, many marine Ascomycetes produce
only their conidial state or no spores at all (Hyde Farrant & Jones, 1987), which means
that their fruiting bodies will not be obtained and they thus can at best be identified as
their anamorphs.
The 681 fungal strains isolated belonged to 13 genera of Ascomycetes, two genera of
Zygomycetes and 38 genera of mitosporic fungi. The isolates of many genera
obviously represented several different species. Except for members of the genera
Aspergillus (Abrell, Borgeson & Crews, 1996a; Varoglu et al., 1997), Cladosporium
(Höhnk & Ulken, 1979), Fusarium (Siepmann & Höhnk, 1962; Höhnk & Ulken,
1979), Microascus (Yu et al., 1996a), Microsphaeropsis (Keusgen et al., 1996; Yu
et al., 1996b), Penicillium (Höhnk & Ulken, 1979) and Trichoderma (Kobayashi
et al., 1993; Amagata et al., 1998), members of all other genera have so far not been
reported from marine sponges. The great taxonomical variety of the fungal isolates
obtained in this study raises the question of their "true" origin.
5.1.2 "True" origin of the fungal isolates
Dealing with the "true" origin of the fungi isolated, two major possibilities have to be
considered: The fungus could have been growing in the sponge, e.g., as a symbiont, or
it was inactive and present merely by chance, most probably filtered of the surrounding
water by the sponge. This differentiation cannot be made unambiguously for each
strain obtained, but some trends are obvious. Presuming the presence of symbiotic or
associated fungi, it is likely that these species dominate by number in their hosts and, if
at all capable to grow under the applied conditions in vitro, would have been obtained
predominantly. Such a dominance of isolates of one or few species isolated only from a
single sponge sample was not observed. The great variety of species, and the moderate
difference between the spectra of isolates obtained from sponges of the same
geographic origin, favours the possibility that the fungi have been filtered of the water
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by the sponges. This might have occured in form of spores, which remained able to
germinate and grow under laboratory conditions. The presence of such propagules in
the sea water at different sites is well established (e.g., Roth, Orpurt & Ahearn, 1964;
Schaumann, 1974; Miller & Whitney, 1981). In one of these studies (Schaumann,
1974), 495 isolates from sediment, water and air samples from the North Sea and
North-East-Atlantic were reported, and "the majority of species is identical with well
known and widespread terrestrial fungi". Members of the genera Aspergillus,
Cladosporium, Doratomyces, Fusarium, Penicillium and Verticillium were reported
to be among the most common isolates. These findings suggest the presence of similar
fungi also for the sea around Helgoland and other oceans. If they were present in the
water, it is likely that they were filtered of and accumulated by the sponges. In effect,
members of all the genera mentioned above were also obtained in the current study
from sponge samples from Helgoland; among them Fusarium, Penicillium and
Verticillium ssp. were obtained in a great variety.
Not only land-born fungi, but also marine species are present in sea water and can
therefore be filtered of by the sponges. In this respect, the unexpected isolation of eight
strains of Asteromyces cruciatus from the sponge Halichondria panicea may also be
the result of sea water containing conidia of this fungus. A. cruciatus is known as a
saprobic marine fungus (Kohlmeyer & Kohlmeyer 1979) and has frequently been
isolated from decaying algae.
There is some further evidence substantiating the proposition that most fungal strains
isolated originated in fact from the seawater. Although the number of fungal isolates
from each sponge sample is, due to modified experimental conditions, not strictly
comparable in a quantitative sense, it is obvious that sponges from Australia and
Tenerife yielded only few isolates compared to those from the other locations. This can
be interpreted as the result of low concentrations of spores in the water at these
collection sites. However, the possibility that antifungal metabolites produced by the
sponges are involved must also be considered.
Finally, it is important to mention that none of the reports dealing with the chemistry of
sponge-derived fungi contains direct evidence that the fungus in question had been
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actively growing in the host sponge (cf. 1.3.3, literature cited in Table 2). Thus, the
possibility that these fungal isolates were also filtered of the water by the sponges is
likely.
Overall it is presumed that most fungi isolated during this study were inactive in the
sponges and filtered of the water: They may be terrestrial species washed or blown into
the sea, or they may represent facultative or even obligate marine species. To date, no
experimental procedure is known to show if a selected strain is a terrestrial or
facultative marine fungus, other than to observe in vivo, that is in the marine
environment, its ability to grow. On the basis of in vitro studies, it can therefore only
be suggested that, e.g., some Phoma isolates which were obtained during this study
from sponge samples from Helgoland, and which were found to sporulate only on
media supplemented with ASW, are facultative, or even obligate marine species. Thus,
a clear distinction between terrestrial and facultative marine strains obtained in this
study is not possible. It is most likely, however, that the majority of the obtained fungal
isolates are terrestrial fungi, able to grow under the applied isolation conditions, and
facultative marine fungi.
5.2 Isolation and taxonomy of fungal strains from algae
The usual method for the isolation of algae-inhabiting marine fungi is the microscopic
examination of the algal thallus, sometimes after an incubation period in the laboratory,
for fungal growth, and the separation and inoculation of single fungal spores (e.g.,
Kohlmeyer & Kohlmeyer, 1979; Nakagiri, 1993; Nakagiri & Ito, 1997). This method
proves the isolate in question to be active in vivo in the alga, but implies that the
fungus is sporulating and visible on its host. In contrast to this, in the current study it
has been attempted to isolate endophytic fungi, causing no obvious symptoms on the
algae.
As for marine sponges, surface sterilisation with EtOH (Schulz et al., 1993) has been
attempted. Algae investigated, which possessed thin thalli, proved to be very sensitive
towards the sterilisation agent. It must therefore be presumed that their tissue, and
therefore also the endophytic fungi, are destroyed much easier than fungal spores
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present by chance on the surface of the algae. Thus, this method is applicable only to
algae possessing a sturdy surface.
A further problem arose from the possibility, that fungi originally present only on the
surface of the algae may have grown into the algal tissue during transport and storage.
Such fungi cannot be differentiated from endophytes even if surface sterilisation was
sufficient.
The isolated fungi represented 19 genera of mitosporic fungi, four genera of
Ascomycetes, and one genus of Zygomycetes. Only one obligate marine (algicolous)
fungus, Varicosporina ramulosa, was obtained.
Members of the genera Acremonium (Chen et al., 1996), Aspergillus (Belofsky et al.,
1998), Fusarium (Chen et al., 1996), Leptosphaeria (Takahashi et al., 1994a and b,
1995) and Penicillium (Numata et al., 1993, 1996; Takahashi et al., 1996; Iwamoto
et al., 1998; Amagata, Minoura & Numata, 1998a) have previously been reported
from algae in publications dealing with the chemistry of these isolates. Similar strains
were also obtained in the current study. The results also agree with the spectrum of
fungal genera obtained in a study of fungi from seaweeds off the Spanish coast
(Genilloud et al., 1994).
Additionally, some similarities were obvious concerning the spectrum of fungal genera
isolated from sponge and algal samples of the same geographic origin. Representatives
of the majority of all genera were obtained both from sponge and algal samples. These
findings suggested that most fungi isolated originated from the sea water and were
present only on the surface of the algae.
5.3 Biological activity of extracts from sponge-derived fungi
Due to the large number of isolates, only some strains could be tested for antimicrobial
activity of their extracts, and a lower number for inhibition of HIV-1 RT and TK. The
results are therefore, striktly spoken, not representative for all sponge-derived fungi
obtained. It must be stressed, that members of ubiquitous genera, such as
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Acremonium, Aspergillus and Penicillium which possess a well known secondary
metabolite production, were not investigated in order to avoid the re-isolation of
known metabolites. As these fungi are also known for the production of antimicrobial
compounds, the percentage of extracts active in the agar diffusion assays might have
been even higher. Nevertheless, the results obtained with the selected fungi
demonstrated that a large number of strains, that is 81.5 %, produced antimicrobially
active natural products. In comparison, 53 % of the phytopathogens, 70 % of the soil
isolates and 91 % of the fungal endophytes that were tested using the same test
organisms were found to have antimicrobial activity, (Schulz et. al., 1999). The
predominant antimicrobial activity of sponge-derived fungi was directed towards fungi
and the alga C. fusca. In this respect it is interesting to note that the culture extracts of
endophytes also predominately inhibited the alga and fungal test organisms (Schulz et.
al., 1999). The relatively high proportion of active culture extracts from sponge-
derived isolates suggested that they are also creative producers of biologically active
metabolites.
The percentage of Coniothyrium and Phoma strains whose extracts showed
antimicrobial activity was very high, 100 % and 86 %, respectively (see 4.2.1.1,
Table 5). TLC analysis of these extracts showed that the strains produced rather
complex mixtures of substances. These results suggested that especially isolates of
these genera are promising sources for biologically active secondary metabolites. Since
the genus Phoma consists of about 2000 species or more (Sutton, 1980), a large array
of secondary metabolites is likely. To date, according to the Chapman & Hall natural
products data base, about 80 compounds from only 21 Phoma sp. have been
described, eight of the producing strains have not been identified to the species level
(Buckingham, 1996). From the genus Coniothyrium, 23 compounds have been
described from only three strains (e.g., Krohn et al., 1992; Krohn et al., 1994).
The most active extracts in the agar diffusion assays, originating from 27 fungal
strains, were further investigated for cytotoxicity towards KB cells, for inhibition of
Mycobacterium tuberculosis, and in ELISAs for the inhibition of tyrosine kinase and
HIV-1 reverse transcriptase. Whereas the assays for antimicrobial activity and
cytotoxicity are whole cell test systems which do not allow the molecular targets
Discussion106
responsible for the observed inhibition to be directly determined, enzymatic assays can
directly reveal specific activities.
Extracts of six strains exhibited significant activity when tested for cytotoxicity
towards KB cells (IC50 < 20 µg/mL) and against Mycobacterium tuberculosis
(inhibition > 90 % at 100 µg/mL), with two extracts being active in both assays.
Together with the results obtained from the agar diffusion assays, this suggested that in
some extracts metabolites with specific activity and no general toxicity were present.
HIV-1 reverse transcriptase and tyrosine kinase are important target enzymes for the
treatment of AIDS and cancer, respectively (e.g., Chang & Geahlen, 1992; Mitsuya &
Broder, 1987). Extracts of 37 % of the investigated fungal strains showed significant
activity in these enzyme assays. In five cases both enzymes were inhibited. This may, of
course, be interpreted as an unspecific activity. Specific activity was observed for two
strains against tyrosine kinase and for three strains against HIV-1 reverse transcriptase.
Although the number of tested strains was low and the concentration of the active
compound(s) in the extracts is not known, the results certainly suggest that further
investigations are warranted.
5.4 Biological activity of extracts from algal-derived fungi
The number (22) of algal-derived fungal strains tested for their production of
biologically active metabolites was considerably lower than the number (92) of sponge-
derived strains tested. From most genera only one species was tested, and only agar
diffusion assays for antimicrobial activity were performed. A moderate overall activity
of 63.6 % was observed. Nevertheless, extracts of four strains of Mycelia sterilia
prominently and selectively inhibited B. megaterium. The potential of these algal-
derived fungi to produce interesting secondary metabolites will have to be further
evaluated by chemical investigations.
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5.5 Metabolites from sponge- and algal-derived fungal strains and their
biological activity
From extracts of 11 fungal strains, 39 pure compounds, including 30 secondary
metabolites were isolated. Six compounds, (+)-2,4-dimethyl-4,5-dihydrofuran-3-
carbaldehyde (10), (3S)-(3’,5’-dihydroxyphenyl)butan-2-one (16), 2-((1’E)-propenyl)-
octa-(4E,6Z)-diene-1,2-diol (17), microsphaeropsisin (26), ulocladol (39) and 9,10-
dihydro-(6R,11R,12R,14R)-colletodiol (46) proved to be new structures, and further
three compounds, (3S,5R)-dimethyl-dihydrofuran-2-one (11), 5,7-dimethoxy-4,6-
dimethylphthalide (33) and 9,10-dihydro-(6R,11S,12S,14R)-colletodiol (45), were for
the first time obtained as natural products. 22 secondary metabolites were obtained
from sponge-derived fungal strains to a total of about 40 so far reported from such
fungi (see 1.3.3, Table 2). Only R-mellein (27) has previously been reported from a
sponge-derived fungus, Aspergillus ?ochraceus (Abrell, Borgeson & Crews, 1996a).
The majority of all metabolites evaluated during this study exhibited biological,
predominantly antimicrobial activity, thus explaining, or at least contributing to, the
initially observed activity of the corresponding extracts. These results certainly justify
further investigations of other fungal strains obtained.
5.5.1 Primary metabolites
Out of the 39 isolated compounds, 9 are supposed to be primary metabolites, or at
least to be closely related to them. The most common metabolites derived from two
obligate marine fungi: D-arabitol (13), D-mannitol (14), D-trehalose (15) from
Asteromyces cruciatus and ergosterol (47) from Varicosporina ramulosa. Ergosterol
is one of the main fungal sterols, and the other three metabolites are also frequently
encountered in fungi. D-arabitol and D-mannitol have been reported to be accumulated
in the mycelium of marine fungi in order to balance the osmotic pressure of the salt
water (Clipson & Jennings 1992), while D-trehalose is a common fungal carbohydrate,
important e.g. as a reserve compound (Pfyffer, 1998).
Tri-O-acetyl-glycerol (12) from A. cruciatus, 1-O-oleyl-glycerol (34) and 1-O-linoleyl-
glycerol (35) from Monochaetia sp., and 2-phenylethanol (21) and
Discussion108
2-(p-hydroxyphenyl)ethanol (22) are closely related to common primary metabolites.
According to literature data (Chapman & Hall and Beilstein data bases; Turner &
Aldridge, 1983) out of the three glycerides, only 1-O-linoleyl-glycerol has previously
been reported from a fungal source, namely as a sporogenic metabolite from Sclerotina
fructicola (Katayama & Marumo, 1978). In the current study, compounds 34 and 35
have been shown to possess antimicrobial activity against E. repens and M. violaceum
in agar diffusion assays, obviously contributing to the observed antimicrobial activity
of the crude extract of the Monochaetia sp. Compounds 21 (2 phenylethanol) and 22
(2-(p-hydroxyphenyl)ethanol) both exhibiting antimicrobial activity, are presumably
degradation products of phenylalanine and tyrosine. They have been previously
reported from various fungi, e.g., Turner & Aldridge (1983).
5.5.2 Secondary metabolites
30 of the isolated compounds most probably represent secondary metabolites, and
include polyketides, terpenes and metabolites of mixed biosynthetic origin.
5.5.2.1 Macrodiolides
Five structurally related macrodiolides (42-46) were obtained from culture extracts of
the obligate marine fungus Varicosporina ramulosa. These metabolites formally
consist of a triketide and a tetraketide unit. 9,10-Dihydro-(6R,11S,12S,14R)-
colletodiol (45) and 9,10-dihydro-(6R,11R,12R,14R)-colletodiol (46) are new fungal
metabolites, 45 being first reported as an intermediate in the total synthesis of 42 (Ohta
et al., 1993). The other three were already reported from terrestrial fungi,
grahamimycin A1 (42) from an isolate of the genus Cytospora (Gurusiddaiah &
Ronald, 1981), and colletoketol (43; MacMillan & Simpson, 1973) and
(6R,11R,12R,14R)-colletodiol (44; Grove, Speake & Ward, 1966) from the plant
pathogen Colletotrichum capsici. In contrast to the prominent antimicrobial activity of
42 and 43 (as grahamimycin A, Gurusiddaiah & Ronald, 1981), no biological activities
have been reported for colletodiol. Its abundant production of 105 mg/L medium
suggests a biological function yet to be discovered.
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5.5.2.2 Tetraketides
Three metabolites, aurantiogliocladin (9), 7-hydroxy-5-methoxy-4,6-dimethylphthalide
(32) and 5,7-dimethoxy-4,6-dimethylphthalide (33) presumably are tetraketides.
Compound 9 was obtained in the current study from an Acremonium sp. It was first
reported as an antibacterial agent from a Gliocladium sp. (Brian et al., 1951). A
similar activity against B. megaterium and additional antifungal activity against
M. mycotypha and M. violaceum was observed in the current investigation.
The two phthalide-derivatives (32 and 33) were obtained from a Monochaetia sp. Both
compounds showed antifungal activity in agar diffusion assays, contributing to the
antifungal activity of the crude extract. Phthalide-derivatives are widespread fungal
metabolites and have been reported with great structural diversity (e.g., Achenbach,
Mhlenfeld & Brillinger 1985). Compound 32 was first described as an antifungal
metabolite from a Hansfordia sp. (Schneider, Anke & Sterner, 1997), while compound
33 has been first obtained as a natural product in this study. So far it had been only
described as the methylation product of both 5-hydroxy-7-methoxy-4,6-
dimethylphthalide and 5,7-dihydroxy-4,6-dimethylphthalide, compounds isolated from
Aspergillus duricaulis (Achenbach, Mhlenfeld & Brillinger 1985).
5.5.2.3 Pentaketides
A major group of common fungal metabolites contains mellein (27), and its derivatives
and biosynthetic analogues. In this study a Coniothyrium sp. (18-20) and a
Microsphaeropsis sp. (27-31) yielded such compounds.
Pentaketides of the mellein-type are frequently reported from various fungi, often with
prominent biological, predominantly antimicrobial, activity. (-)-Mellein (27) was first
described in 1933 from Aspergillus melleus (Nishikawa, 1933a and b). Since then both
stereoisomers have been frequently reisolated (e.g., Krohn et al., 1997; Turner &
Aldridge, 1983), including also a report from a sponge-derived A. ?ochraceus strain
(Abrell, Borgeson & Crews, 1996a). The mellein derivatives (3R)-6-methoxy-7-
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chloromellein (19), (3R,4S)-hydroxymellein (28) and (3R,4R)-hydroxymellein (29) also
represent typical fungal metabolites, first isolated from Septoria nodorum (Devys et
al., 1992), Lasiodiplodia theobromae (Aldridge et al., 1971) and Sporormia affinis
(McGahren & Mitcher, 1968). In contrast, (3R)-6-methoxymellein (18) was first
reported from stored carrots (Sondheimer, 1957), and has since been described both as
a fungal metabolite (e.g., McGahren & Mitcher, 1968), and as a phytoalexin produced
by cultured carrot cells in response to fungal infection (Kurosaki & Nishi, 1983).
Cryptosporiopsinol (20) is biosynthetically related to mellein and thus also belongs to
this class of compounds (Giles & Turner, 1969; Holker & Young, 1975).
4,8-Dihydroxy-3,4-dihydro-2H-naphthalene-1-one (30) was first isolated from a
fungus of the genus Scytalidium and named 4,8-dihydroxytetralone (Findlay & Kwan,
1973). Stereoisomers have since then been reported not only from other fungi, e.g., as
(+)-isosclerone from Sclerotinia sclerotiorum (Morita & Aoki, 1974), but also from
the stem bark of the walnut tree Juglans regia as (-)-regiolone (Talapatra et al., 1988).
The unidentified compound 31 is obviously structurally related to 30 and also
presumed to belong to this group of metabolites.
Except for cryptosporiopsinol (20), all compounds tested, that is R-mellein (27),
(3R)-6-methoxymellein (18), (3R)-6-methoxy-7-chloromellein (19),
(3R,4S)-hydroxymellein (28), (3R,4R)-hydroxymellein (29) and 4,8-dihydroxy-3,4-
dihydro-2H-naphthalene-1-one (30), showed antifungal activity in the agar diffusion
assays. This finding in combination with the high content of R-mellein (27,
4.6 mg/L medium) and its two 4-hydroxyl-derivatives (28, 94 mg/L medium and 29,
11 mg/L medium) in the crude extracts investigated explains the activity observed in
the initial screening for antimicrobial activity. Their relatively high production, their
antimicrobial activity, and the fact that these metabolites are particularly common to
many fungi makes the selection of fungal strains for chemical investigations on the
basis of the agar diffusion assays alone difficult. It seems therefore to be advisable to
evaluate the presence of mellein-derivatives in extracts prior to further chemical
investigations.
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5.5.2.4 Heptaketides
Compounds 1233A (37), 38, ulocladol (39), botrallin (40) and 1-hydroxy-6-methyl-8-
hydroxymethylxanthone (41) are heptaketides.
From Ulocladium botrytis the new compound ulocladol (39) and a known xanthone-
derivative (41) have been obtained. Metabolites with a basic structure similar to 39
have been reported from several fungi, e.g., botrallin (40), the presence of which in the
current extract could only be tentatively determined, from Botrytis allii (Kameda et
al., 1974), and recently the 4-methoxyl-derivative of 39 from the lichen mycobiont of
Graphis scripta var. pulverulenta (Tanahashi et al., 1997). Xanthone-derivatives
similar to compound 41 are mainly known from higher plants, but have also been
reported from fungi with great structural variety (e.g., Turner & Aldridge, 1983). 41
was originally reported from Cyathus intermedius, a Basidiomycete (Ayer & Taylor,
1976).
The crude extract of U. botrytis showed the most prominent inhibition of all extracts
tested for their tyrosine kinase inhibitory activity. By bio-assay guided fractionation it
was possible to isolate the new metabolite ulocladol (39) and to show that it
substantially contributed to this activity (93% inhibition of enzyme activity at
0.02 µg/µL).
Crude extracts of an isolate of Scopulariopsis candida were among the most active
extracts in the agar diffusion assays for antifungal activity. Bioassay-guided work-up
led to the isolation of 1233A (37), the by far most active antifungal metabolite
obtained in this study. Additionally, the inactive derivative 38 was obtained.
Compound 37 turned out to be originally reported from a Cephalosporium sp.
(Aldridge, Giles & Turner, 1971), and has been particularly comprehensively studied.
Its absolute configuration was determined by degradation studies and derivatisations
(Chiang et al., 1988). Additionally, a total synthesis (Chiang et al., 1989) and the
elucidation of its biosynthesis in a Scopulariopsis sp. (Kumagai, Tomoda & Omura,
1992) were reported. Investigations for biological activity revealed 37 to be the first
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specific inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A synthase, and to be an
inhibitor of cholesterol biosynthesis (Omura et al., 1987; Greenspan et al., 1987).
5.5.2.5 Terpenes
Only two terpenes, both being sesquiterpenes, have been obtained during this study,
microsphaeropsisin (26) from a Microsphaeropsis sp. and dihydrobotrydial (24) from
Emericellopsis minima.
Microsphaeropsisin is a new sesquiterpene of the eremophilane type. This structural
class of sesquiterpenes has been reported mainly from higher plants (Buckingham,
1996), but is also encountered in fungi, e.g., in Penicillium roqueforti (Moreau et al.,
1976) and the marine mitosporic fungus Dendryphiella salina (Guerriero et al., 1988,
1989, 1990). In most sesquiterpenes of the eremophilane type described to date
CH3-14 and CH3-15 are cis, indicating microsphaeropsisin (26) to be a rare
eremophilane derivative having these moieties trans configurated.
Dihydrobotrydial (24) was previously reported from Botrytis cinerea (Fehlhaber et al.,
1974), together with the similar botrydial, formally an oxidation product of 24.
Whereas for botrydial antimicrobial activity has been reported (Fehlhaber et al., 1974),
24 was inactive in similar tests. This could explain the observed differences in
antimicrobial activity of the extracts from E. minima. While the extract from the initial
small scale culture probably contained botrydial, it showed antifungal activity; the
extract from the up-scaled culture, which was investigated chemically, contained no
botrydial but its hydrogenation product 24, and was therefore inactive.
5.5.2.6 Compounds of mixed biosynthetic origin
The two metabolites fungerin (25) and pycnidione (36), obviously are of mixed
biosynthetic origin. From the molecular structure of fungerin its biosynthesis may
involve one isoprene unit and a histidine derivative, while pycnidione probably is
derived from polyketide and terpenoid precursors.
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Fungerin, from a Microascus sp. was the only nitrogen containing metabolite obtained
during this study. Literature data about this compound is inconsistent and confusing.
The metabolite seemed to be published twice with a different trivial name and structure
as to the location of the N-methyl group, but with identical spectroscopic data: as
visoltricin, isolated from a Fusarium sp., exhibiting toxicity against Artemia salina
larvae, cytotoxicity against selected human tumour cell lines and showing an
anticholinesterase activity (Visconti & Solfrizzo, 1994); and as fungerin isolated from a
different Fusarium sp., exhibiting antifungal activity (Kato et al., 1996). A recent total
synthesis (Benhida, Lezama & Fourrey, 1998) proved the structure determined by
Kato et al. to be correct. An antifungal activity, observed for the crude extract of the
Microascus sp. was also exhibited by the pure compound. 25 turned out to be the
second most active antifungal metabolite obtained in this study (Table 10). This finding
stands in good agreement with the reported antifungal activity (Kato et al., 1996).
Pycnidione (36) isolated in this study from the culture extract of a Phoma sp. derived
from a sponge-sample from Helgoland, was first reported from a Phoma sp.
originating from Micronesia (Harris et al., 1993). The C-8 epimer eupenifeldin was
described the same year by Mayerl et al. from Eupenicillium brefeldianum. For both
compounds prominent biological activities were reported, mainly cytotoxicity for
eupenifeldin and inhibition of stromelysin for pycnidione. Recently the re-isolation of
pycnidione together with two new derivatives has been reported from an unidentified
fungal strain originating from twigs out of a seasonal, deciduous alluvial forest from
Brazil (Cai et al., 1998). In the same study these compounds were shown to induce
erythropoietin expression in human cells. In the current investigations, pycnidione
showed prominent in vitro activity against different Plasmodium falciparum strains
with an IC50 of 0.2 µg/mL against the chloroquine resistant W2 strain. In the agar
diffusion assays only moderate activity against B. megaterium was observed.
5.5.2.7 Miscellaneous compounds
The remaining metabolites, (+)-2,4-dimethyl-4,5-dihydrofuran-3-carbaldehyde (10),
(3S,5R)-dimethyl-dihydrofuran-2-one (11), (3S)-(3’,5’-dihydroxyphenyl)butan-2-one
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(16), 2-((1’E)-propenyl)-octa-(4E,6Z)-diene-1,2-diol (17) and 2-(hydroxymethyl)furan
(23) are relatively small molecules, with 10, 16 and 17 being new compounds, and 11
being first reported as a natural product. Only 2-(hydroxymethyl)furan (23) has so far
been reported from fungi as a reduction product of furfural by yeasts (Windholz,
1983). A similar process may by involved in the current finding with furfural possibly
originating from the decomposition of media ingredients during autoclaving.
5.6 Chemical investigations of the sponge samples
In the course of this study (since 1995), a growing number of reports about secondary
metabolites from sponge-derived fungi has been published (see 1.3.3, Table 2). These
compounds appeared to be typical fungal metabolites, deriving from metabolic
pathways common to these organisms, and were clearly distinct from sponge
metabolites. It seemed thus unlikely, that fungi are playing an important role in the
production of metabolites found in sponges. Therefore only two sponge samples, parts
of which were used for the isolation of fungi in this study, were thoroughly
investigated chemically. This led to the isolation of eight pure compounds: taurine (1)
from Callyspongia sp. cf. C. flammea, 22-O-methyl derivatives of five sesterterpene
tetronic acids (2-6) from Ircinia oros, two of them, (8Z,13Z,18S,20Z)-strobilinin (2)
and (7E,12Z,18S,20Z)-variabilin (3) being new metabolites, a clathridine Zn complex
(8) and an as yet unelucidated metabolite (7) from Leucosolenia challengeri. Except
for taurine, these compounds were not related to known fungal metabolites.
Sesterterpene tetronic acids are commonly encountered in sponges of the order
Dictyoceratida (Demospongiae), mainly in the genera Ircinia, Psammocinia and
Sarcotragus, where they are reported to be of chemotaxonomic significance (Perry
et al., 1987; Bergquist, 1978). Many similar metabolites have been reported, differing
only in number, position and/or stereochemistry of the chain double bonds. Variabilin,
the first representative of a group of secondary metabolites termed variabilins,
sesterterpene tetronic acids with a ∆7,8 double-bond, was first reported from the
sponge Ircinia variabilis as an antimicrobial agent (Faulkner, 1973). Sesterterpene
tetronic acids of this type with a ∆8,10 double-bond are referred to as strobilinins; the
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basic structure of strobilinin without stereochemistry and double-bond geometry was
first described from Ircinia strobilina (Rothberg & Shubiak, 1975). In 1994 Davis &
Capon showed that the originally described strobilinin was in fact a mixture of two
isomers, namely (8E,13Z,20Z)- and (8Z,13E,20Z)-strobilinin. Several stereo-,
geometric and regioisomers of variabilin and strobilinin and other related types have
been described to date (Martinez et al., 1997; Gonzáles, Rodríguez & Barrientos,
1983; Shubiak, 1976; Barrow et al., 1988) and shown to possess antiviral and
cytotoxic activity (Barrow et al., 1988; Jacobs, White & Wilson, 1981).
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6 Summary
Higher filamentous fungi were isolated from marine sponges and algae. Their
taxonomy, the biological activity of their extracts, their secondary metabolite
production, and the biological activity of the obtained pure compounds were
investigated. Additionally, selected sponge samples were investigated chemically.
Out of 16 sponge samples from six different locations, Australia (Bear Island and The
Great Barrier Reef), Dominica (Caribbean), Helgoland (North Sea, Germany), Malta
and Tenerife (Spain), 681 fungal strains, representing 53 genera (38 genera of
mitosporic fungi, including two clearly obligate marine fungi, 13 genera of
Ascomycetes, two genera of Zygomycetes), and 37 strains of Mycelia sterilia, were
isolated. Representatives of most of these fungal genera have thus far not been
reported from marine sponges. The taxonomy and diversity of the isolated fungal
strains suggested, however, that the majority of them were not associated with the
host-sponge, but had been simply filtered from the sea water. These isolates were most
likely to be mainly terrestrial and facultative marine species.
In order to enable preliminary investigations of their biologically active secondary
metabolite production, 92 sponge-derived fungal strains were chosen for small scale
cultivation on different media. EtOAc extracts of 75 strains (81.5 %) showed
antimicrobial activity in agar diffusion assays for antibacterial, antifungal and antialgal
activity. Extracts of 27 strains were further tested in different assays: Extracts of six
strains showed significant cytotoxicity towards KB cells, and further six exhibited
prominent Mycobacterium tuberculosis inhibition. HIV-1 reverse transcriptase was
inhibited by extracts of eight strains, and tyrosine kinase by extracts of seven strains.
Out of 10 algal samples from Tenerife (Spain) and Helgoland (Germany) 105 fungal
strains, representing 25 genera (four genera of Ascomycetes, one genus of
Zygomycetes, 19 genera of mitosporic fungi, including one obligate marine fungus)
and seven strains of Mycelia sterilia, were isolated. Agar diffusion assays showed
extracts of 14 (63.6 %) out of the 22 algal-derived strains investigated to have
antimicrobial activity.
Summary 117
Extracts of 11 fungal strains, including 10 sponge-derived and one algal-derived strain,
were investigated chemically. This investigation resulted in the isolation and structure
elucidation of 39 pure compounds, including 30 secondary and 9 primary metabolites.
Six compounds, (+)-2,4-dimethyl-4,5-dihydrofuran-3-carbaldehyde (10), (3S)-(3’,5’-
dihydroxyphenyl)butan-2-one (16), 2-((1’E)-propenyl)-octa-(4E,6Z)-diene-1,2-diol
(17), microsphaeropsisin (26), ulocladol (39) and 9,10-dihydro-(6R,11R,12R,14R)-
colletodiol (46) proved to be new compounds, and a further three compounds were
obtained for the first time as natural products: (3S,5R)-dimethyl-dihydrofuran-2-one
(11), 5,7-dimethoxy-4,6-dimethylphthalide (33) and 9,10-dihydro-(6R,11S,12S,14R)-
colletodiol (45).
From the three sponge species investigated eight pure compounds were isolated,
including 22-O-methyl derivatives of the two new sesterterpene tetronic acids
(8Z,13Z,18S,20Z)-strobilinin (2) and (7E,12Z,18S,20Z)-variabilin (3).
The antimicrobial activity of 28 compounds was investigated in agar diffusion assays:
22 were found to possess antifungal, three antibacterial, and two antialgal activity.
These findings explained in many cases the previously observed activity of the
corresponding fungal crude extracts. Two of the isolated metabolites exhibited
additional prominent biological activities: the new compound ulocladol (39) inhibited
tyrosine kinase (93% inhibition of enzyme activity at 0.02 µg/µL), and pycnidione (36)
showed an in vitro antimalarial activity against the Plasmodium falciparum strains
FCR3F86, W2 and D6 with IC50 values of 0.3, 0.2 and 0.4 µg/mL, respectively.
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O
O
O
(8Z,13Z,18S,20Z)-22-O-Methyl-strobilinin (2)
(7E,12E,18S,20Z)-22-O-Methyl-variabilin (4)
(7E,13Z,18S,20Z)-22-O-Methyl-variabilin (5)
O
O N
N
N
NN
O
O
Zn2+
2
Clathridine Zn complex (8)
O
O
O
O
Aurantiogliocladin (9)
O
O
OHC
O
(+)-2,4-Dimethyl-4,5-dihydrofuran-
3-carbaldehyde (10)
(3S,5R)-Dimethyl-
dihydrofuran-2-one (11)
O
O
O
O
O
O
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CH2OH
HO
OH
OH
CH2OH
HO
OH
OH
CH2OH
CH2OH
HO
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HO
H
HO H
O
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H H
HO
O H
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H
OHH
HO
HH
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D-Trehalose (15)
O
O
O
O
O
O
O
O
(7E,12Z,18S,20Z)-
22-O-Methyl-variabilin (3)
(7Z,12Z,20Z)-22-O-Methyl-variabilin (6)
Figure 9: Metabolites 1-6 and 8-15 isolated during this study.
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OHHO
O
(3S)-(3’,5’-Dihydroxyphenyl)-
butan-2-one (16)
OH
OH
2-((1’E)-Propenyl)-octa-
(4E,6Z)-diene-1,2-diol (17)
O
OOH
R1R2
R4
R3
R1   R2   R3   R4
H     H     H      H    R-Mellein (27)
OH  H     H      H    (3R,4S)-Hydroxymellein (28)
H     OH  H      H    (3R,4R)-Hydroxymellein (29)
H     H    OMe  H    (3R)-6-Methoxymellein (18)
H     H    OMe  Cl   (3R)-6-Methoxy-7-chloro-mellein (19)
Cl
OH
Cl
HO
Cryptosporiopsinol (20)
O O
O
OHOH
OH
OH
2-Phenylethanol (21) 2-(p-Hydroxyphenyl)-
ethanol (22)
2-(Hydroxymethyl)furan (23)
O
OH
HO
HO
O
Dihydrobotrydial (24)
N
N
OO
Fungerin (25)
O
OHO
O
Microsphaeropsisin (26)
OOH
OH
4,8-Dihydroxy-3,4-dihydro-
2H-naphthalene-1-one (30)
HO
OH
O R
1-O-Oleyl-glycerol (34)  R = oleyl
1-O-Linoleyl-glycerol (35) R = linoleyl
O
O
O
O
HO
HO
H
H
OH
Pycnidione (36)
O
OO
R
O
7-Hydroxy-5-methoxy-4,6-dimethylphthalide (32)  R = H
5,7-Dimethoxy-4,6-dimethylphthalide (33) R = CH3
Figure 10: Metabolites 16-30 and 32-36 isolated during this study.
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Grahamimycin A1 (42) R1,R2=O; R3,R4=O
9,10-Dihydro-(6R,11S,12S14R)-colletodiol (45)
 R1 = R4 = H; R2 = R3 = OH
9,10-Dihydro-(6R,11R,12R,14R)-colletodiol (46)
 R1 = R4 = OH; R2 = R3 = H
9,10-Dihydro-(11R,12R)-di-(p-bromobenzoate)-
(6R,14R)-colletodiol (46a)
 R1 = R4 = p-bromobenzoate; R2 = R3 = H
3,4,9,10-Tetrahydro-(6R,11R,12R,14R)-
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OH
OOH
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OHOH
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O
OH O
O O
OH
O
OH
O
O
1-Hydroxy-6-methyl-8-hydroxy-
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OH
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O
O
OH
OH
O
O OH
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O
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 38 (tentative stereochemistry)
OO
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Figure 11: Metabolites 37-47 isolated during this study.
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8.2 1H NMR spectra of selected compounds
page
(8Z,13Z,18S,20Z)-22-O-Methyl-strobilinin (2) 129
(7E,12Z,18S,20Z)-22-O-Methyl-variabilin (3) 129
Clathridine Zn complex (8) 130
(+)-2,4-Dimethyl-4,5-dihydrofuran-3-carbaldehyde (10) 130
(3S,5R)-Dimethyl-dihydrofuran-2-one (11) 131
Tri-O-acetyl-glycerol (12) 131
(3S)-(3’,5’-Dihydroxyphenyl)butan-2-one (16) 132
2-((1’E)-Propenyl)-octa-(4E,6Z)-diene-1,2-diol (17) 132
Cryptosporiopsinol (20) 133
Dihydrobotrydial (24) 133
Fungerin (25) 134
Microsphaeropsisin (26) 134
(3R,4S)-Hydroxymellein (28) 135
(3R,4R)-Hydroxymellein (29) 135
4,8-Dihydroxy-3,4-dihydro-2H-naphthalene-1-one (30) 136
Unknown 2 (31) 136
1-O-Oleyl-glycerol (34) 137
1-O-Linoleyl-glycerol (35) 137
Pycnidione (36) 138
Ulocladol (39) 138
1233 A (37) 139
(38) 139
1-Hydroxy-6-methyl-8-hydroxymethylxanthone (41) 140
Grahamimycin A1 (42) 140
Colletoketol (43) 141
(6R,11R,12R,14R)-Colletodiol (44) 141
9,10-Dihydro-(6R,11S,12S,14R)-colletodiol (45) 142
9,10-Dihydro-(6R,11R,12R,14R)-colletodiol (46) 142
A "X" marks resonances due to an impurity.
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(7E,12Z,18S,20Z)-22-O-Methyl-variabilin (3)
400 MHz, CDCl3
O
O
O
O
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
(8Z,13Z,18S,20Z)-22-O-Methyl-strobilinin (2)
600 MHz, CDCl3
O
O
O
O
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
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Clathridine Zn complex (8)
300 MHz, CDCl3
O
O N
N
N
NN
O
O
Zn2+
2
(ppm)
2.62.83.03.23.43.63.84.04.24.44.64.85.05.25.45.65.86.06.26.46.66.87.07.27.4
(+)-2,4-Dimethyl-4,5-dihydrofuran-3-carbaldehyde (10)
400 MHz, CDCl3
O
OHC
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5
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(3S,5R)-Dimethyl-dihydrofuran-2-one (11)
400 MHz, CDCl3
O O
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
Tri-O-acetyl-glycerol (12)
300 MHz, CDCl3
O
O
O
O
O
O
(ppm)
2.02.42.83.23.64.04.44.85.25.66.06.46.87.2
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(3S)-(3’,5’-Dihydroxyphenyl)butan-2-one (16)
300 MHz, CDCl3
OHHO
O
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
2-((1’E)-Propenyl)-octa-(4E,6Z)-diene-1,2-diol (17)
300 MHz, CDCl3
OH
OH
(ppm)
2.02.42.83.23.64.04.44.85.25.66.06.46.87.2
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Cryptosporiopsinol (20)
400 MHz, CDCl3
Cl
OH
Cl
HO
O O
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
Dihydrobotrydial (24)
400 MHz, CDCl3
O
OH
H
O
HO
O
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
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Fungerin (25)
300 MHz, CDCl3
N N
O
O
(ppm)
2.02.53.03.54.04.55.05.56.06.57.07.58.0
Microsphaeropsisin (26)
300 MHz, CDCl3
O
O
HO
O
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
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(3R,4S)-Hydroxymellein (28)
300 MHz, CDCl3
O
OOH
OH
(ppm)
1.02.03.04.05.06.07.08.09.010.011.0
(3R,4R)-Hydroxymellein (29)
300 MHz, CDCl3
O
OOH
OH
(ppm)
1.02.03.04.05.06.07.08.09.010.011.0
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4,8-Dihydroxy-3,4-dihydro-2H-naphthalene-1-one (30)
300 MHz, CDCl3
OOH
OH
(ppm)
2.42.83.23.64.04.44.85.25.66.06.46.87.27.6
12.412.8
Unknown 2 (31)
300 MHz, CDCl3
(ppm)
2.42.83.23.64.04.44.85.25.66.06.46.87.27.6
14.414.815.2
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1-O-Oleyl-glycerol (34)
400 MHz, CDCl3
OH
OHO
O
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
1-O-Linoleyl-glycerol (35)
400 MHz, CDCl3
OH
OHO
O
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
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Pycnidione (36)
400 MHz, CDCl3
O
O
O
O
HO
HO
H
H
OH
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
Ulocladol (39)
300 MHz, CDCl3
O
O
OH
OH
O
O
OH
(ppm)
4.04.55.05.56.06.57.07.58.08.59.09.510.0
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1233 A (37), mixture with 2-(p-hydroxyphenyl)ethanol (21).
300 MHz, CDCl3
OO
OH
O
OH
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
38 (tentative stereochemistry)
400 MHz, CD3OD
HO
O
OH
O
OH
OH
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
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1-Hydroxy-6-methyl-8-hydroxymethylxanthone (41)
400 MHz, CDCl3
O
OH O
OH
(ppm)
3.04.05.06.07.08.09.010.011.012.0
Grahamimycin A1 (42)
300 MHz, CDCl3
O
O
O
O
O
O
(ppm)
1.52.02.53.03.54.04.55.05.56.06.57.0
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Colletoketol (43)
300 MHz, CDCl3
O
O
O
O
OH
O
(ppm)
1.52.02.53.03.54.04.55.05.56.06.57.0
(6R,11R,12R,14R)-Colletodiol (44)
300 MHz, CDCl3
O
O
O
O
OH
OH
(ppm)
1.52.02.53.03.54.04.55.05.56.06.57.0
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9,10-Dihydro-(6R,11S,12S,14R)-colletodiol (45)
400 MHz, CDCl3
O
O
O
O
OH
OH
(ppm)
1.52.02.53.03.54.04.55.05.56.06.57.0
9,10-Dihydro-(6R,11R,12R,14R)-colletodiol (46)
400 MHz, CDCl3
O
O
O
O
OH
OH
(ppm)
1.52.02.53.03.54.04.55.05.56.06.57.0
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Table 12: Results of the agar diffusion assays with extracts of fungal cultures;
for abbreviations and details see p. 151
Me- Inhibition (cm) against test organism
Fungal strain di-
um
E. c. B. m. M. v. E. r. F. o. M. m. C. f.
Aspergillus B n.t. n.t. n.t. n.t. n.t. n.t. n.t.
Ja23 Bs n.t. n.t. n.t. n.t. n.t. n.t. n.t.
Bfl - - 0.2 - - - -
Myxotrichum B - 0.3 0.2 - 0.2 - 0.5
deflexa Bs - 0.3 0.2 - 0.3 - 0.3
Ka12 Bfl* - 0.1 - 0.4 0.2 0.3 P
Monascus B - - 0.3 0.5 - - 0.5
K12 Bs - - 0.5 1.0 T - 0.2 0.3
Bfl - - 1.0 1.0 T - - 0.5
Microascus B* - 0.1 T 0.2 1.3 T - - -
K14 Bfl 0.2 - 0.3 - - - -
MS* - - - 1.5 T - - -
Ulocladium B* - 0.4 T 0.4 T - - 0.2 T -
botrytis MS - - 0.1 - - - -
193A4 Bfl - 0.2 - - - - -
Monochaetia B - - - - - - -
193A6 MS - - - - - - -
Bfl - - - - - - -
Monochaetia B - 0.2 - - - - -
193A18 MS - - 0.1 - - - -
Bfl - 0.1 0.1 - - - -
Monochaetia B - - 0.5 T 1.0 T 0.3 - -
193A20 MS* - 0.3 0.8 T 1.4 T 0.4 0.4 T -
Bfl - - 0.3 0.5 - 0.2 -
Leptosphaeria B - - - - - 0.2 T -
193A21 MS - 0.3 T 0.2 T - - 0.3 -
Bfl - - - - - - -
M. s. B - - - - - - -
193A23 MS - - - - - - -
Bfl - 0.1 - - - - -
Myrothecium B n.t. n.t. n.t. n.t. n.t. n.t. n.t.
rorideum MS - 0.8 T - - - - -
193A25 Bfl - 0.2 1.2 T 2.5 T - 0.5 3.0 T
Phoma B - 0.4 T 0.2 T 0.1 0.1 0.4 T -
193A26 MS - - - - - - -
Bfl - 0.1 0.2 T 0.1 0.1 0.4 T -
M. s. B* - 0.8 T 0.7 T 1.1 T 0.4 T 0.6 T 0.1
193A27 MS - 0.5 T 0.5 T 0.4 T 0.1 0.3 T -
Bfl - 0.2 - - - - -
Myrothecium B - - - - - - -
gramineum MS - 0.1 - - - - -
193A34 Bfl - 0.1 T - - - - -
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Table 12 continued; for abbreviations and details see p. 151
Me- Inhibition (cm) against test organism
Fungal strain di-
um
E. c. B. m. M. v. E. r. F. o. M. m. C. f.
Phoma B - 0.1 0.2 T - - 0.1 T -
193A35 MS - - 0.1 - - - -
Bfl - - - - - - -
Myrothecium B - - 0.1 T - - -
verrucaria MS 0.1 0.9 T 0.6 T 0.1 0.1 0.2 T -
193A45 Bfl - 0.3 - - - - -
M. s. B - - - - - - -
193A46 MS - 0.1 0.1 - - - -
Bfl - - - - - - -
Aplosporella B 0.2 - 2.0 0.3 - 0.5 0.3
193H1 Bs - - 0.3 0.5 - - 0.3
Bfl - - 0.3 0.5 - - 0.5
Coniothyrium B - - - 0.2 - - 0.3
193H3 Bs* - - - 0.3 - - 0.4
Bfl - - - 0.2 - - 0.1
M. s. B - 0.2 T 0.2 T - - - 0.5 T
193H5 Bfl - 0.2 0.1 - - - -
M. s. B - - 0.3 - - - -
193H6 MS - - - - - - -
Bfl - - 0.3 - - - -
M. s. B - 0.1 0.4 T - - 0.2 0.1
193H7 Bfl - - 0.3 T 0.1 - - -
M. s. B - 0.2 T - - 0.3 0.4 0.3
193H8 Bfl - - 0.1 0.3 - - -
Gliocladium B - - 0.2 0.3 0.2 0.3 0.2
193H15 Bs* 0.4 0.3 1.5 0.9 T 0.5 0.7 T 0.1
Bfl - - 0.2 - - - 0.5
Phoma B - - - 0.4 - 0.1 0.1
193H16 Bs - - 0.2 T 0.5 - 0.1 0.1
Bfl - 0.2 0.2 0.4 - 0.1 0.1
Cladosporium B - - - - - - -
193H17 Bfl - - 0.1 0.1 - - -
Phoma B - - - 0.2 - - -
193H19 MS - - - - - - 0.1 T
Bfl - - - 0.3 - - -
M. s. B - 0.1 0.3 0.3 0.1 - 0.1
193H28 Bfl - 0.1 0.4 0.1 - - 0.1
Sporothrix B - - - 0.3 - - -
193H29 Bs 0.2 0.3 - - - - -
Bfl - 0.5 0.3 T 0.3 - - -
M. s. B - - - 0.2 - 0.2 -
193H31 Bfl - - 0.1 - - - -
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Table 12 continued; for abbreviations and details see p. 151
Me- Inhibition (cm) against test organism
Fungal strain di-
um
E. c. B. m. M. v. E. r. F. o. M. m. C. f.
Coniothyrium B 0.4 0.4 T 0.5 T 0.5 - 0.1 0.3 T
193H34 Bs 0.2 - 0.3 T 0.5 - 0.1 0.2 T
Bfl 0.5 0.4 T 0.5 T 0.5 - 0.1 0.1 T
Coniothyrium B n.t. n.t. n.t. n.t. n.t. n.t. n.t.
193H36 Bs - - - 0.3 - - -
Bfl - - - 0.3 - - -
Aplosporella B - - - - - - -
193H38 Bs n.t. n.t. n.t. n.t. n.t. n.t. n.t.
Bfl - 0.1 T - 0.5 - - -
Coniothyrium B* - - 1.0 T 0.5 0.8 1.0 T 1.0 T
193H39 MS - - 0.3 0.3 - 0.3 -
Bfl - - 0.2 - - - P
Phoma B - - 0.2 0.2 - - 0.5
193H41 Bs - - - 0.2 - - 0.5
Bfl - - - 0.2 - - 0.5
Beauveria B 0.2 0.2 - - - - -
193H43 Bs - - - - - - -
Bfl 0.2 0.2 - - - - -
Coniothyrium B* - 0.1 0.3 T 0.5 0.5 - 0.2
193H44 Bs - - - 0.3 0.5 - 0.6
Bfl - - 0.5 T 0.2 0.3 - 0.7
Phoma B - - - - - - -
193H45 MS - 0.1 0.2 - - - 0.2
Bfl - 0.1 0.3 - - - 0.2
Phoma B - - - - - 0.2 -
193H48 MS - - - - - 0.2 -
Bfl - - - - - 0.2 -
Coniothyrium B - 0.3 T 0.3 0.5 - - 0.2
193H49 Bs - 0.2 0.2 0.5 - 0.2 0.5
Bfl - - 0.2 0.3 - - 0.3
Coniothyrium B - - 0.3 0.2 - - -
193H52 Bs - - 0.2 0.2 - - -
Bfl - - 0.2 0.3 - - -
Phoma B - - 0.3 - - - -
193H57 MS - - 0.3 0.5 - - -
Bfl - - 0.2 0.2 - - -
M. s. B* - 0.1 0.2 0.5 - 0.3 0.5 T
193H60 Bfl - - - - - - -
M. s. B - - - - - 0.2 -
193H64 Bfl - - 0.2 0.2 - - 0.3
M. s. B - - - - - 0.3 -
193H75 Bfl - - 0.2 0.2 0.1 - P
Phoma B - - - - - - -
193H76 MS - - - - - - -
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Table 12 continued; for abbreviations and details see p. 151
Me- Inhibition (cm) against test organism
Fungal strain di-
um
E. c. B. m. M. v. E. r. F. o. M. m. C. f.
Coniothyrium B n.t. n.t. n.t. n.t. n.t. n.t. n.t.
193H77 Bs - - 0.2 T 0.7 - 0.1 0.7 T
Bfl - 0.2 T 1.0 T 1.0 - 0.5 0.8 T
M. s. B n.t. n.t. n.t. n.t. n.t. n.t. n.t.
193H79 Bfl - - 0.2 0.2 0.1 - -
M. s. B - - 0.5 - - - -
193H82 Bfl - - 0.1 0.1 - - -
Ulocladium B - 0.6 T - - - - -
193I2 MS - 0.4 - - - - -
Bfl - 0.2 - - - - -
M. s. B - 0.2 - - - - -
193I10 MS 0.6 T - - - - - -
Bfl - 0.1 - - - - -
Phoma B - 0.2 - 0.4 - - 0.1
193I27 MS - - - - - - -
Bfl - - - - - - -
M. s. B 0.5 - - - - - -
193I28 MS - 0.2 0.2 - - - -
Bfl - - - - - - -
Phoma B - 0.2 - - - - -
193I31 MS - - - - - - -
Bfl 0.1 - - - - - -
M. s. B - 0.2 - - - - -
193I35 MS - - - - - - -
Bfl - 0.4 T - - - - -
M. s. B* - 0.3 0.4 T 1.2 T - 0.3 T 0.1
195I36 MS - - - - - - -
Bfl - 0.3 - - - - -
Stachylidium B n.t. n.t. n.t. n.t. n.t. n.t. n.t.
293K4 Bs n.t. n.t. n.t. n.t. n.t. n.t. n.t.
Bfl - - 0.2 0.5 - - -
Sporormiella B - - - 0.2 - - 0.2
293K5 Bs - - - 0.2 - - 0.5
Bfl - - - 0.2 - - 0.5
M. s. B - - - - - - -
293K6 Bfl - - - - - - -
M. s. B - 0.1 - - - - -
293K7 Bfl - - - - - - -
M. s. B - - - 0.3 - - -
293K8 Bfl - 0.2 0.3 0.3 0.3 - -
M. s. B* 0.5 T 2.8 T 3.0 T 1.9 T 0.1 T 0.9 T 0.1
293K9 Bfl 0.3 T 1.4 T 0.4 T 0.5 T - 0.2 T -
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Table 12 continued; for abbreviations and details see p. 151
Me- Inhibition (cm) against test organism
Fungal strain di-
um
E. c. B. m. M. v. E. r. F. o. M. m. C. f.
M. s. B n.t. n.t. n.t. n.t. n.t. n.t. n.t.
H1-1 Bfl - - 0.3 0.1 T - - 0.2
M. s. GPY - - 0.2 - - - -
H-2 MS - - 0.2 - - - -
Westerdykella B - 0.3 T - - - - -
H3-1 MS - - - - - - -
Bfl - - 0.2 - - - -
Gymnoascus B - 0.1 - - - 0.2 T -
H3-4 MS - 0.2 T 1.0 - - - 0.5
Bfl - - 0.2 - - 1.4 0.2
Phoma B - - 0.2 0.3 - - 0.3
H3-13 Bs - - 0.2 0.3 - 0.1 0.7
Bfl - - 0.2 0.2 - - 0.3
Phoma B - - - - - - -
H3-23 MS - - 0.3 - - - -
Bfl - 0.1 0.2 - - - -
Phoma B - - 0.3 0.2 - - -
H4-12 Bs - - - 0.5 - - -
Bfl - - - 0.2 - - -
Coniothyrium B/Bs - - 0.2 - - - -
H4-52 Bfl - - 0.2 T 0.1 - - -
Phoma B - 0.3 T 0.3 - - - 0.5
H4-71 MS - 0.5 T 0.3 0.5 - - 0.2
Bfl - - 0.2 - - - -
Phoma B - 0.2 - 0.2 - - 0.5
H4-77 Bs* - 0.3 T - 0.4 - - 0.6
Bfl - 0.2 T - 0.2 - - 0.3
Coniothyrium B - 0.2 - - - 0.2 -
H4-83 MS - - 0.3 - - - -
Bfl - 0.2 0.1 T 0.4 - 0.2 -
Coniothyrium B 0.3 T - - - - 0.5 0.2
H4-87 MS - - 0.2 - - - -
Bfl - - 0.2 T 0.2 - - 0.1
Beauveria B - - - - - - -
H5-6 Bs - 0.5 T - - - - 0.2
Bfl - 0.5 T - - - - 0.2
Drechslera B* - 0.1 2.0 1.0 0.3 0.5 T 0.1
H5-28 Bs 0.2 0.1 1.5 0.8 0.2 0.3 T 0.3
Bfl - 0.1 0.8 0.8 0.2 0.5 T 0.3
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Table 12 continued; for abbreviations and details see p. 151
Me- Inhibition (cm) against test organism
Fungal strain di-
um
E. c. B. m. M. v. E. r. F. o. M. m. C. f.
Micro- B* - 0.3 T 1.0 0.5 - - 0.3
sphaeropsis Bs - - - 0.3 - - 0.3
H5-50 Bfl - - - 0.3 - - 0.6
Phoma B - - 1.0 T - - - -
H5-58 MS - 0.3 T 0.3 T - - - 0.2
Bfl - - 0.2 - - - 0.3
Coniothyrium B - 0.2 - - - 0.2 -
H5-63 MS - - 0.5 T - - - 0.2
Bfl - 0.5 - - - 0.2 -
Preussia B* - 0.6 T 0.5 T 0.5 - - P
H5-73 MS - 0.5 T 0.3 0.2 - - -
Bfl - - 0.3 0.3 - - -
Phoma B - 0.2 - - - 0.3 -
H5-75 MS 0.3 - - 0.3 - - -
Bfl - 0.2 - - - 0.3 -
Phoma B 0.1 - - 0.3 - - -
H5-76 MS 0.3 - 0.2 0.3 - - -
Bfl - - 0.1 - - - 0.1
Coniothyrium B - - 0.3 - - 0.2 -
H5-78 MS - - - - - 0.2 0.5 T
Bfl - - - - - 0.2 -
Coniothyrium B* 0.2 - 0.4 T 0.5 - - 0.5 T
H5-80 Bs - - 0.2 0.4 - - 0.3
Bfl - - - 0.5 - - 0.1
Asteromyces B - - - - - - 0.2
cruciatus Bs - - - - - - 0.3
H5-81 Bfl* 0.2 0.2 0.2 - - - 0.5
Phoma B - - 0.2 0.2 - - 0.2
H5-83 Bs - - 0.3 0.5 - - 0.4
Bfl - - 0.2 0.2 - - 0.2
Phoma B - - 0.2 T 0.2 - - 0.7
H5-85 Bs - - 0.3 T 0.3 - - 0.5
Bfl - - - 0.5 - - 0.5
Niessla/ B* - 0.2 T 0.3 2.0 - - -
Monocillium MS* - - - 1.5 - - -
H6-9 Bfl - - - 1.0 - - 0.2
Gonatobotrys B 0.1 0.1 - - - - -
H6-15 Bs 0.1 - - - - - -
Bfl 0.1 0.2 - - - - -
Phoma B* - - 0.8 - - 0.2 T 1.2
H6-51 MS - - 0.3 - - 0.3 0.3
Bfl - - - - - - -
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Table 12 continued; for abbreviations and details see p. 151
Me- Inhibition (cm) against test organism
Fungal strain di-
um
E. c. B. m. M. v. E. r. F. o. M. m. C. f.
Microascus B - 0.2 2.5 T 1.7 T - 1.0 T -
H6-57 MS - 0.2 0.5 - - - -
Bfl - 0.2 - - - - -
Scopulariopsis B* - - 2.5 T 2.0 T - 1.3 T -
candida Bs 0.2 0.3 T 0.7 T 0.5 T - - -
H7-19 Bfl - - 2.0 T 1.5 T - 0.7 T -
Phoma B - - - 0.2 - - 0.3
H7-58 MS - - - 0.5 - - -
Bfl - - - 0.3 - - 0.2
Emericellopsis B* - 0.6 T 1.5 T 0.8 T 0.2 - 0.5
minima Bs - 0.3 T 1.2 T 0.5 T 0.2 - 0.3
H7-65 Bfl - 0.3 0.5 - 0.2 - 0.1
Drechslera B 0.1 - 0.8 0.3 - - 0.3
H8-31 Bs 0.1 - 1.0 - - - 0.2
Bfl 0.1 - 1.3 - - 0.2 0.3
Coniothyrium B* - - 0.3 0.3 - - 0.8 T
H8-42 Bs - - 0.2 0.3 - - 0.3
Bfl - - 0.3 0.5 - - 0.5
Beauveria B 0.1 - - - - - -
H8-49 Bs 0.2 - - - - - -
Bfl - - - - - - -
Coniothyrium B - 0.2 0.2 - - 0.2 0.5
H8-53 MS - - - - - 0.2 -
Bfl - - - - - - -
Phoma B - - 0.5 0.7 T - - 0.3
H8-54 Bs* - - 1.5 0.2 - 0.2 0.3
Bfl - - - 0.2 - - 0.5
Coniothyrium B* - 0.3 T 1.0 0.5 - - 0.3
H8-57 Bs - 0.3 T 0.5 0.3 - - 1.0
Bfl - 0.1 0.7 0.3 - - 0.7
M. s. B 0.9 T 0.6 T - 1.0 T - 1.0 T -
195-2 (I) MS n.t. n.t. n.t. n.t. n.t. n.t. n.t.
Bfl 0.3 0.3 T - 0.6 T - 0.4 T -
M. s. B 0.1 0.2 0.1 - - - 0.1
195-8 (Y) MS n.t. n.t. n.t. n.t. n.t. n.t. n.t.
Bfl - - - - - - -
Curvularia Bs - 0.1 - - - - -
195-9 (Y) MS - 0.1 - - - - -
Bfl - - - - - - -
Phoma B - - 0.2 - - - -
195-10 (Y) MS - - 0.3 - - - -
Bfl - - - - - - -
Appendix: 8.3 Results of the agar diffusion assays with extracts of fungal cultures150
Table 12 continued; for abbreviations and details see p. 151
Me- Inhibition (cm) against test organism
Fungal strain di-
um
E. c. B. m. M. v. E. r. F. o. M. m. C. f.
Alternaria B - - - - - - -
195-15 (I) MS 0.2 - 0.5 0.5 - - -
Bfl 0.2 - - - - - -
Ulocladium B - - - - - - -
195-18 (Y) MS - - - - - - -
Bfl - - - - - - -
Scoleco-
basidium Bs - - - - - - -
constrictum MS - - - - - - 0.1
195-19 (E) Bfl - - - - - - -
Phoma B - - - - - - -
195-22 (I) MS - - 0.2 - - - -
Bfl - 0.3 - - - - -
Varicosporina B - - - - - - -
ramulosa MS - - - - - - -
195-31 (L) Bfl - - - 0.2 T - - -
M. s. Bs - 1.0 T - - - - -
195-32 (I) MS - 1.1 T - - - - -
Bfl - 0.3 T - - - - -
Chryso-
sporium B - - 0.2 - - - -
195-38 (L) MS - - 0.2 - - - -
Bfl - - - - - - -
M. s. Bs - 1.4 T - - - - -
195-39 (I) MS - 1.0 T - - - - -
Bfl - 1.1 T - - - - -
Phialophoro-
phoma B* - - - - - - -
litoralis MS* - 0.4 T - - - - 0.3
195-40 (T) Bfl - - 0.2 - - - -
Drechslera B - - - - - - -
195-42 (Y) MS - - - 0.3 - 0.9 T -
Bfl 0.2 - - - - - -
Leptosphaeria B
195-43 (Y) MS* - - 1.4 T 1.5 T - 0.5 T 0.5
Bfl - - 0.2 - - - -
M. s. B - 0.5 T - - - - -
195-51 (X) MS - 0.5 T - - - 0.1 -
Bfl - 0.3 T - - - - -
Scoleco-
basidium B - - - - - - -
variabile MS - - - - - - -
195-54 (Y) Bfl - - - - - - -
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Table 12: Results of the agar diffusion assays with extracts of fungal cultures:
abbreviations and details.
Extracts were prepared, and agar diffusion assays were performed as described in the
materials and methods section. Applied amounts were ~250 µg extract per test disk.
Inhibition zones (cm) were measured from the edge of the filter disks.
Fungal strain:
Genus, and if determined species name of fungal strain tested, M. s. = Mycelia sterilia.
The code marks the sponge or algal sample from which the fungal isolate was
obtained, and the no. of the strain; e.g. 193H77 = fungal isolate no. 77 from the
sponge sample CT 193 H; H5-50 = fungal isolate no. 50 from the sponge sample H-5.
Strain Ja23 was isolated from sample CT 912 J, strains Ka12 and K14 were isolated
from sample CT 912 K. For strains from Tenerife, the origin is indicated in brackets;
e.g. 195-31 (L) = fungal isolate no. 31 from sample CT 195 L, for origin of samples
see 3.1.
Medium: B = solid biomalt medium; Bs = solid biomalt medium with ASW; MS =
solid malt extract soymeal medium with ASW; Bfl = liquid biomalt medium with ASW;
GPY = glucose peptone yeast extract medium; for media compositions see materials
and methods section.
Some fungal cultures were additionally extracted with n-BuOH. Both the EtOAc and
the n-BuOH extract were also tested for inhibition of tyrosine kinase and HIV-1
reverse transcriptase, for cytotoxicity towards KB cells and inhibition of
Mycobacterium tuberculosis. They are marked with an asterics (*) after the
abbreviation of the medium. If two media are marked, a 1:1 mixture of both resulting
extracts was tested. For results of the active extracts see 4.2.1.2.
Test organisms: E. c. Escherichia coli, B. m. Bacillus megaterium, M. v.
Microbotryum violaceum, E. r. Eurotium repens, F. o. Fusarium oxysporum, M. m.
Mycotypha microspora, C. f. Chlorella fusca.
T: complete inhibition, no growth in the indicated zone.
P: inhibition only on the test disk itself
- no inhibition observed
n.t. not tested
